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Deutsche Zusammenfassung
ABC-Transporter kommen in allen Organismen von Archaen, Bakterien bis hin zu Eukaryoten
vor. Sie sind an zahlreichen zellulären Prozessen beteiligt, z.B. an der Nährstoffaufnahme, am
Lipidtransport und der Antigenprozessierung. ABC-Transporter können eine Vielzahl chemisch
diverser Substrate, unter anderem Kohlenhydrate, Antibiotika, Lipide sowie Polypeptide und
Proteine mit mehr als 100 kDa Molekulargewicht durch zelluläre Membranen transportieren.
Die humanen ABC-Transporter werden nach Sequenzhomologie innerhalb der
ATP-Bindungskassette (ATP-binding cassette, ABC) in sieben Unterfamilien eingeteilt, die mit
ABCA bis ABCG bezeichnet werden. Grundsätzlich haben ABC-Transporter eine
Minimalzusammensetzung aus zwei Nukleotidbindedomänen (NBD), welche die Energie für
die Translokation zur Verfügung stellen und zwei wenig konservierten Transmembrandomänen
(TMD), die die Transporter in der Plasmamembran oder in intrazellulären Membranen
verankern und den Translokationspfad ausbilden.
Der humane ABC Transportkomplex ABCB9 wurde als lysosomaler Polypeptidtransporter
identifiziert. ABCB9 hat eine hohe Sequenzidentität zu TAP1 („transporter associated with
antigen processing 1“) und TAP2 und wird deshalb „TAP-Like“ (TAPL) genannt. In
lysosomalen Membranen organisiert sich TAPL als Homodimer, wobei sich das Monomer aus
der N-terminalen TMD mit 10 putativen Transmembranhelices fusioniert mit der C-terminalen
NBD zusammensetzt.
Von humanem TAPL wurden Orthologe in Invetrebraten, wie Caenorhaditis elegans und
Pflanzen, nachgeweisen, was auf ein hohes evolutionäres Alter von TAPL hindeutet. Humanes
TAPL wird in verschiedenen Geweben exprimiert, u.a. im zentralen Nervensystem und im
Herz. Auffallenderweise wird die Expression von TAPL während der Differenzierung von
Monozyten zu dendritschen Zellen und Makrophagen stark induziert, somit wird eine
Funktion von TAPL in der Antigenprozessierung vermutet. Allerdings ist dieser
Peptidtransporter nicht an den klassischen MHC Klasse I und II-Prozessierungswegen beteiligt.
Im Gegensatz zu TAP besitzt TAPL eine niedrige Affinität verbunden mit einer breiten
Längenspezifität (6mer bis zu 59mer) für die Substratpeptide. Grundsätzlich besitzen TAPL
und TAP ein ähnliches Substraterkennungsprinzip, da beide Transporter Peptide mittels
Peptidrückgrat, den freien N- und C-Termini und Seitenketteninteraktionen, binden.Deutsche Zusammenfassung
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Die zentrale Frage auf dem TAPL-Forschungsgebiet beschäftigt sich momentan damit, die
physiologische Bedeutung dieses Transporters aufzuklären. Um diese Fragestellung
beantworten zu können ist die Kenntnis der Substratspezifität von essentieller Bedeutung.
Die Ziele meiner Doktorarbeit waren (i) die funktionale Solubilisierung, Reinigung und
Rekonstitution von humanem TAPL in Liposomen. (ii) Des weiteren sollte die
Substratspezifität detailliert entschlüsselt werden. (iii) Die Generierung und Charakterisierung
einer Cystein-freien TAPL Variante sollte den Grundstein legen um den
Translokationsmechanismus und die Struktur aufzuklären. (iv) Weiterhin sollten Orthologe von
TAPL, Haf-4 und Haf-9 aus Caenorhabditis elegans, biochemisch charakterisiert werden, um
weitere Kenntnisse über die physiologische Funktion von humanem TAPL zu erhalten.
Da es nicht möglich war, an isolierten TAPL-haltigen Membranen die Substratspezifität von
TAPL zu entschlüsseln, wurde eine Prozedur bestehend aus Expresssion in Sf9 Insektenzellen,
unter Verwendung des Baculovirus Expressionssystems, Solubilisierung, Reinigung und
funktionaler Rekonstitution in Liposomen etabliert. Durch intensives „Screening“ von
Detergenzien zur Solubilisierung von TAPL kristallisierten sich die nicht-ionischen
Detergenzien Digitonin und n-Dodecyl-β-D-maltosid (DDM) bezüglich Langzeitstabilität und
Funktionalität von TAPL heraus. Für Digitonin konnte eine Solubilisierungseffizienz von 56%
und für DDM von 52% nachgewiesen werden, wohingegen n-Octyl-β-D-glucopyranosid
TAPL nur schwach solubilisiert (13%). Das Detergenz
3-[(3-Cholamidopropyl)dimethylammonio]-1-propansulfonat (CHAPS) solubilisierte TAPL
(40% Solubilsierungseffizienz), jedoch war TAPL in diesem Detergenz nicht stabil. Das
Detergenz Foscholin 14 zerstörte sogar den Homodimer. Nach Solubilisierung wurde TAPL in
einem zwei Stufen Prozess, bestehend aus Kationenaustauscher und
Metall-Affinitätschromatographie, mit einer maximalen Ausbeute von 500 µg TAPL/Liter
Insektenzellkultur gereinigt. Im Vergleich zu DDM konnte mit Digitonin eine höhere Reinheit
während der Reinigung erzielt werden. Der Oligomerisierungszustand von TAPL in der
Digitionin- bzw. DDM-Mizelle wurde durch Größenausschlußchromatographie und „blue
native“ PAGE untersucht. TAPL bildete einen Komplex mit einem apparenten
Molekulargewicht von 200 kDa aus, was auf einen Homodimer mit einem theoretischen
Molekulargewicht von 172 kDa hinweist.
Zur Charakterisierung des Peptidtransports wurde eine Rekonstitution von TAPL in
Liposomen etabliert. Dabei wurden die Liposomen mit Triton X-100 destabilisiert und die
Detergenzien mit „Bio-Beads“ entfernt. Nach der funktinonalen Rekonstitution wies TAPLDeutsche Zusammenfassung
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die gleichen kinetischen Parameter wie TAPL in Membranen von Insektenzellen auf. Der
KM-Wert für das Modelpeptid RRYC
fKSTEL (f steht für Acetamidfluorescein gekoppelt an
eine Cysteinseitenkette) konnte auf 10,5 ± 2,3 µM und für ATP auf 97,6 ± 2,7 µM bestimmt
werden. Somit ist die Funktionalität von rekonstituierten TAPL nicht beeinträchtigt.
Für den Peptidtransport konnte eine starke Abhängigkeit für die Lipidzusammensetzung
detektiert werden. Interessanterweise stellten sich Lipide von E. coli im Vergleich zu
Lipidextrakten aus Säugerzellen als bevorzugt heraus. Des weiteren zeigte sich, dass
Phosphatidylcholin, das meist verbreitete Lipid in eukaryontischen Zellen, einen
Dosis-abhängigen Effekt auf die Transportaktivität von TAPL hat. Die höchste
Peptidtransporteffizienz wurde in Liposomen bestehend aus 70% E .coli Lipidextrakt und 30%
(w/w) 1,2-dioleoyl-sn-glycero-3-phosphocholin (DOPC) nachgewiesen, höhere
Konzentationen von DOPC reduzierten die Pepitdtransporteffizienz. Des weiteren wurde
TAPL in Liposomen rekonstituiert bestehend aus rein synthetisch hergestellten
Phospholipiden. Dabei stellte sich heraus, dass Proteoliposomen aus 100% DOPC inaktiv
waren. Wurden allerdings DOPC mit negativ geladenen Phospolipiden
1,2-dioleoyl-sn-glycero-3-phosphat (DOPA) oder 1,2-dioleoyl-sn-glycero-3-phospho-L-serin
(DOPS) gemischt, so konnte eine Dosis-abhängige Transportaktivität festgestellt werden. Für
die ebenfalls negativ geladenen Lipide 1,2-dioleoyl-sn-glycero-3-phosphoethanolamin (DOPE)
und L-α-phosphatidylglycerol (PG) trat dieser Effekt nicht auf. Somit beeinflusst nicht nur die
Ladung der Lipide den Peptidtransport durch TAPL, sondern auch die spezifische Kopfgruppe
der Lipide.
Rekonstitutiertes TAPL zeigte eine spezifische ATP-Hydrolyseaktivität, welche durch
ortho-Vanadat inhibiert werden konnte. Die ATP-Hydrolyseaktivität in Proteoliposomen war
6-fach höher als in gereinigtem TAPL. Dieser Effekt könnte durch die erniedrigte
Proteinflexibilität auf Grund des lateralen Drucks und Krümmungsstress in den Liposomen
erklärt werden. Des Weiteren konnte eine durch Peptid stimulierte ATP-Hydrolyseaktivität
nicht nachgewiesen werden.
Nach funktionaler Rekonstitution und Charakterisierung von TAPL in Liposomen wurden mit
Hilfe von kombinatorischen D-Amino Peptidbibliotheken die Schlüsselpositionen für die
Substraterkennung identifiziert. Sowohl die N- als auch die C-terminale Position innerhalb des
Substratpeptids haben einen wesentlichen Einfluß auf die Substraterkennung. Die C-terminale
Position innerhalb des Peptids hat den stärksten Einfluss auf die Substraterkennung, da
kovalente Modifikationen den Peptidtransport drastisch reduzieren. Zusätzlich wiesen dieDeutsche Zusammenfassung
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N-terminalen Positionen 2 und 3 einen Einfluss auf die Peptidselektivität auf. Die weitere
Charakterisierung der Schlüsselpositionen mittels detaillierten Peptidbibliotheken ergab, dass
TAPL sowohl bei der N- als auch bei der C-terminalen Position positiv geladene, aromatische
oder hydrophobe Aminosäuren bevorzugt. Negativ geladene Aminosäuren, Asparagin und
Methionin sind nicht präferiert. Diese Selektivitätsregel für die Peptiderkennung durch TAPL
konnte für Peptide mit verschiedener Länge verifiziert werden. Diese Regel kann in Bezug auf
elektrostatische Interaktionen erweitert werden, da Substratpeptide mit einer positiven
Nettoladung effektiver transportiert werden als welche mit einer negativen Nettoladung. Diese
Ergebnisse deuten auf eine Interaktion von TAPL mit den Termini des Substratpeptids hin,
wobei Länge als auch die Aminosäuresequenz zwischen diesen Ankerpositionen promiskuitiv
sein können. Dadurch das die Peptide nur über zwei Seitenreste erkannt werden, wird
sichergestellt, dass ein Transporter eine Vielzahl verschiedenster Peptide transportieren kann
und somit nicht der limitierende Faktor in diesem Prozess darstellt.
Ein wichtiger Grundstein, um den Translokationsmechnismus und die Struktur von TAPL
aufzuklären, ist die Generierung einer Cystein-freien TAPL Variante. Durch gezielte
Mutagenese wurden acht Cysteine im TAPL Monomer durch Alanin bzw. Valin ersetzt. Die
Cystein-freie TAPL Mutante zeigte eine gleiche Peptidtransportaktivität wie TAPL Wildtyp.
Nach der Gewährleistung der Funktionalität von Cystein-freiem TAPL wurden einzelne
Cysteine an strategischen Positionen wieder eingeführt. Die eingeführten Cysteine hatten
keinen Einfluss auf die Faltung von TAPL, da alle TAPL-Varianten in vergleichbaren Mengen
exprimiert wurden und der Peptidtransport durch diese Mutationen nicht beeinflusst wurde.
Eine Ausnahme bildete die TAPL-Variante L701C, welche nahe der konservierten H-Schleife
in der NBD lokalisiert ist und eine signifikant reduzierte Transportaktivität aufweist.
Die orthologen TAPL Varianten in Caenorhabditis elegans, Half-4 und Haf-9, besitzen eine
Sequenzidentität von 40% mit humanem TAPL und 50% untereinander. Insbesondere Haf-4
scheint ein funktionales Homolog von humanem TAPL zu sein, da TAPL in Haf-4 defizienten
Tieren die Formierung von Darm-Granula wiederherstellt und die Lebenszeit von Nematoden
unter Hungerbedingungen auf Wildtyp Niveau erhöht. Für eine detaillierte Charakterisierung
der physiologischen Funktion und deren Substrate wurden Half-4 und Haf-9 mit Hilfe des
Baculovirussystems in Sf9-Insektenzellen exprimiert. Beide Proteine transportieren in
Abhängigkeit von ATP das Modelpeptid. Allerdings ist der Transport 10–20 mal geringer als
von TAPL. Interessanterweise scheinen diese Halbtransporter sowohl als Homodimere wie
auch als Heterodimere die Funktion als Peptidtransporter erfüllen zu können.Abstract
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Abstract
The transporter associated with antigen processing-like (TAPL) acts as a lysosomal
ATP-dependent polypeptide transporter with broad length selectivity. To characterize in detail
its substrate specificity, a procedure for solubilization, purification and functional
reconstitution of human TAPL was developed. TAPL was expressed in Sf9 insect cells with
the baculovirus expression system and solubilized from crude membranes. By intensive
screening of detergents, the mild non-ionic detergents digitonin and dodecylmaltoside were
found to be ideal for solubilization with respect to efficiency, long term stability, and
functionality of TAPL. TAPL was isolated in a two-step procedure with a yield of 500 μg/L
cell culture and, subsequently, reconstituted into proteoliposomes. The KM(pep) for the peptide
RRYC
fKSTEL (f refers to fluorescence label) and KM(ATP) were determined to be 10.5 ±
2.3 µM and 97.6 ± 27.5 µM, respectively, which are in the same range as the
Michaelis-Menten constants determined in the membranes. The peptide transport activity of
the reconstituted TAPL strongly depends on the lipid composition. Interestingly, the E. coli
lipids are prefered over other tested natural lipids extracts. Moreover, phosphatidylcholine, the
most abundant phospholipid in eukaryotic cells influenced TAPL activity in a dose dependent
manner. In addition, some negatively charged lipids like DOPA and DOPS increased peptide
transport activity with preference for DOPS. However, DOPE or egg PG which are also
negatively charged had no effect. It seems not only the charge but also the specific head group
of phospholipids that has impact on the function of TAPL.
With the help of combinatorial peptide libraries containing D-amino acid residues at defined
positions as well as bulky fluorescein labeled peptides, the key positions of the peptides were
localized to the N- and C-terminal residues with respect to peptide transport. The C-terminal
position has the strongest selectivity since modification at this position shows strongest impact
on peptide transport. Additionally, positions 2 and 3 of the peptide also have weak influence
on peptide selectivity. Subsequently, the residue preferences at the key positions were
systematically investigated by combinatorial peptide libraries with defined residues at certain
positions. At both ends, TAPL favors positively charged, aromatic, or hydrophobic residues
and disfavors negatively charged residues as well as asparagine and methionine. The residue
preferences at the key positions are valid for peptide substrates with different length,
indicating a general rule for TAPL selectivity. Besides specific interactions of both terminal
residues, electrostatic interactions are important, since peptides with positive net charge areAbstract
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more efficiently transported than negatively charged ones.
By size exclusion chromatography (SEC) and blue native PAGE, TAPL purified in the
presence of digitonin or dodecylmaltoside had an apparent molecular weight of 200 kDa
which is close to the theoretical molecular mass of the TAPL homodimer (172 kDa). The
purified and reconstituted TAPL showed specific ATP hydrolysis activity which can be
inhibited by orthovanadate. TAPL in proteoliposomes showed 6-fold higher ATP hydrolysis
than digitonin solubilized protein, indicating the phospholipids impact on TAPL function.
However, no peptide substrate stimulated ATPase activity was observed.
For site-specific labeling of TAPL, eight cysteines in each half transporter were replaced by
alanine or valine. The TAPL cys-less mutant showed the same peptide transport activity as
TAPL wt. Based on the functional TAPL cys-less mutant, seven single cysteine mutants were
introduced into strategic positions. All single cysteine mutants in the TMD did not influence
peptide transport, whereas the mutant L701C, which is close to the conserved H-loop motif,
displayed impaired transport.
TAPL orthologs Haf-4 and Haf-9 from Caenorhabditis elegans possess around 40% sequence
identities with TAPL and 50% with each other. Both proteins are putative half transporters and
reported to be involved in the intestinal granule formation (Bauer, 2006; Kawai et al., 2009).
To further understand the physiological functions of these two proteins, they were expressed
in Sf9 insect cells. Haf-4 and Haf-9 showed weak but specific ATP- and peptide-dependent
peptide transport activity for the given peptide RRYC
fKSTEL. Therefore, it was proposed that
the physiological roles for Haf-4 and Haf-9 might be related to their peptide transport activity.
Besides forming functional homodimeric complex as estimated by the peptide transport
activities, both half transporter could also form heteromers which was confirmed by
co-immunoprecipitation. However, the heteromers showed decreased transport activity.Introduction
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1 Introduction
1.1 ABC Transporters
The ATP-binding cassette (ABC) transporters form a family of membrane proteins, which
couple the energy of ATP hydrolysis with solute translocation (Higgins, 1992). The ABC
transporter superfamily represents the largest class of active transporters in prokaryotes, and
the second largest class (after the major facilitator superfamily) in eukaryotes. They are
involved in many cellular processes and transport a wide variety of substrates, ranging from
sugars and amino acids, hydrophilic drugs and lipids to large proteins (Higgins, 1992; Schmitt
and Tampé, 2002). ABC transporters can be found in the plasma membrane as well as in
membranes of various organelles. In eukaryotes, ABC transporters exclusively function as
exporters, whereas in archaea and eubacteria, they can mediate solute uptake by the help of
high-affinity solute-binding proteins in the periplasm (Davidson and Chen, 2004). There are
48 ABC genes in the human genome, which are divided into seven subfamilies (A-G) based on
homology of the nucleotide-binding domain (Dean et al., 2001). The function of only 16
human ABC transporters is deciphered (Borst and Elferink, 2002). Notably, 17 members of
this family are associated with defined human diseases (Dean and Annilo, 2005). For example,
dysfunctions in the cystic fibrosis transmembrane conductance regulator (CFTR or ABCC7)
cause genetic lung disease cystic fibrosis (Sheppard and Welsh, 1999); mutations in ABCA1,
which is a major regulator in cellular cholesterol and phospholipids homeostasis, lead to
Tangier disease (Oram and Vaughan, 2000); deficiencies of the transporter associated with
antigen processing (TAP) are related to certain autoimmune diseases and tumor developments
(Lankat-Buttgereit and Tampé, 2002).
1.1.1 Structural organization
ABC transporters contain a conserved core structure of two transmembrane domains (TMDs)
and two nucleotide-binding domains (NBDs) facing the cytosol (Schmitt and Tampé, 2002).
The TMDs of ABC exporters normally comprise 2×6 membrane-spanning helices (Dean et al.,
2001; Seeger and van Veen, 2009). However, for ABC importers, the number of
transmembrane helices is variable (Biemans-Oldehinkel et al., 2006; Davidson et al., 2008).
The TMDs form the translocation pathway and, in the case of exporters, the substrate-binding
site. The NBDs contain the highly conserved Walker A and Walker B motifs, as well as theIntroduction
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C-loop (ABC signature motif), which is the hallmark of ABC transporters. The NBDs bind
and hydrolyzeATP via the conserved motifs and energize the solute transport.
More than two dozens of crystal structures of the NBDs have been determined in the presence
or absence of nucleotides after the HisP protein from Salmonella typhimuriun (Hung et al.,
1998). The overall structures and arrangements of the NBDs are highly conserved and can be
divided to two subdomains: a catalytical core domain (RecA-like domain) and a helical
domain (Figure 1-1A). The two subdomains of the NBD monomer form an ‘L’ shaped
structure (Hung et al., 1998). Upon ATP binding the two NBDs can dimerize. There are
several conserved sequence motifs within the NBD, all with specific functions (Jones and
George, 2004). These motifs include the Walker A motif or the P-loop (GXXGXXGK(S/T))
that binds nucleotides; the Walker B motif (ɸɸɸɸD, ɸ stands for a hydrophobic residue)
providing an aspartate coordinates Mg
2+ (Yuan et al., 2001; Verdon et al., 2003), and having
the glutamate following the Walker B to bind and probably polarize a water molecule
attacking ATP (Geourjon et al., 2001; Moody et al., 2002b); the C-loop that contacts the
α-phosphate of nucleotide; the Q-loop believed to sense the γ-phosphate moiety via the
glutamine, and to serve as a hinge involved in the rigid-body movement between two
subdomains as well as the contact interface with the coupling helix of the TMD (Jones and
George, 2002; Locher et al., 2002; Zaitseva et al., 2006); the H-loop (also called His-loop or
switch region) required for ATP binding and hydrolysis (Zaitseva, 2005; Zaitseva et al., 2006);
the A-loop, which stacks against the adenine moiety of bound nucleotide with its aromatic
residue (Ambudkar et al., 2006); and the D-loop (also SALD motif) involved in the contact
interface between two NBDs (Locher et al., 2002; Smith et al., 2002; Chen et al., 2003a).
Residues of the D-loop in the cis-NBD contact residues in the trans-NBD (the aspartate of the
cis-D-loop forms a hydrogen bond with the trans-Walker A serine wherase the alanine
upstream of the aspartate interacts with the histidine in the trans-H-loop), and vice versa.
Therefore, the D-loop seems to play an important role in NBD-NBD communication (Zaitseva
et al., 2005a).
Similar in the isolated NBDs and intact ABC transporters, the ATP hydrolysis cycle starts with
the dimerization of the NBDs in a so called ‘head-to-tail’fashion upon ATP binding. Two ATP
molecules are sandwiched at the dimer interface (Loo et al., 2002; Moody et al., 2002a; Smith
et al., 2002; Chen et al., 2003a; Janas et al., 2003b; Zaitseva et al., 2005b; Dawson and Locher,
2006; Oldham et al., 2007). ATP binding induces a rigid-body rotation of the helical domain
towards the catalytical domain. The ATP-binding site is formed by the Walker A/B and theIntroduction
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H-loop from one NBD and the C-loop from the other (Figure 1-1B). ATP hydrolysis induces
dissociation of the dimer and, subsequently, ADP and inorganic phosphate are released. These
nucleotide-dependent conformational changes in the NBDs drive the conformational changes
in the TMDs via the contact interface (Locher et al., 2002), resulting in substrate translocation.
Unlike the NBDs, the TMDs vary considerably in primary sequence, length, architecture and
the number of transmembrane (TM) helices (Hollenstein et al., 2007a). Based on the
architectures of the TMDs from the available intact ABC transporter structures (Locher et al.,
2002; Dawson and Locher, 2006; Dawson and Locher, 2007; Hollenstein et al., 2007b; Hvorup,
2007; Pinkett et al., 2007; Ward et al., 2007; Gerber et al., 2008; Kadaba et al., 2008; Aller et
al., 2009), the structures of ABC transporters are categorized to exporters, type I importers and
type II importers (Locher, 2009; Rees et al., 2009) (Table 1-1).
Table 1-1. Structurally characterized ABC transporter systems, as classified by the TMD fold
*
Transporter Organism Nucleotide state Orientation PDB code Resolution
Type I ABC importer
ModABC Archaeoglobus fulgidus Apo Inward 2ONK 3.1 Å
MalFGK2 Escherichia coli ATP-bound Outward 2R6G 2.8 Å
MaModBC Methanosarcina acetivorans Apo Inward 3D31 3.0 Å
MetNI Escherichia coli Apo Inward 3DHW 3.7 Å
Type II ABC importer
BtuCD Escherichia coli Apo or (VO2)4 Outward 1L7V 3.2 Å
Hi1470/1 Haemophilus influenzae Apo Inward 2NQ2 2.4 Å
BtuCDF Escherichia coli Apo Occluded 2QI9 2.6 Å
ABC exporter
Sav1866 Staphylococcu aureus ADP-bound Outward 2HYD 3.0 Å
AMPPNP-bound Outward 2ONJ 3.4 Å
MsbA Salmonella typhimurium AMPPNP-bound Outward 3B60 3.7 Å
ADP-VO4
3--bound Outward 3B5Z 4.2 Å
Escherichia coli Apo Inward 3B5W 5.3 Å
Vibrio cholerae Apo Inward 3B5X 5.5 Å
P-gp Mus musculus Apo Inward 3G5U 3.8 Å
*Note that while the outward-facing conformation generally corresponds to the ATP (or suitable analogue)-bound
state, exceptions are evident in the structures of ADP bound to Sav1866 and nucleotide-free BtuCD. Btu, vitamin
B12 importer; Mal, maltose transporter; Met, Met transporter; Mod, molybdate transporter; P-gp, P-glycoprotein;
PDB, Protein Data Bank; (VO2)4, cyclotetravanadate; VO4
3-, orthovanadate (Rees et al., 2009).Introduction
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Figure 1-1 Structure and arrangement of the NBD. A, side view on the crystal structure of HisP monomer (PDB
code: 1B0U). The structure is rainbow-colored starting with the N-terminus (N-ter) in blue and ending with the
C-terminus (C-ter) in red. The catalytical core domain is composed of α-helices and β-sheets, whereas the helical
domain is mostly made of α-helices. The bound ATP is demonstrated by black sticks. B, NBD arrangement in a
functional ABC transporter. The NBDs of the multidrug ABC transporter Sav1866, crystallized with bound
AMP-PNP (PDB code: 2ONJ), are shown in a view from the side (left panel) or from the membrane (showing the
surface facing the TMDs, right panel). The two NBDs are in green and yellow, with mechanistically important
sequence motifs colored and labeled with different colors. Bound AMP-PNP is shown as black sticks. Note that
two AMP-PNP molecules are sandwiched between the P-loop of one NBD and the C-loop of the other, and vice
versa (‘head-to-tail’ arrangement). The short, black helices are the coupling helices from the TMDs, with arrows
indicating the direction of the polypeptide chain from the N-terminus to the C-terminus.Introduction
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ABC exporters are found in the genomes of all sequenced organisms. The physiological
functions of these transporters are diverse, but many of them are involved in multidrug
resistance, which can lead to failure in cancer chemotherapy (Gottesman et al., 2002). Their
TMDs share a core-complex of 12 TM helices (Figure 1-2) (Locher, 2009; Rees et al., 2009).
The first high resolution crystal structure of the exporter Sav1866 from Staphylococcu aureus
is an excellent model for the core architecture of ABC exporters (Stenham et al., 2003;
Hollenstein et al., 2007a). In this structure, the TMDs for each subunit embrace each other and
have a significant twist. The TMDs are organized into two ‘wings’ that are formed by helices
TM1-2 from one subunit and TM3-6 for the other in the outward-facing conformation.
Remarkably, no clear gating region was identified in Sav1866 (Dawson et al., 2007). The
TMDs of exporters such as Sav1866 are fused to the NBDs, whereas the TMDs and the NBDs
are often separate subunits in importers. Due to the long intracellular loops (ICLs), the NBDs
are located approximately 25 Å away from the membrane surface (Dawson and Locher, 2006).
In Sav1866, both intracellular loops, ICL1 (between TM2 and TM3) and ICL2 (connecting
TM4 and TM5), have short ‘coupling helices’ oriented parallel to the membrane plane and are
in contact with the NBDs. Coupling helix 1 contacts both NBDs, whereas coupling helix 2
interacts with the NBD of the opposite subunit. Such a swapping architecture forms another
difference between exporters and importers. The latter, in contrast, have no swapping resulting
in no direct contact between diagonally positioned TMD/NBD pairs and a large gap at the
center of four subunits (Dawson and Locher, 2006). In the NBDs, residues around the Q-loop
provide contacts with the TMDs in both exporters and importer. In addition to the Q-loop, the
conserved glutamate of the X-loop motif found only in exporters forms contacts with both
coupling helices of the opposite half transporter and is believed to play a prime role in the
TMD-NBD interdomain communications (Dawson and Locher, 2006; Zolnerciks et al., 2007;
Serohijos et al., 2008; Oancea et al., 2009; Seeger and van Veen, 2009). Conformational
changes in the NBDs induced by ATP binding and hydrolysis are transmitted to the TMDs via
the so called ‘transmission interface’ (NBD-TMD contact surface). Therefore, two distinct
conformational changes (NBD dimerization and substrate translocation) are tightly coupled.
The type I importers including the molybdate/tungstate transporters A. fulgidus ModABC and
the M. acetivorans MaModBC, as well as the E. coli maltose transporter MalFGK2 and the
methionine transporter MetNI, mediate the uptake of ions, sugars and other small substrates by
utilizing a specific binding protein. The typical TMD of this type contains at least 5 TM
helices (in the case of MetI) in each subunit (Kadaba et al., 2008; Rees et al., 2009).Introduction
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Additional the N-terminal TM helices reach around and interact with the partner TMD, as in
the case of ModABC, MalFGK2 and MaModBC (Hollenstein et al., 2007b; Oldham et al.,
2007; Gerber et al., 2008; Locher, 2009). This kind of intertwining organization of the TM
helices is also present in MetI of which the N-terminal helix (TM1) wraps around and contacts
with TM2-TM5 in the other TMD (Gerber et al., 2008; Rees et al., 2009). The numbers of
TMDs among type I importers are different, thus the numbering of the following TMs is
refered to that in the structure of ModB, which is the TMD of ModABC. The structures of
ModABC and MalFGK2 revealed an external gate beneath the interface with substrate binding
protein. The gate is formed by the gating region 1 (located between TM3 and helix 3a) and the
gating region 2 (located between TM5 and helix 5a) of each TMD (Hollenstein et al., 2007b;
Oldham et al., 2007). The coupling helix in importers contains the consensus EAA motif
(Saurin et al., 1994; Mourez et al., 1997), and in the case of ModB, it is helix 4a within the
loop between TM4 and TM5. Similar to exporters, the coupling helix in type I importers also
lies approximately parallel to the membrane bilayer and is embedded in a groove at the
boundary between the catalytical core domain and the helical domain of the NBD. However,
in contrast to exporters, the coupling helix forms contact mainly with the Q-loop of the NBD
on the same side.
The type II importers represented by the E. coli vitamin B12 transporter BtuC and H.
influenzae Hi1471 have distinct TMD architecture from type I importers, with 10 TM helices
from each subunit forming 20 transmembrane spans in total. Unlike the helix fold of exporters
and type I importers, the 10 α-helices of each TMD form a single bundle and cross the
membrane independently of the other TMD. Remarkably, helix TM2 is placed in the center of
the subunit in proximate to most of the other helices. The N- and C-terminal halves of the
BtuC subunit have similar helix packing, but opposite polarities through the membrane. The
TMD-TMD interface is formed by helices TM5 and TM10. BtuCD revealed a closed internal
gate formed by intracellular loops between TM4 and TM5 from each BtuC subunit. In contrast,
Hi1470/1 revealed a closed external gating region formed by extracellular loops between TM5
and helix5a from each Hi1471 subunit. Moreover, the intracellular loops of BtuC and Hi1471
are shorter than in the Sav1866 structure, therefore, the NBDs are closer to the membrane
region (Locher et al., 2002; Pinkett et al., 2007; Rees et al., 2009). The cytosolic loop between
TM6 and TM7 in BtuC folds into two short helices. Because the shape of these two helices
resembles a shape of an L, it is also called the L-loop. The L-loop is composed of helices L1
and L2, both extensively contact the NBD on the same side. The sequence of the L-loop isIntroduction
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similar to ICL4 of CFTR, ‘EAA loop’ of bacterial importers and ICL1 of exporters (Locher et
al., 2002).
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Figure 1-2. Crystal structures of ABC transporters and topology schemes of the TMDs. A, ribbon representation
of three crystal structures of ABC transporters belong to three different families. The gray box depicts the
position of the membrane. The TMDs of exporters such as Sav1866 are fused to the NBDs, whereas the TMDs
and NBDs are separated subunits in importers. ModA is the substrate binding protein of ModBC. The
stoichiometries of the assembled transporters are (Sav1866)2, ModB2C2A and BtuC2D2. Note that one subunit of
Sav1866 is in a yellow coil representation for clear demonstration of the transmission interface formed by
coupling helix 1 (red), coupling helix 2 (blue), the X-loop (pink) and the Q-loop (cyan). B, topological schemes
of the TMDs. The open box represents the membrane region. TM helices are numbered consecutively, and short
helices following TM helices additionally carry letters. For Sav1866, the schematic emphasizes the long
intracellular loops, the two ‘wings’ formed by TM1-2 and TM3-6, respectively, and the pseudo-twofold
symmetry relating TM1-3 to TM4-6 (with the black ellipse depicting the approximate position of the rotation
axis). For ModB, the schematic emphasizes the conserved gate formed by segments from TM3 and TM5. For
BtuC (Hi1471), the schematic depicts the internal and external gates. The coupling helices in each TMD are the
main site of contact with the NBD in the assembled transporter (Hollenstein et al., 2007a).Introduction
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1.1.2 Transport mechanism
The similarities of ABC transporters suggest a common transport mechanism for both ABC
importers and exporters. An ‘alternating access’ model (Jardetsky, 1966; Locher et al., 2002;
Dawson et al., 2007) for transport has been accepted generally. In this model, the
substrate-binding site can alternately access either the extracellular or intracellular side of the
membrane, corresponding to the outward-facing and inward-facing conformations of the
transporter. Binding and hydrolysis of ATP drive the switch between both conformations. In
the case of ABC importers, the outward-facing conformation is expected to have a higher
affinity for substrate than the inward-facing conformation, whereas the situation is the
opposite in the ABC exporter (Rees et al., 2009). Comparing the crystal structures of
ModABC (nucleotide-free state, ‘open’ conformation) and Sav1866 (ATP-bound state, ‘close’
conformation), the distance between the two coupling helices decreases drastically (10-15 Å)
upon ATP binding (Dawson et al., 2007; Hollenstein et al., 2007a) (Figure 1-3). As the
coupling helices approach, the TMDs flip from the inward-facing conformation to the
outward-facing conformation. ABC importers can accept substrate from the cognate binding
proteins. In contrast, ABC exporters might release substrates acquired previously. After ATP
hydrolysis, the NBDs switch back to the ‘open’ conformation and then ADP as well as
inorganic phosphate dissociates. Subsequently, the distance between coupling helices increase
and the TMDs flip back to inward-facing conformation. As a consequence, importers might
release the previously bound substrates, whereas exporters can recruit new substrates.
Figure 1-3. Conserved coupling mechanism of ABC transporters. The molecular motion induced by binding of
ATP triggers the closing of a gap between the motor domains (NBDs). This moves the coupling helices, an
architecturally conserved feature, closer together and flips the TMDs to an outward-facing conformation.
Hydrolysis of ATP and NBD dissociation revert the TMDs to adopt an inward-facing conformation (Locher,
2009).Introduction
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1.2 Transporter associated with antigen processing-like (TAP-like or TAPL)
The transporter associated with antigen processing like (TAPL, also called ABCB9) is a half
transporter of the ABCB subfamily. Due to the significant homology with one of the best
characterized ABC transporters, the transporter associated with antigen processing (TAP1 and
TAP2 subunits), TAPL belongs to the TAP family together with TAP1 and TAP2. TAPL forms
a homodimer which is localized in lysosomal compartment (Zhang et al., 2000; Demirel et al.,
2007). It functions as an ATP-dependent peptide transporter with a broad peptide specificity
(Wolters et al., 2005).
1.2.1 Phylogenetic relationship and gene organization
Phylogenetic analysis of TAPL with ABC transporters showed that it appeared to be closely
related to TAP1 and TAP2, which shares 38% and 40% amino acid sequence identity with
TAP1 and TAP2, respectively, while the identity between TAP1 and TAP2 is 39% (Zhang et al.,
2000). Comparing the deduced primary structures of rat TAPL with the human and mouse
counterparts, the mammalian TAPLs (rat, mouse, and human) are highly conserved, since
about 99% of the amino acid residues are identical between rat and mouse, and 95% of the
residues are identical between rodents and man in pairwise comparison. In contrast, only 75%
of the residues from TAP1 or TAP2 are identical between rodents and human in spite of 90%
identity between rat and mouse (Kobayashi et al., 2000). Therefore, the evolutional rate of
TAPL is much slower than those of TAP1 and TAP2 as deduced from sequence alignment
analysis (Figure 1-4). Moreover, a sequence closely related to mammalian TAPL but not to
TAP was found in the genome of the jawless vertebrate sea lamprey (Petromyzon marinus)
(Uinuk-ool et al., 2003). TAPL seems to be the phylogenetic progenitor of TAP with a
different physiological role, as lamprey does not possess an adaptive immune system. In
addition, Caenorhabditis elegans has three TAPL orthologs with a sequence identity between
35-38%. They were identified as half ABC transporters (Sheps et al., 2004). haf-2 is expressed
in muscle cells, whereas the closest orthologs haf-4 and haf-9 are found in intestinal cells
(Zhao et al., 2004). Haf-4 and Haf-9 were reported to be involved in intestinal granule
formation (Bauer, 2006; Kawai et al., 2009).Introduction
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Figure 1-4. Phylogenetic relationship of TAPL to other ABC transporters. Predicted amino acid sequences from
members of the human ABCB subfamily and its orthologs from other organisms were aligned using ClustalX. A
neighbour-joining tree was generated with Phylodendron
(http://www.iubio.bio.indiana.edu/treeapp/treeprint-form.html). Full transporters were subdivided into an N- (n)
and C-terminal (c) half for analysis. The horizontal bar indicates the genetic distance. Transporters without any
given species name are human ABC transporters. The species of the ABC transporters used for generation of the
phylogenetic tree are: human, Homo sapiens; dog, Canis familiaris; mouse, Mus musculus; rat, Rattus norvegicus;
bovine, Bos taurus; rainbow trout, Oncorhynchus mykiss; zebrafish, Brachydanio rerio; nurse shark,
Ginglymostoma cirratum; horn shark, Heterodontus francisci; sea lamprey, Petromyzon marinus; the nematode,
Caenorhabditis elegans; Xaenopus laevis; and thale cress, Arabidopsis thaliana.
The TAPL gene is localized on chromosome 12 (12q24), which does not contain genes related
to the adaptive immunity (Kobayashi et al., 2000). As shown in Figure 1-5, the TAPL gene
consists of 12 exons, and translation starts at position 87 of exon 2 (Kobayashi et al., 2003;
Uinuk-ool et al., 2003). The gene organization of TAPL is closely related to the TAP2 gene,
since both genes have a first non-coding exon, and similar splicing pattern of exon 12
(Kobayashi et al., 2003; Penfornis et al., 2003). In contrast, the TAP1 gene has only 11 exons
and the translation starts at exon 1. Moreover, no other splicing isoform is reported for the
TAP1 gene. Exon 1 in the TAP1 gene is corresponding to exon 2 in the TAPLand TAP2 genes,
and is longer than the other exons. Exons 3 to 11 of the TAPL and TAP2 genes, exons 2 to 10Introduction
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in the case for the TAP1 gene, have the same length. Nevertheless, the intron length in the
TAPL gene is much longer than in the TAP1 and TAP2 genes. Four splicing isoforms of TAPL
have been identified. Three of them named 12A, 12B and 12C, respectively, are generated by
alternative splicing of exon 12 (Kobayashi et al., 2003). The full length TAPL cDNA (12A),
containing an open reading frame of 2298 bp and coding for 766 amino acids, was cloned
from human T-lymphoblast CEM cell line (Zhang et al., 2000). The splicing isoform 12B (683
amino acids) was cloned from HEK-293 cells, while isoform 12C (681 amino acids) was
cloned from both HEK-293 and HeLa cells (Kobayashi et al., 2003; Uinuk-ool et al., 2003).
Isoforms 12B and 12C lack 86 and 85 C-terminal amino acids, respectively, including the
highly conserved H-loop. The fourth splicing isoform of TAPL has an internal deletion of 129
bp, which codes for 43 amino acids (residue 418 to 460), encompassing the last hydrophobic
region (predicted TM9 and TM10) and contains exon 7 (Zhang et al., 2000). This splice
variant of TAPL was speculated to have different substrate specificity than full length TAPL,
since this region corresponds partially to the putative peptide-binding region. Interestingly, at
least 4 different C-terminal splicing isoforms were found for rat TAPL, with a length of 693,
708, 762 and 766 amino acids, respectively (Yamaguchi et al., 2004).
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Figure 1-5. Comparison of the exon-intron organization of human TAPL, TAP1 and TAP2 genes. Boxes indicate
exons, in which filled boxes represent coding sequences and open boxes untranslated sequences. Introns are
shown by horizontal lines. Exons are drawn in proportion to real length. The exon and intron size (bp) is given by
the numbers below and above the exons and introns, respectively. The position of the translation initiation codon
is indicated with ATG and those of termination codons by TGA and TAA
1.2.2 Topology model and homodimerization
TAPL is a half transporter composed of the N-terminal hydrophobic domain and C-terminal
hydrophilic NBD. On the basis of hydrophobicity analysis and sequence alignment with TAP
subunits, we propose a topology model of TAPL with 10 transmembrane helices (Figure 1-6).Introduction
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The sequence comparison with TAP subunits shows that the transmembrane domain can be
subdivided into two regions. The core transmembrane domain comprising the six C-terminal
transmembrane helices (TMD1) shows a high sequence identity to TAP1 as well as TAP2, and
appears to form the binding pocket and pathway for the cargo, whereas the extra N-terminal
domain composed of four putative transmembrane helices (TMD0) are distinct. In homology
to TAP (Koch et al., 2004), the N-terminal domain could be involved in recruiting accessory
factors, while the core unit of six helices may assemble a functional transport complex similar
to TAP1 and TAP2. The N- and C-termini of TAPL as well as the putative peptide-binding site
are located in the cytosol. Based on the sequence identities with the predicted peptide-binding
region of TAP1 and TAP2 (Nijenhuis and Hammerling, 1996; Ritz et al., 2001), the putative
peptide-binding region of TAPL is localized at the cytosolic loop between transmembrane
helix 4 and 5 of the TMD1 (peptide-binding region 1 (PBR1)) and a stretch of 15 residues at
the C-terminal of the last transmembrane helix connecting the TMD with the NBD (PBR2).
The NBDs contain highly conserved sequences, which are involved in ATP binding (Walker A
and B) and hydrolysis (C-loop, H-loop and D-loop), thus driving active transport across the
membrane.
The eukaryotic ABC transporters are encoded either as full transporters consisting of a
polypeptide with two TMDs and two NBDs, or as half transporters comprising only one TMD
and one NBD. The latter must form either homo- or heterodimers to act as transporter (Jones
and George, 2004). The members of the TAP family are half transporters. Therefore, the
formation of dimers is essential for a functional transporter. TAP1, together with TAP2, forms
an active transport complex (Powis et al., 1991; Spies and DeMars, 1991). TAP1 or TAP2
alone are not active in peptide binding and transport (Meyer et al., 1994). Since TAPL shows
the same sequence identity to TAP as the TAP subunits do to one another, the dimerization of
TAPL was studied. In dihydrofolate reductase protein-fragment complementation assays in
SKOV3 cells (human ovarian carcinoma cell line) (Leveson-Gower et al., 2004), pull down
assays with different tagged TAPL (Wolters et al., 2005), and cross-linking assays (Ohara et al.,
2008), the homodimerization of TAPL was demonstrated. TAPL showed no functional
interaction with TAP subunits and no ER localization (Zhang et al., 2000; Demirel et al., 2007).
The information for the assembly of the transporter monomer was reported recently to reside
in the core domain (Arg
141–Ala
766) (Kamakura et al., 2008). Similar to TAP, the core domain
transporter (core-TAPL) is fully functional in respect of ATP-dependent peptide transport (Ö.
Demirel, I. Bangert, R. Tampé and R.Abele, unpublished data).Introduction
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Figure 1-6. Topology model of TAPL. TAPL forms a half transporter composed of an N-terminal TMD (consists
of TMD0 and TMD1) and a C-terminal, hydrophilic NBD localized in the cytosol. Based on hydrophobicity
analysis and sequence alignments of TAPL with human TAP1 and TAP2, 10 transmembrane helices are
predicted. The numbers resemble the N- and C-terminal residues of the membrane helices. To show the sequence
identity between the transmembrane region of human TAPL and human TAP, residues—identical in the sequence
alignment between TAPL and TAP1, TAP2 or both TAP subunits—are coloured in orange, red or blue,
respectively. The putative peptide-binding regions (PBR1 and PBR2) are highlighted in dashed boxes. The
topology model was created with the program Textopo (Beitz, 2000).
1.2.3 TAPLfunctions as a peptide transporter
The function of TAPL as a specific and ATP-dependent lysosomal peptide transporter was
demonstrated by heterologous expression in Sf9 insect cells and retroviral transducted
Burkitt’s lymphoma (Raji) cells (Wolters et al., 2005; Demirel et al., 2007). The transport
activity of TAPLstrictly requires ATP hydrolysis, since non-hydrolyzable ATP analogues, such
as AMP-PNP  and  ATPγS,  do  not  energize  peptide  translocation.  Similar to other ABC
transporters, the transport could be inhibited by orthovanadate which can trap ABC
transporters in a post-hydrolysis state. The half maximal inhibition concentration (IC50) wasIntroduction
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determined to be 11.5 ± 1.0 μM, similar to other ABC transporters (Ambudkar et al., 1992;
Landmesser et al., 2002). The optimal temperature and pH value for TAPL transport activity
are 37 °C and pH 7.0. Peptide transport follows a Michaelis-Menten kinetic with a KM(pep) in
the micromolar range (6.8 ± 2.8 μM for the peptide RRYQNSTC
fL, where f resembles the
covalently bound labeled fluorescein). The turnover number of TAPL was calculated to
30 peptides/min, which is comparable to the transport activity of other ABC transporters
(Eytan et al., 1996; Ambudkar et al., 1997; Patzlaff et al., 2003). Moreover, TAPL is an active
transporter accumulating peptides more than 60 fold in the vesicle lumen.
In contrast to TAP, which is a high-affinity transporter (van Endert et al., 1994; Uebel et al.,
1997; Neumann and Tampé, 1999), no peptide-binding activity was detected for TAPL by
rapid filter assays, suggesting a low-affinity transporter (Wolters et al., 2005). Accordingly,
TAPL seems to bind peptides in a different manner as TAP, although TAPL and TAP share a
sequence identity of more than 49% with respect to the putative peptide-binding regions.
The recognition principle of TAPL and TAP is similar, since both transporters recognize
peptides via their backbone, including the free N- and C-termini, and by side chain
interactions (Uebel et al., 1997; Wolters et al., 2005). However, the peptide specificity of
TAPLis very broad, ranging from 6-mer up to at least 59-mer peptides with a slight preference
for 23-mers. TAPL appears to be highly promiscuous in peptide recongnition since 10-fold
longer peptides could be transported with the same efficiency as 6-mer peptides. In contrast,
TAP most efficiently transports peptides from 8 to 12 amino acids in length optimized for
peptide loading of MHC class I molecules (Koopmann et al., 1996). TAPL seems to work as a
vacuum cleaner transporting a large variety of peptides with low affinity but high efficiency.
1.2.4 Nucleotide-dependent peptide transport
The peptide transport is energized by ATP hydrolysis. The transport follows Michaelis-Menten
kinetics with a KM(ATP) of 17.6 ± 2.4 μM for ATP (Wolters et al., 2005), which is 4–20 fold
lower than for TAP, P-glycoprotein, CFTR, and maltose permease from E. coli (Sarkadi et al.,
1992; Li et al., 1996; Landmesser et al., 2002; Chen et al., 2003b). Based on the physiological
ATP concentration, this KM(ATP) value ensures that TAPL is always fully active. In order to
determine the binding constant of ATP for TAPL, 8-azido[α-
32P]-ATP photocross-linking
assays were performed, in which 8-azido[α-
32P]-ATP is a competitive substrate for ATP. An
apparent dissociation constant of Mg•ATP of 90 ± 12 μM for TAPL was derived. This value is
in the same range as that of other ABC transporters (Horn et al., 2003; Qu et al., 2003). AIntroduction
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lower KM(ATP) value than the KD for TAP indicates that the ATP-binding step is followed by
intermediates before final hydrolysis occurs (Fersht, 1997). For such a multi-domain
machinery, a multi-step process is conceivable, where peptide and ATP binding, ATP
hydrolysis, and peptide transport occur in an ordered manner. As known from biochemical
studies on isolated NBDs, ATP binding induces a conformational change of the NBD enabling
the dimerization of the catalytic domain, which is the prerequisite for ATP hydrolysis and
substrate transport (Moody et al., 2002b; Janas et al., 2003a; van der Does and Tampé, 2004;
Zaitseva et al., 2005a).
In competition assays with 8-azido[α-
32P]-ATP, and by transport studies, the nucleotide
specificity of TAPL was disclosed and ranked into three categories (Wolters et al., 2005): ATP
as the substrate with the highest affinity for TAPL; GTP, AMP-PNP, ADP, and UTP with an
intermediate affinity; and CTP as well as AMP with a very low affinity. The similar nucleotide
specificity was also observed in an ATP-agarose binding assay of solubilized rat TAPL (Ohara
et al., 2008). The rTAPL binds to ATP-agarose, ADP-agarose, but not to AMP-agarose. The
binding can be competed by free ATP, ADP, GTP or dATP, but not by AMP. Pyrimidine
nucleotides such as UTP and CTP are less effective competitors. The binding of ATP requires
Mg
2+, and was observed at neutral pH value. Furthermore, this nucleotide-binding preference
is also reflected in the transport activity, where GTP shows 40%, UTP 20%, and CTP 10% of
the ATP-driven transport activity (Wolters et al., 2005). Therefore, TAPL can be energized by
different nucleotide triphosphates with a slight preselection for purine based nucleotides. This
broad specificity is also found with other ABC transporters (Al-Shawi and Senior, 1993;
Meyer et al., 1994; Muller et al., 1994) and results from a π−π interaction between the base of
the nucleotide with the NBD (Hung et al., 1998).
1.2.5 Tissue distribution and cellular localization
Based on its mRNA level, TAPL is highly expressed in testis and moderately expressed in
brain, spinal cord, and thyroid (Zhang et al., 2000). However, it was also found in other tissues
such as intestine, kidney, lung and stomach (Yamaguchi et al., 1999; Mutch et al., 2004).
Notably, the high expression of TAPL in Sertoli cells of mouse and rat testis was confirmed by
immunostaining (Zhang et al., 2000), and these cells possess numerous lysosomes for
phagocytosis. Moreover, TAPL expression is strongly upregulated during the maturation of
monocytes to dendritic cells (Demirel et al., 2007). Dendritic cells are the most potent antigen
processing cells, expressing MHC class II beside MHC class I on their cell surface.Introduction
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In silico analysis did not detect a signal sequence for ER insertion and subcellular targeting. In
double immunofluorescence staining of stable transfected SKOV3 using an anti-TAPL
antibody and a panel of organelle markers, anti-TAPL-specific staining showed a pattern
overlapping with the lysosomal markers LAMP-1 and LAMP-2 (LAMP, lysosome-associated
membrane protein), and partially overlapping with the staining pattern of a marker for
endosomes (Zhang et al., 2000). The lysosomal localization of TAPLwas further confirmed by
subcellular fractionation. More recently, the subcellular distribution of TAPL was addressed by
quantitative immunofluorescence confocal laser scanning microscopy in HeLa cells, which
transiently expressed TAPL C-terminal tagged with a Myc-epitope or eGFP. Both TAPL
variants colocalized with LAMP-2 but not with calnexin as an ER marker or EEA1 as an early
endosome marker (Demirel et al., 2007). Furthermore, indirect evidence for the localization of
TAPL in a post-ER compartment results from peptide transport studies on crude membrane
preparations derived from TAPL expressed in Sf9 cells. Only a minor fraction of the
transported peptide was found N-glycosylated and therefore transferred into the ER-lumen
(Wolters et al., 2005).
The sorting signal for lysosomes is likely present within the amino-terminal transmembrane
domain (Met
1–Arg
141) of TAPL molecule. As visualized by means of fluorescent microscopy,
both N-terminal domain and full-length transporter fused with GFP were targeted to lysosomal
membranes in stable-transfected CHO-K1 cells, while the core domain was broadly distributed
in intra-cellular membranes (Kamakura et al., 2008)
1.2.6 Physiological function
The adaptive immune system uses two sets of cells to protect hosts from various pathogens:
B-cells and T-cells. T cells recognize antigenic peptides presented on the surface of host cells
via two types of MHC molecules: MHC class I and II molecules. In general, MHC class I
molecules present peptides of endogenous proteins to CD8
+ cytotoxic T-cells and MHC class
II molecules present peptides of exogenous proteins to CD4
+ helper T-cells (Abele and Tampé,
2004). However, in professional antigen-presentation cells like macrophages, dentritic cells
and B-cells, antigen cross-presentating also exists (Malnati et al., 1992; Cresswell et al., 2005).
In these specialized cells, MHC class I molecules can present peptides from exogenous
antigens in TAP-dependent and TAP-independent pathways (Cresswell et al., 2005; Shen and
Rock, 2006). In the latter pathway, peptides were loaded onto MHC class I molecules in
endolysosomes (Bachmann et al., 1995; Norbury et al., 2001; Lizee et al., 2003). Additionally,Introduction
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MHC class II molecules have the ability to present endogenous peptides in a TAP-independent
pathway (Rudensky et al., 1991; Chicz et al., 1993; Lich et al., 2000; Dani et al., 2004).
The physiological function of TAPL is still an open issue. However, it has been confirmed that
TAPL shows no multidrug resistance, its gene regulation is different from TAP subunits, and it
is not involved in MHC class I antigen presentation pathway (Kobayashi et al., 2000; Zhang et
al., 2000; Demirel et al., 2007). Remarkably, TAPL expression is strongly upregulated during
the maturation of monocytes to dendritic cells or macrophages (Demirel et al., 2007).
Moreover, TAPL transports peptides into lysosomal compartments by hydrolyzing ATP
(Demirel et al., 2007). Therefore, it was speculated that TAPL functions as a peptide
transporter in the cross-presentation of endogenous antigens in the MHC class II pathway or
delivers peptides of exogeneous antigens into endolysosomes for MHC class I molecule
loading (Demirel et al., 2007).
Nevertheless, a more general function should be considered, since TAPLis also found in MHC
class II deficient Sertoli cells (Zhang et al., 2000) and still in lampreys which have no
complicated immune system. Additionally, both TAPL orthologs Haf-4 and Haf-9 from
Caenorhabditis elegans were reported to be localized in non-acidic intestinal but LAMP
homologue (LMP-1)-positive granules and involved in the granule formation (Bauer, 2006;
Kawai et al., 2009). In addition to granule defects, other phenotypes such as reduced brood
size, slow growth and prolonged fececation cycles were also observed in haf-4 and haf-9
deletion animals. The functions of Haf-4 and Haf-9 were proposed to be required for normal
growth and spermatogenesis at the larval stage; in adult stage, their expressions may lead to
the proper oogenesis (Kawai et al., 2009)Introduction
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1.3 Objective
It is of utmost importance to decipher the substrate specificity of the lysosomal transporter
TAPL, since it is connected to its physiological function. Previous work has demonstrated that
TAPL has a broad length specificity for peptides, and peptides are recognized by the free
termini and backbone (Wolters et al., 2005). However, detailed biochemical analysis of TAPL,
especially, the detailed characterization of substrate specificity, is impossible to perform on
crude membranes due to high background and side reactions. Therefore, a sobulization,
purification and reconstitution procedure has to be developed for this ABC transporter
individually since there is no common protocol for all membrane proteins. After optimization
on many parameters in the solubulization, purification and reconstitution, the peptide
specificity of TAPL on single residue level will be deciphered with combinatorial peptide
libraries. First, the key peptide residues involved in TAPL recognition will be determined and,
in a detailed screening, the amino acid preferences at these positions will be analyzed.
Moreover, with the optimized purification and reconstitution procedure, it is planed to
investigate whether the ATP hydrolysis of TAPLis coupled to substrate translocation. If so, the
stoichiometry between substrate transport and ATP hydrolysis can be determined. This
important mechanical question is always unter debate in the field of ABC transporters
(Davidson and Nikaido, 1990; Chen et al., 2001; Borths et al., 2005; Poolman, 2005).
To study the structure, dynamics and mechanism of TAPL, single cysteine mutations will be
introduced into strategic positions for site-directed labeling. The prerequisite for introducing
single cysteines to TAPL is the creation of the functional cysteine-less mutant. The functions
of these mutants have to be characterized in a current project. The functional single cysteine
mutants will be a good starting point for studying conformational changes by electron
paramagnetic resonance, fluorescence energy transfer and/or chemical cross-linking.
TAPL orthologs Haf-4 and Haf-9 in C. elegans have about 40% sequence identity with TAPL.
They are localized in lysosomal-related intestinal granules and are involved in these granules
formation. In order to understand the function of Haf-4 and Haf-9 in more detail, both proteins
will be expressed in Sf9 insect cells as well as characterized for their interactions and peptide
transport activities since their human ortholog TAPL was shown to be a lysosomal peptide
transporter.Material
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2 Materials
2.1 Chemicals
Table 2-1. Chemicals list
Chemical Company
Acrylamide (fourth-crystallized) Carl Roth
Acrylamide-bisacrylamide (37:1), Rotiphorese 30 Carl Roth
Adenosine-5’-triphosphate (ATP) disodium salt hydrate Fluka
6-Aminohexanoic acid Fluka
Ampicillin Carl Roth
AmpLigase Epicentre
Anti-His antibody Qiagen
Anti-Myc antibody Millipore
Anti-mouse IgG Sigma
Anti-rabbit IgG Sigma
Apyrase Sigma
ATP-agarose Sigma
Bac-to-Bac baculovirus expression system Invitrogen
BD BaculoGold transfection buffers BD Biosciences
Benzonase nuclease Merck
Bio-Beads SM-2 Bio-Rad
Blue-Gal Fermentas
Bradford assay kit Pierce
Calf intestine alkine phosphatase (CIAP) Fermentas
Chloramine T trihydrate Sigma
Coomassie blue G-250 Serva
Coomassie blue R-250 Carl Roth
n-Decyl-β-D-maltoside (DM) Glycon
Digitonin Calbiochem/Carl Roth
Dimethylformamide (DMF) Carl RothMaterial
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Chemical Company
Dimethyl sulfoxide (DMSO) Calbiochem
1,4-Dithiothreitol (DTT) Fermentas
6×DNAloading dye Fermentas
n-Dodecyl-β-D-maltoside (DDM) Glycon
DOWEX 1×8 (200–400 mesh) analytical grade Serva
Ethidium bromide solution (1 %) Carl Roth
Ethylenediaminetetraacetic acid (EDTA) Carl Roth
Fetal calf serum (FCS) Biochrom
Foscholine-14 (n-Tetradecylphosphocholine) Anatrace
Gel filtration molecular weight markers Sigma
Gentamicin Carl Roth
HIS-Select nickel affinity gel Sigma
HiTrap chelating HP column GE Healthcare
Imidazole Merck
5-Iodoacetamidoflourescein (5-IAF) Molecular Probes
Isopropyl-β-D-thiogalactopyranoside (IPTG) Fermentas
Kanamycin Carl Roth
Lipids Avanti Polar Lipids
β-Mercaptoethanol Carl Roth
Micro BCAprotein assay reagent kit Pierce
MultiScreen plates with glass fibre filter (PVDF membrane, pore size
0.65 µm) Millipore
Na
125I Hartmann Analytic
0.1% Neutral red solution Sigma
Ni-NTAagarose Qiagen
β-Nicotinamide adenine dinucleotide hydrate (NAD) Sigma
Nitrocellulose membrane Whatman
n-Octyl-β-D-glucopyranoside (OG) Glycon
Penicillin/streptomycin (100×concentrated) PAA
Pfu DNApolymerase FermentasMaterial
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Chemical Company
Phenylmethylsulphonyl fluoride (PMSF) Carl Roth
Plasmid DNApurification kit (NucleoSpin Plasmid) MACHEREY-NAGEL
Pluronic F-68 Invitrogen
Proteinase inhibitors (AEBSF, aprotinin, leupeptin, benzamidin,
pepstatinA) Calbiochem
PVDF membrane Carl Roth
QIAquick gel extraction kit Qiagen
QIAquick spin PCR purification kit Qiagen
Restriction enzymes Fermentas
SF-900 II serum free medium Invitrogen
Solution master detergent kit (10% solution ampules) Anatrace
SP Sepharose FF GE Healthcare
Strep-Tactin HRP IBA
Strep-Tactin matrices IBA
Superdex 200 PC 3.2/30 column GE Healthcare
Superose 6 PC 3.2/30 column GE Healthcare
T4 DNAligase Fermentas
Taq polymerase Fermentas
Tetracycline Carl Roth
N,N,N’,N’-Tetramethylethylendiamin (TEMED) Carl Roth
Triton X-100 SupelcoAnalytical
Trypan blue solution (0.4%) Sigma
Other chemicals Carl RothMaterial
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2.2 Primers
Table 2-2. Primers designed for mutagenesis of hTAPL
*
Primer Sequence
WalkerA
hTAPL_K545A CGGGCAGTGGGGCGAGCTCCTGTGTC
H-loop
hTAPL_H699A CTCATCATCGCGGCCCGGCTGAGCAC
Cys-less
hTAPL_C19A GAGTGTGGACATCGCCGTGACCACGGCC
hTAPL_C54A CTGGGCAGCCGCCCTGTACCGCAGC
hTAPL_C59A CTGTACCGCAGCGCCCTGCTGCTGGG
hTAPL_C90A GTCATCACCCTCGTGGCCCTCTTCGTGGGC
hTAPL_C233A CGTCATCGTGGCCCTGCTGGCCATTGGC
hTAPL_C264A CGCCTTCGAAACGCCCTCTTCCGCTCACTGGTG
hTAPL_C458A GTCCTGGGAGATGCCATGGAGTCCGTGGGC
hTAPL_C548V GGGAAGAGCTCCGTGGTCAACATCCTGG
Single cysteine mutants
hTAPL_S105C GCTGCTCTTCTGCGAGGTGCGCAG
hTAPL_S170C GAGCAGGCGTGCGGGGCCAC
hTAPL_M222C CATCCAGAAAAGCTGCGATCAGTTCAGC
hTAPL_A264C CCTTCGAAACTGCCTCTTCCGC
hTAPL_Y409C GCAGCTGCCTGCATGTACTACG
hTAPL_V465C CGTGGGCTCCTGCTACAGTGGCC
hTAPL_L701C CGCGCACCGGTGCAGCACCGTGG
* The mutation sites are underlined.Material
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Table 2-3. Primers designed for Haf-4 or Haf-9 cloning
*
Primer Sequence
haf-4_SacI_KpnI_for CGATTAGAGCTCGGTACCATGAATTCGACGGTGGCTT
CC
haf-4_rev AATTTATTCCGGCCGATGCG
haf-9_SacI_for CGATTAGAGCTCATGAGTTCTTCTCTTTACACGGGTG
G
haf-9_His10_NotI_rev ATAGCGGCCGCTCAGTGATGGTGATGGTGATGGTGAT
GGTGGTGGCTCAAATAGCTGCTTGCAAATGAGG
* The restriction sites are underlined.
Table 2-4 Sequencing primers
Primer Sequence
hTAPL_for2 ACCTTCACCTACCGCACTCG
hTAPL_for3 GGCCATTGGCAGCTCATTTG
hTAPL_revC GAGCGGAAGAGACAGTTTCG
haf-4_for_1 GTATCTTCGTTCCCTATTAC
haf-4_for_2 CACTTGATGTCACCAGAACC
haf-4_for_3 GTTCGCTCGTTCTGTGATGG
haf-4-rev CCTTGCGTAGGCGTACTCGAAGG
haf-9_for1 GCTCTCATTGGCTTCAACTG
haf-9_for2 TCACGTGGCGTTCAGTTATC
haf-9_revA TTGTAGCGTGTGCATAGGTG
ME-774FW CTTCTGCTCTAAAAGCTGCG
Table 2-5 M13 Primers
Primer Sequence
M13 Forward (-40) GTTTTCCCAGTCACGAC
M13 Reverse CAGGAAACAGCTATGACMaterial
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2.3 Peptides
Table 2-6 Peptides list
Peptide Sequence
C4F RRYC
fKSTEL; f: cysteine is labeled with fluorescein
R9LQK RRYQKSTEL
X9 library (X)9, X represents any L-amino acid residue except L-cysteine
X6 library (X)6, X represents any L-amino acid residue except L-cysteine
D-library (9 mer) (x)9, x represents any D-amino acid residue except D-cysteine
OX8 sublibraries O(X)8, O reflects a defined amino acid residue at the N-terminal
X8O sublibraries (X)8O, O reflects a defined amino acid residue at the C-terminalMethods
34
3 Methods
3.1 Molecular cloning
3.1.1 Plasmid DNApreparation
Single colonies of Escherichia coli (E. coli) strain DH5α transformed with the pFastBac
TM 1
plasmid were inoculated into 5 ml LB (Luria Bertani) medium (1% tryptone or peptone, 0.5%
yeast extract, 1% NaCl) supplemented with 100 µg/ml ampicillin using sterilized toothpicks
and cultivated on a shaker at 200 rpm overnight at 37 °C. Plasmid DNAwas prepared with the
NucleoSpin
® Plasmid kit (MACHEREY-NAGEL) according to the manufacturer’s
instructions. The plasmid DNA concentration was determined by measuring OD260 on the
NanoDrop
® spectrophotometer (NanoDrop Technologies, Inc.)
3.1.2 Ligase chain reaction for site-directed in vitro mutagenesis
Single or multiple defined point mutations of TAPL were achieved by ligase chain reaction
(LCR) using pFastBac
TM1_tapl_his (containing the gene of TAPL wt with a C-terminal
His10-tag) as the template (Wolters et al., 2005). The primers were phosphorylated by T4
Polynucleotide Kinase (T4 PNK) before LCR reaction. The LCR product was purified via
QIAquick PCR Purification Kit (Qiagen) and the parental plasmid DNA was digested by DpnI.
The digestion products were transformed into DH5α competent cells. Plasmid DNA was
prepared from single colonies and sequenced by corresponding sequencing primers.
Primer phosphorylation
2 µl primer (100 pmol/µl)
2 µl 10×Kinase BufferA
2 µlATP (10 mM)
1 µl T4 Polynucleotide Kinase (10 U/µl)
13 µl water
30 min incubation at 37 °C
10 min incubation at 70 °CMethods
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LCR reaction
1 µl plasmid DNA(ca. 1 µg)
10 µl 10×Pfu Buffer with MgSO4 (25 mM)
2 µl phosphorylated mutagenic primer (10 pmol/µl)
10 µl dNTP (2 mM)
1 µl NAD (100 mM)
1 µl Pfu DNAPolymerase (2.5 U/µl)
1 µlAmpLigase (5 U/µl)
74 µl water
LCR program
95 °C 3 min
95 °C 1 min
x °C 1 min 30 cycles
65 °C 16 min
65 °C 16 min
4 °C pause
x represents the annealing temperature for defined primers
DpnI digestion
2 µl 10×Buffer Tango
19 µl purified LCR product
2 µl DpnI (10 U/µl)
minimal 6 h or overnight incubation at 37 °C
20 min incubation at 80 °C
3.1.3 Plasmid DNArestriction analysis
Plasmid DNArestriction analysis was performed for 1 h at 37 °C. The reaction was stopped by
addition of 6×DNA loading dye (10 mM Tris/HCl, pH 7.6, 0.03% bromophenol blue, 0.03%
xylene cyanol FF, 60% (w/v) glycerol, 60 mM EDTA). The digested fragments were separated
by 0.8% agarose gel electrophoresis in 1×TAE (Tris-Acetate-EDTA) buffer (40 mM
Tris/acetate, pH 8.0, 1 mM EDTA). The electrophoresis was performed for around 1 h at 150 V.Methods
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The gel was stained with ethidium bromide solution (40 µl of 1% ethidium bromide solution
resolved in 400 ml deionized H2O) for 10 min and subsequently visualized under UV light.
3.1.4 Subcloning the gene of interest by restriction digestion and ligation
For subcloning the genes of interest into different vectors, 6 µg of plasmid DNA, containing
gene inserts or target vectors, were digested with corresponding restriction enzymes for 3 h at
37 °C. The amount of enzymes in a total reaction volume of 100 µl and the buffer system were
chosen according to the instruction provided by the manufacturer (Fermantas Life Sciences).
To prevent the vector from self ligation, 1 µl (1 U/µl) of CIAP (calf intestine alkaline
phosphatase) was added to dephosphorylate the vector after double digestion. The reactions
were stopped by inactivating the enzymes for 20 min at 80 °C.
The restriction products were separated by electrophoresis using 0.8% agarose gel in 1×TAE
buffer and purified via a gel purification kit (QIAquick Gel Extraction Kit, Qiagen). DNA
concentration in the 50 µl eluate was determined by OD260. The purified insert and vector were
mixed in different molar ratio (from 3:1 to 6:1) and ligated with T4 DNA ligase overnight at
16 °C. Subsequently, the ligation products were transformed into DH5α competent cells (see
3.2.3) for further characterizations.
3.1.5 Subcloning the cDNAs of Haf-4 and Haf-9 by PCR
The cDNAs of human TAPL orthologs Haf-4 and Haf-9 from Caenorhabditis elegans were
subcloned into the baculovirus expression system by PCR. The cDNA of Haf-4 with a
C-terminal Myc-tag was subcloned from the construct pJG98_haf-4_myc (Bauer, 2006) into
pFastBac
TM1 using the forward primer haf-4_SacI_KpnI_for and reverse primer haf-4_rev.
The PCR product and vector pFastBac
TM1 were restricted by SacI and NotI followed by
ligation as described above. The cDNA clone (yk1417f02) of Haf-9 (ORF name=ZK484.2a)
was kindly provided by Prof. Dr. Yuji Kohara (National Institute of Genetics, Mishima/Japan).
The Haf-9 cDNA was subcloned from the pME18-FL3 vector into pFastBac
TM1 by PCR using
the forward primer haf-9_SacI_for and reverse primer haf-9_His10_NotI_rev (introducing a
C-terminal His10-tag). The PCR products were purified via a gel purification kit and digested
with SacI and NotI. The vector pFastBac
TM1 was digested in the same way and ligated with
PCR fragments as described above.Methods
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PCR reaction
1 µl plasmid DNA(ca. 20 ng)
5 µl 10×Pfu Buffer with MgSO4
0.25 µl primers (100 pmol/µl)
5 µl dNTP (2 mM)
0.5 µl Pfu DNAPolymerase (2.5 U/µl)
2.5 µl DMSO
35 µl water
PCR program
95 °C 4 min
95 °C 1 min
x °C 1 min 35 cycles
72 °C 6 min
72 °C 10 min
4 °C pause
x represents the annealing temperature for defined pair of primers
3.1.6 Isolation of the recombinant Bacmid DNA
Transformation of DH10Bac
TM cells and isolation of recombinant Bacmid DNA were
performed according to the manual for the Bac-to-Bac
® Baculovirus Expression System
(Invitrogen). This procedure was originally developed to isolate large plasmids (>100 kb) and
has been adapted to allow isolation of Bacmid DNA. PCR analysis (using M13 primers) was
used to verify the presence of the gene of interest in the recombinant Bacmid. DNA
concentration was determined by OD260.
3.2 Microbiological techniques
3.2.1 Bacterial culture
E. coli strain DH5α and DH10Bac were routinely cultivated in either LB medium (1%
tryptone or peptone, 0.5% yeast extract, 1% NaCl, pH 7.0) or on a LB agar plate (LB medium
supplied with 1.5% agar). If not otherwise indicated, antibiotics were added to a certain
concentration after autoclaving.Methods
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Antibiotic stock solution (mg/ml) Working concentration
Ampicillin 100 mg/ml in water 100 μg/ml
Kanamycin 50 mg/ml in water 50 μg/ml
Tetracycline 10 mg/ml in water 10 μg/ml
Gentamicin 7 mg/ml in water 7 μg/ml
filter-sterilized, stored at -20 °C and protected from light
3.2.2 Preparation of competent cells
DH5α cells were inoculated into 10 ml LB medium without any antibiotics and cultivated at
200 rpm overnight at 37 °C. Subsequently, the culture was scaled up into a shaker flask
containing 200 ml LB medium with no antibiotics, and shaken at 200 rpm at 37 °C until OD600
reaches 0.3–0.4. The culture was cooled down for 10 min on ice, and then centrifuged at
2000×g for 10 min at 4 °C. The cell pellet was resuspended in 40 ml ice cold TBF-I buffer
(30 mM KAc, 100 mM RbCl, 50 mM MnCl2, 10 mM CaCl2, 15% (w/v) glycerol, adjusted to
pH 5.8 with 1 M acetic acid, sterile filtered), incubated for 1 h on ice and centrifuged at
4000×g for 10 min at 4 °C. Finally, the cell pellet was resuspended in 8 ml ice cold TFB-II
buffer (10 mM MOPS, 10 mM RbCl, 75 mM CaCl2, 15% (w/v) glycerol, adjusted to pH 6.8
with 1 M KOH, sterile filtered), 100 µl aliquots were snap-frozen in liquid nitrogen and stored
at -80 °C. To prepare DH10Bac competent cells, the same procedure was applied except that
the cells were grown in LB medium supplied with 50 µg/ml kanamycin and 10 µg/ml
tetracycline.
3.2.3 Transformation of plasmid DNAinto chemical competent bacterial cells
For the transformation of DH5α cells, 1 ng of the plasmid DNA was incubated with 100 µl of
DH5α competent cell suspension for 30 min on ice, if not otherwise mentioned. The mixture
was heat shocked for 90 sec at 42 °C and then cooled down on ice for 1–2 min. 500 µl of LB
medium without any antibiotic was added to the mixture and the cells were shaken on a
thermomixer (Eppendorf) at 300 rpm for 45 min at 37 °C. After centrifugation at 19000×g for
1 min at room temperature, the cell pellets were resuspended in 100 µl LB medium without
antibiotics and plated onto LB agar plates containing corresponding antibiotics. The plates
were incubated overnight at 37 °C.
For the transformation of DH10Bac cells, 1 ng of the plasmid pFastBac
TM1 containing the
gene of interest was added to the cells (100 μl suspension) and mixed gently. After incubatingMethods
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for 30 min on ice, the cells were heat shocked for 45 sec at 42 °C and immediately cooled
down for 2 min on ice. 900 µl of S.O.C. medium (2% tryptone, 0.5% yeast extract, 0.05%
NaCl, 2.5 mM KCl, 20 mM glucose, pH 7.0) was added to the cells and they were shaken on
the thermomixer at 300 rpm for 4 h at 37 °C. An aliquot of 100 µl of suspension was plated on
a LB agar plate supplied with 50 µg/ml kanamycin, 7 µg/ml gentamicin, 10 µg/ml tetracycline,
100 µg/ml Bluo-gal, and 40 µg/ml IPTG. The plates were incubated for 48 h at 37 °C. White
colonies were picked and restreaked onto fresh LB agar plates containing the above additives
and cultivated overnight at 37 °C. Single colonies confirmed to be white were inoculated into
2 ml LB liquid cultures supplied with 50 µl/ml kanamycin, 7 µg/ml gentamicin, 10 µg/ml
tetracycline. The recombinant Bacmid DNAwas prepared as described in 3.1.6.
3.3 Cell biology techniques
3.3.1 Thawing and freezing of Sf9 insect cells
Before starting transfection and expression experiments, Spodoptera frugiperda (Sf9) insect
cells had to be cultured. Normally, the cell culture started from an aliquot of cryo stock in
liquid N2. The cryo tube containing 1 ml Sf9 cells (density≥1.0×10
7/ml) was thawed in a water
bath at 27 °C. As soon as the cells were thawed, they were diluted with 4 ml ice cold modified
Sf-900 II SFM medium (containing 5% fetal calf serum, 50 u/ml penicillin, 50 µg/ml
streptomycin, 0.5 µg/ml Fungizone and 0.1% (v/v) Pluronic F-68) and incubated in a T25 Roux
flask for 20 min at 27 °C. Subsequently, the medium was changed to 5 ml prewarmed medium
(27 °C) and the cells were cultivated for several days at 27 °C until they grew confluent. The
medium was changed every second day. For long term storage, aliquots of cryo stocks can be
prepared from either adherent culture (50–60% confluency) or suspension culture (cell density
of 1.3–1.5×10
6/ml). Cell viability should be higher than 99%. The cells were harvested by
centrifugation at 1000×g for 5 min at room temperature and resuspended in a freezing mixture
(Sf-900 II SFM medium containing 10% fetal calf serum, 10 u/ml penicillin, 10 µg/ml
streptomycin and 10% DMSO) to a cell density of 1.0×10
7/ml. Aliquots of 1 ml cell
resuspension were frozen for 1 h at -20 °C, then for 24 h at -80 °C and finally stored in liquid
N2. The cell viability after such a treatment can be checked by thawing an aliquot of the cryo
stocks.Methods
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3.3.2 Sf9 insect cells culture
Sf9 cells were routinely maintained in adherent culture. When cells grew 80–90% confluent,
the medium was discarded by aspiration. Then fresh, prewarmed medium was added to the
flask (5 ml for T25 flask and 15 ml for T75 flask), and cells were resuspended by pipetting.
Subsequently, the cells were inoculated into a new flask (2×10
4for T25 flask and 5×10
4 for T75
flask) and cultured at 27 °C until 80–90% confluent.
In order to have large amounts of cells, the cell culture had to be adapted to suspension culture
and scaled up in shaker flasks. The cells in a T75 flask were cultured until 2-3 layers and
dislodged by gentle patting on the bottom of the flask. Subsequently, the cells were diluted to
0.4×10
6/ml (100 ml volume) and shaken in a 250-ml shaker flask at 110 rpm at 27 °C. When
the cell density reached 2.0×10
6/ml, the cells were subcultured in a 1.8 L-Fernbach flasks
(Schott Duran) with up to 700 ml medium and shaken at 60 rpm at 27 °C.
3.3.3 Transfecting Sf9 cells with recombinant Bacmid DNA
The transfection of Sf9 insect cells was carried out using the calcium phosphate mediated
transfection kit (BD BaculoGold
TM Transfection kit containing buffer A and B) from BD
Biosciences. 1.5×10
6 Sf9 cells were seeded per well (of a 6-well tissue culture plate) and
allowed to attach for at least 15 min at 27°C. In the mean time, 500 µl of buffer B with 10 µg
Bacmid DNA were incubated for 10 min at room temperature. When the cells were attached,
the medium was removed by aspiration and 500 µl of buffer A was added to the plate.
Subsequently, the Bacmid DNA in buffer B was added drop by drop into buffer A. The
suspension was mixed by gentle shaking and the plates were incubated for 4 h at 27 °C with
gentle mixing every hour. After removing the suspension, the cells were washed once with
medium and then incubated in 3 ml fresh medium for 6–7 days at 27 °C until harvesting the
supernatant (corresponding to P0 virus stock) by centrifugation at 500×g for 5 min at room
temperature.
3.3.4 Amplification of the recombinant baculovirus
To obtain a high virus titer and an optimal expression, the virus stock had to be amplified
several times. 0.8 ml of the P0 stock was used to infect 4×10
6 cells seeded into a T25 flask
containing 5 ml medium. After 6–7 days, the virus was harvested by centrifugation and named
P1 virus stock. The P2 virus stock was amplified by infecting 12×10
6 cells (in 12 ml medium)
in a T75 flask with 0.8 ml P1 virus stock. Finally, 13 ml of the P2 virus stock was used toMethods
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amplify 500 ml of the P3 virus stock in a Fernbach flask with a cell density of 1.5×10
6/ml.
After 7 days, the P3 virus stock was harvested (the cell death ratio should be around 95%) by
centrifugation at 4000×g for 25 min at room temperature. All virus stocks were stored at 4 °C
and protected from light.
3.3.5 Virus titer determination
In order to determine the virus titer or pick up single virus colonies which showed high
expression levels, a plaque assay was performed. Before infection, 1.2×10
6 of Sf9 cells were
seeded in a well of 6-well plates. During attachment of the cells (15 min, 27 °C), 10-fold serial
dilutions (10
-3 to 10
-8) of the virus were prepared in Sf-900 II SFM medium without
supplements. The medium was removed by aspiration and each well was inoculated with 1 ml
of the virus dilutions (10
-6 to 10
-8). The plates were incubated for 1 h at 27 °C. After removing
the virus inoculums, 3 ml of 2% low melting agarose solution (1 g agarose in 50 ml medium,
prewarmed at 40 °C) was added to the wells. After incubating the plates for 5 days at 27 °C,
0.5 ml of 0.1% neutral red solution (Sigma) was used to stain the agarose plates for 1 h at
27 °C. The supernatant was removed and the plates were incubated for another 24 h at 27 °C
before counting the plaques. If necessary, single colonies were picked from the agarose plates
with a Pasteur pipette to infect Sf9 cells (0.1×10
6 cells in 1 medium) seeded into 24-well plates
for virus amplifications. The following formula was used to calculate the titer (plaque forming
units (pfu)/ml) of the viral stocks. Note that the optimal range to count is 3 to 20 plaques per
well of a 6-well plate.
ell inoculum/w of ml
1
factor dilution plaques of number (pfu/ml) titer   
3.3.6 Recombinant membrane protein expression
Once a recombinant pFastBac baculoviral stock with a suitable titre (around 1×10
8 pfu/ml)
had been generated, Sf9 insect cells were infected for expression of recombinant membrane
proteins. Sf9 cells were cultivated in shaker flasks in modified Sf-900 II SFM medium to a
density of 2×10
6/ml. Then the baculoviral stock was added to reach a MOI (multiplicity of
infection, defined as the number of virus particles per cell) of 2. The expression was carried
out for 48 h at 27 °C. The protein expression was detected by immunoblotting using specific
antibodies. To prepare the immunodetection samples, 0.5 ml cell culture was harvested 48 h
after infection by centrifugation at 1000×g for 5 min at 4 °C. The cell pellet was washed onceMethods
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with phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4,
1.8 mM KH2PO4, pH 7.4) and solubilized with 45 μl of 5×SDS sample buffer (313 mM
Tris/HCl, pH 8.0, 10% SDS, 50% glycerol, 0.5% bromophenol blue) supplemented with 1 μl
Benzonase
® Nuclease (25 U/μl, Merck) and 100 mM DTT. The sample was incubated for
30 min at 37 °C before SDS-PAGE (10%) and immunoblotting. Alternatively, the cell pellets
after virus harvesting could also be treated in the same way and analyzed for expression.
3.4 General biochemical methods
3.4.1 Protein concentration determination
The total protein concentration in the membranes or concentrations of synthetic peptides were
determined by BCA assay using the Micro BCA
TM Protein Assay Kit (Pierce). The assay
utilizes bicinchoninic acid (BCA) as the detection reagent for Cu
1+, which is formed when
Cu
2+ is reduced by the protein in an alkaline environment. Apurple-colored reaction product is
formed by the chelation of two molecules of BCA with one cuprous ion (Cu
1+). This
water-soluble complex exhibits a strong absorbance at 562 nm that is linear with increasing
protein concentrations. The macromolecular structure of the protein, the number of peptide
bonds and the presence of four amino acids (cysteine, cystine, tryptophan and tyrosine) are
reported to be responsible for the color formation with BCA (Wiechelman et al., 1988). A
microplate procedure (linear working range of 2–40 µg/ml) was used in all membrane
preparations. All of the samples and standard protein albumin were serial diluted in PBS.
150 µl of the sample or standard was mixed with 150 µl of freshly prepared working reagent
in a 96-well microplate. The plate was incubated for 40 min at 37 °C before measuring the
absorbance at 584 nm on a plate reader. The working reagent was prepared by mixing the
following kit contents (25:24:1, reagent MA: MB: MC). The Micro BCA
TM Protein Assay Kit
contents are the following: Micro BCA
TM Reagent A (MA) with sodium carbonate, sodium
bicarbonate and sodium tartrate in 0.2 N NaOH; Micro BCA
TM Reagent B (MB) with 4%
bicinchoninic acid in water; Micro BCA
TM Reagent C (MC) with 4% cupric sulfate and
pentahydrate in water.
The concentration of the purified protein was determined via the modified Bradford method
using Coomassie Plus—The Better Bradford
TM Assay Reagent (Pierce), which is compatible
with glycerol and high concentrations of imidazole. When Coomassie dye binds the protein in
an acidic surrounding, an immediate shift in absorbance maximum occurs from 465 nm to
595 nm. A standard microplate protocol (linear working range of 100–1500 µg/ml) was usedMethods
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by mixing 10 µl of the purified protein with 300 µl assay reagent (Coomassie G-250 dye,
methanol, phosphoric acid and solubilizing agents in water). After incubation of the plate for
10 min at room temperature, the absorbance at 584 nm was recorded on a plate reader.
3.4.2 SDS-PAGE
SDS-PAGE gels (8×9 cm² size) were prepared with a home made gel casting system (8–9 gels
at the same time). The separating gels and stacking gels were prepared with the components
listed in Table 3-1. Normally, 10% SDS-PAGE gels were used.
Table 3-1. Components for the preparation of 10% SDS-PAGE gels (The amounts are for 8–9 gels)
Compound Separating gel (10 %) Stacking gel (4.5 %)
H2O 31.25 ml 18.0 ml
Separating buffer
1 18.75 ml –
Stacking buffer
2 – 7.5 ml
Rotiphorese 30 25.0 ml 4.5 ml
10 % APS
3 300 μl 180 μl
TEMED 70 μl 60 μl
1 Separating buffer: 1.5 M Tris/HCl, pH 8.8, 0.4 % SDS.
2 Stacking buffer: 0.5 M Tris/HCl, pH 6.8, 0.4 % SDS.
3 10% (w/v) ammonium persulfate solution (APS) must be made freshly or stored frozen.
The samples for the SDS-PAGE were prepared by mixing crude membranes or purified
proteins with 5×SDS sample buffer (313 mM Tris/HCl, pH 8.0, 50% glycerol, 10% SDS and
0.5% bromophenol blue) and 100 mM DTT. The samples were incubated for 30 min at 37 °C.
The gels were run for approximately 60 min at 175 V in 1×Tris-glycine electrophoresis buffer
(25 mM Tris/HCl, pH 8.3, 192 mM glycine, 0.1% SDS). Prestained protein molecular weight
marker (Fermentas) was used as a standard. The gels were either stained in Coomassie blue
R-250 staining solution (40% methanol, 10% acetic acid, 0.25% Coomassie blue R-250) or
electroblotted for immunodetection.
3.4.3 Immunoblotting
The proteins on SDS-PAGE were transferred onto a nitrocellulose (NC) membrane by
electroblotting. Before blotting, the NC membrane and two layers of Whatman filter paper
were soaked shortly in electroblotting buffer (192 mM glycine, 25 mM Tris, 20% (v/v)
methanol). A sandwich of paper-membrane-gel-paper was placed on to a semi-dry blot
apparatus (Bio-Rad) and blotted for 90 min under constant current (100 mA per gel). The NCMethods
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membrane was incubated for at least 1 h in blocking buffer and afterwards washed 3 times
(5 min each) with TBS-T buffer (10 mM Tris/HCl, pH 8.0, 150 mM NaCl, 0.1% Triton X-100).
Membranes were normally blocked in milk-containing blocking buffer (5% (w/v) skim milk
powder, 0.1% NaN3 in TBS-T buffer) except for Strep-Tactin HRP blotting, of which the
membrane was blocked with α-strep blocking buffer (3% BSA in TBS-T buffer). The different
antibodies used for various proteins are listed in Table 3-2. Subsequently, the NC membrane
was incubated for 1 h with the primary antibody and washed 3 times (5 min each) with TBS-T
buffer. Afterwards, it was incubated for another hour with the secondary antibody and washed
again 3 times with TBS-T buffer. For developement, the NC membrane was first incubated in
ECL (Enhanced chemilumiscence) solution 1 (100 mM Tris/HCl, pH 8.5, 2.5 mM luminol
sodium salt, 0.4 mM coumaric acid) for 1 min after which ECL solution 2 (100 mM Tris/HCl,
pH 8.5, 0.02% H2O2) was added to the mixture. The chemiluminiscent signals on the
membrane were documented after 1 min using a Lumi-Imager
TM F1 (Roche). The
immunoblotting signal intensity could be quantified by LumiAnalysis
TM image analysis
software.
Table 3-2. The conditions for immunoblotting with antibodies for different proteins
Detected
protein
Used detection
Primary
antibody Epitope Dilution Secondary
antibody
1 Dilution Company/
reference
TAPL Purified α-TAPL
2
(final bleeding)
17 a.a. at the
C-terminus
1:500 in 2%
milk/TBS-T α-rabbit 1:10,000 in
TBS-T
BioScience
(Wolters et
al., 2005)
His-tagged α-His His10-tag 1:2,000 in TBS-T α-mouse 1:10,000 in
TBS-T Qiagen
Strep-tagged Strep-Tactin HRP Strep-tag 1:10,000 in
1.5% BSA/TBS-T – – IBA
Myc-tagged α-Myc Myc-tag 1:2,000 in TBS-T α-mouse 1:10,000 in
TBS-T Millipore
1All secondary antibodies were purchased from Sigma.
2Purified using the epitope coupled to NHS (N-hydroxyl succinimide) activated agarose.
If the NC membrane had to be redeveloped with the second primary and secondary antibodies,
membrane stripping was applied to remove the original primary and secondary antibodies. The
membrane was incubated in stripping buffer (62.5 mM Tris/HCl, pH 6.8, 2% SDS and
100 mM β-mercaptoethanol) for 30 min at 50 °C. The stripped membrane was washed twice
with TBS-T buffer, blocked in blocking buffer followed by development with the new primary
and secondary antibodies as described in the normal protocol.Methods
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3.5 Biochemical assays for TAPL
3.5.1 Peptide labeling with 5-iodoacetamidofluorescein
All peptides were synthesized by solid phase technique applying conventional Fmoc-chemistry.
Peptides containing cysteine residues at various positions were coupled to fluorescein by
incubating 2.5 mg of peptides with a 1.2 molar excess of 5-iodoacetamidofluorescein (5-IAF,
Molecular Probes) in PBS (pH 6.5), 20% (v/v) dimethylformamide (DMF) for 2 h at room
temperature in the dark. Labeled peptides were purified by reversed-phase C18 analytical
column (column size 4.6 mm×250 mm, particle size 5 μm, pore size 300 Å, Vydac) on a Jasco
HPLC system. The elution was monitored with the absorbance detector (280/450 nm). A
gradient of water/acetonitrile (0.1% trifluoroacetic acid (TFA)) was used to separate labeled
peptide from free dyes as well as unlabeled peptides. The fractions from the HPLC were
pooled, snap-frozen in liquid N2 and lyophilized. Finally, the labeled peptides were resolved in
water and stored at -20 °C. The identity and purity of labeled peptides were verified by
MALDI-TOF (Matrix-assisted laser desorption/ionisation-time of flight) mass spectrometry.
The peptide concentration was determined by OD492 in 100 mM Tricine buffer, pH 9.0 (molar
extinction coefficient (ε): 75000 cm
-1M
-1).
3.5.2 Peptide labeling with Na
125I
Peptides were iodinated using the chloramine T-method (Hunter and Greenwood, 1962).
Before start, 15 µl of 8.8 µM peptides were diluted with 35 µl PBS (pH 7.4). The reaction was
initiated by addition of 10 µl 1% (w/v) chloramine T/PBS and 10 µl (100 µCi) Na
125I. After a
5-min incubation at room temperature, the reaction was stopped by addition of 120 µl sodium
disulfite (Na2S2O5) solution (0.17 mg/ml in PBS). To remove free iodine, 220 µl Dowex 1X8
resin (stored in 100 mg/ml in PBS/0.2% dialyzed BSA/0.1% NaN3; washed 3 times with PBS
before use) were added to the radiolabeled reaction mixture, vortexed and incubated for 5 min
at room temperature. The suspension was applied to an empty spin column (Bio-Rad) and
centrifuged at 750×g for 30 sec at room temperature. The flow-through containing
radiolabeled peptides was collected and complemented with 500 µM unlabeled peptides to the
final concentration of 10 µM. The specific activity of the peptides was measured on a
γ-counter (Beckman Coulter). Normally 2 µl of the iodinated peptides has about 400,000 CPM
(counts per minute). For the labeling of peptide libraries, a peptide concentration of 40 µM
instead of 8.8 µM was used in the reaction. Correspondingly, 200 µCi of Na
125I were added to
achieve high labeling efficiency.Methods
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3.5.3 Membrane preparation
Membranes containing the target protein were prepared from Sf9 insect cells infected with
recombinant baculovirus. After 48 h of infection, 10 µl aliquot of cell culture was incubated
with 10 µl of 0.4% trypan blue solution (Sigma) for several minutes at room temperature. The
numbers of total cells and dead cells were counted on a cell counting chamber (Roth), and the
cell density as well as the viability was calculated. From a standard 500 ml expression, the
cells were harvested by centrifugation at 1000×g for 10 min at 4 °C. Afterwards, the pellet was
washed with ice cold PBS and centrifuged again at 1000×g for 5 min at 4 °C. The pellet was
frozen at -20 °C before preparing membranes. For membrane preparation, the cell pellet was
thawed on ice in the presence of 50 ml of ice cold 10 mM Tris/HCl (pH 7.4) supplemented
with 1% PI-Mix (5 mg/ml AEBSF hydrochloride, 0.1 mg/ml aprotinin, 1 mg/ml leupeptin,
0.5 mg/ml pepstatin A and 15.6 mg/ml benzamidine). As an alternative, a mixture of 1 mM
phenylmethylsulfonyl fluoride (PMSF) and 2.5 mM benzamidine was used instead of 1%
PI-Mix. The cells were disrupted by douncehomogenization (30 times) with a dounce tissue
grinder (Wheaton). To remove the cell debris and nuclei, sampleswere centrifuged at 200×g
for 4 min followed by another centrifugation at 700×g for 8 min at 4 °C. Subsequently, the
supernatant was pelleted by centrifugation at 20,000×g for 30 min at 4 °C. Crude membranes
were resuspended in HEPES buffer (20 mM HEPES, 140 mM NaCl, pH 7.5), and aliquots
were snap-frozen in liquid nitrogen and storedat -80 °C. The total protein concentration was
determined by BCAassay.
3.5.4 Membrane solubilization
To find the optimal detergent for solubilization, crude membranes were pelleted and
resuspended in solubilization buffer (20 mM HEPES, 140 mM NaCl, 15% (w/v) glycerol, pH
7.5) supplemented with 1 mM PMSF, 2.5 mM benzamidine to end up with a protein
concentration of 5 mg/ml. Detergents were added to reach a ρ value of 2, where ρ is given as 
follows (Rivnay and Metzger, 1982),
 
  lipid
CMC detergent 
 
where CMC represents the critical micelle concentration of the detergent. The lipid-to-protein
ratio (w/w) was assumed to be 1, and the average molecular mass of phospholipids was taken
as 700 Da. After incubation with detergent for 30 min on ice, the solubilized samples were
centrifuged at 100,000×g for 30 min at 4 °C. To determine the solubilization efficiency, theMethods
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supernatant was analyzed by SDS-PAGE (10%) followed by immunoblotting using an
epitope-purified anti-TAPL polyclonal antibody (see 3.4.3) and quantified by
chemiluminescence using Lumi-Imager
TM F1. The signals were normalized to the
solubilization efficiency of crude membranes observed with 1% SDS.
3.5.5 Determination of critical micelle concentration
The critical micelle concentration of digitonin and dodecylmaltoside (DDM) in the
purification solutions was determined by a fluorimetric method (De Vendittis et al., 1981). The
anionic dye, 8-anilinonaphthalene-1-sulfonic acid (ANS), is almost nonfluorescent in water
but becomes highly fluorescent in organic solvents or in the interior of a micelle. In brief,
1.26 ml of ANS solutions (30 µM ANS in IMAC (Immobilized Metal Affinity
Chromatography) binding buffer or elution buffer (20 mM HEPES, 140 mM NaCl, 15% (w/v)
glycerol, pH 7.5, with 20 mM or 250 mM imidazole, respectively)) were titrated in 5 µl steps
with detergent solutions (20 mM HEPES, pH 7.5, 0.5% detergent, 30 μM ANS, 140 mM NaCl,
15% (w/v) glycerol, 20 mM or 250 mM imidazole) in the Fluorolog-3 fluorescence
spectrometer (Horiba). The exitation wave length was set to 410 nm, and emission intensity
was recorded at a wave length range of 450–520 nm. The excitation and emission slit widths
were at 5/5 nm. The integration interval was set to 1 nm and the sample was stirred constantly
at 5 °C. The intensity at maximal emission (493 nm) was plotted against the detergent
concentrations. The CMC was given by the intercept of two extrapolated lines with low and
high slopes.
3.5.6 Purification
Crude membranes containing TAPL (5 mg/ml) prepared from Sf9 insect cells were solubilized
in solubilization buffer supplemented with 20 mM imidazole, 1 mM PMSF, 2.5 mM
benzamidine, and 1% digitonin. After 30-min incubation on ice and centrifugation (30 min at
100,000×g at 4 °C), the supernatant was applied to a SP Sepharose
TM Fast Flow column
equilibrated with binding buffer (20 mM HEPES, 140 mM NaCl, 20 mM imidazole, 15% (w/v)
glycerol, pH 7.5) supplemented with 0.1% digitonin. The flow-through was loaded onto a
Zn
2+-iminodiacetate (Zn-IDA) column (Sepharose
TM) equilibrated with binding buffer
supplemented with 0.1% digitonin. After stringent washing with up to 100 mM imidazole, the
specifically bound protein was finally eluted with elution buffer (20 mM HEPES, 140 mM
NaCl, 250 mM imidazole, 15% (w/v) glycerol, pH 7.5) supplemented with 0.1% digitonin.Methods
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The eluate was concentrated in a 100 kDa cut-off Amicon
TM concentrator (Millipore). When
DDM instead of digitonin was used for purification, a concentration of 0.3–0.5% was used for
solubilization, and 0.05% for washing and elution. When Triton X-100 was used for the
purification, the detergent concentration for solubilization and purification were 1% and 0.1%,
respectively.
3.5.7 Gel filtration
TAPL with a concentration of 1 mg/ml was centrifuged at 100,000× g for 30 min at 4 °C and
subjected to gel filtration (size exclusion chromatography (SEC)). A 50 µl aliquot of TAPL
was applied to a Superose
TM 6 PC 3.2/30 column on Ettan LC system (GE Healthcare). The
protein was eluated with elution buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 250 mM
imidazole, 15% (w/v) glycerol) supplemented with 0.1% digitonin or 0.05% DDM, at a flow
rate of 50 µl/min. The absorbances at 254 nm and 280 nm were recorded. Fractions of 100 µl
were collected and analyzed by SDS-PAGE (10%) and immunodetection. For column
calibration, soluble protein standards from Sigma were used. To determine the size
(hydrodynamic radius) and oligomeric status of TAPL, Ve/Vo of TAPL was compared to Ve/Vo
of the protein standards (Ve is the elution volume and Vo is the void volume). The Vo was
determined by the elution volume of blue dextran (molecular weight approx. 2,000,000 Da).
The logarithms of the molecular mass of standard proteins versus their respective Ve/Vo values
were plotted and fitted by a linear regression.
3.5.8 Blue native PAGE
For Blue native PAGE (BN-PAGE), a 4–13% gradient gel was used, which covers protein
mass range of 10 kDa to 3 MDa. The amount of each reagent used to cast 9 mini gels
(0.1×9×7 cm) are given in Table 3-3. The separation gels were casted in the cold (4 °C) using
a gradient mixer. Before casting the separation gels, 1-cm height of water was loaded into the
gel-casting device and, subsequently, the acrylamide solution was pumped in through a hole
from the bottom. The sample gels were casted after the separation gels were polymerized at
room temperature. For storage, the sample combs were removed and gels were covered with
1×gel buffer (25 mM imidazole, 0.5 M 6-aminohexanoic acid, pH 7.0). The gels were stored at
4 °C for up to 4 weeks if the overlayed 1×gel buffer was changed at three days intervals.Methods
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Table 3-3. Solutions for preparating 9 BN-PAGE gels (0.1×9×7 cm)
Sample gel Gradient separation gel
3.5% acrylamide 4% acrylamide 13% acrylamide
Acrylamide-bisacrylamide mixture
1 2.64 ml 3 ml 7.8 ml
3×gel buffer 12 ml 12 ml 10 ml
Glycerol (86%) – – 6.2 ml
Water 20.4 ml 20.8 ml 6 ml
Total volume 36 ml 36 ml 30 ml
10% APS
2 300 μl 200 μl 150 μl
TEMED 30 μl 20 μl 15 μl
1 Acrylamide-bisacrylamide mixture: 48 g acrylamide and 1.5 g bisacrylamide per 100 ml. Stored at 4 °C.
2 10% (w/v) ammonium persulfate solution (APS) must be made freshly or stored frozen.
The crude membranes used for BN-PAGE were suspended in BN-PAGE solubilization buffer
(50 mM imidazole/HCl, pH 7.0, 50 mM NaCl, 1 mM EDTA, 2 mM 6-aminohexanoic acid),
snap-frozen in liquid N2 and stored at -80 °C. For sample preparation, 500 μg membranes were
solubilized in BN-PAGE solubilization buffer supplemented with detergent. The detergent was
added to a given detergent/protein ratio of 6 g/g for digitonin and 2.5 g/g for DDM,
respectively. The membranes were solubilized for 30 min on ice, and the insoluble parts were
pelleted by centrifugation at 20,000×g for 15 min at 4 °C. Subsequently, glycerol (86%, w/v)
and 5% (w/v) Coomassie blue G-250 (Serva) (suspended in 500 mM 6-aminohexanoic acid,
stored at 4 °C) were added to the supernatant to give an end glycerol concentration of 5% (w/v)
and detergent/dye ratio of 8 g/g, respectively. If the purified protein was analyzed in
BN-PAGE, 5% (w/v) glycerol and 0.01% Ponceau S from a Ponceau S/glycerol stock solution
(0.1% Ponceau S, 50% glycerol, (w/v)) was added instead of Coomassie blue dye to avoid
dissociation of the detergent-labile subunits. As a molecular mass standard, bovine heart
mitochondria (400 μg protein, as a generous gift from Prof. Dr. Hermann Schägger and Dr.
Ilka Wittig, Uni-Frankfurt) were solubilized and treated as described in the original protocol
(Wittig et al., 2006). 7.5 μg of purified TAPLwas loaded onto the BN-PAGE.
The electrophoresis was performed at 4 °C using the buffers listed in Table 3-4. The power
supply was set at 100 V until the samples had entered the gel. Then, the electrophoresis was
continued with a constant voltage of 300 V (current limited to 10 mA). After the blue running
front had moved about one third of the desired total running distance, the cathode buffer B was
changed to slightly blue cathode buffer B/10 for better detection of faint protein bands, and to
improve native blotting (Wittig et al., 2006). The gel was stained in Coomassie blue R-250Methods
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(40% (v/v) methanol, 10% (v/v) acetic acid, 0.25% (w/v) Coomassie blue R-250) and
destained with destaining solution (40% (v/v) methanol, 10% (v/v) acetic acid).
Table 3-4. Electrode and gel buffers for BN-PAGE
*
Cathode buffer B Cathode buffer B/10 Anode buffer 3×gel buffer
Tricine (mM) 50 50 – –
Imidazole (mM) 7.5 7.5 25 75
Coomassie blue G-250 (%) 0.02 0.002 – –
6-Aminohexanoic acid (M) – – – 1.5
pH 7.0 7.0 7.0 7.0
*Adapted from the original protocol (Wittig et al., 2006).
Electroblotting was carried out on a semi-dry electronic blotter (Bio-Rad). Before blotting,
PVDF (Polyvinylidene difluoride) membrane was first soaked in methanol and BN-PAGE
electroblotting buffer (50 mM Tricine, 7.5 mM imidazole, pH 7.0) together with two pieces of
3-mm Whatman chromatographic papers. The transfer was performed for 3 h at room
temperature with current limited to 0.5 mA/cm
2 gel area. The membrane was destained in
destaining solution (40% (v/v) methanol, 10% (v/v) acetic acid) to record the protein standards.
Afterwards, the membrane was further destained by methanol and sequentially developed for
immunoblotting (3.4.3).
3.5.9 Reconstitution
To remove all kinds of contaminations, the E. coli total lipid extract (Avanti) was washed by
aceton/ether. The crude lipid extract was dissolved in chloroform (2.5 ml per 0.5 g lipid).
Resolved lipids were dropped slowly into 100 ml cold (-20 °C) acetone containing 1 mM DTT.
The suspension was stirred vigorously for 4 h (or overnight) at 4 °C and protected from light.
Importantly, a clamp was added on the stopper, otherwise, the increased pressure upon stirring
would blow it away. The insoluble part was precipitated by centrifugation in a glass tube at
2500×g for 15 min at room temperature. The pellet was washed once with 100 ml cold acetone
containing 1 mM DTT, and dried thoroughly by a N2 stream. Lipids were dissolved in 200 ml
of diethyl ether with 10 mg of DTT under stirrer mixing for 1 h at room temperature. The
suspension was centrifuged again at 2500×g for 15 min at room temperature to remove the
insoluble material. The supernatant was carefully transferred to a preweighed round bottom
flask, and diethyl ether was evaporated on a rotary evaporator at 40 °C. Finally, the lipid filmMethods
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was weighed and resolved in chloroform to a concentration of 20 mg/ml. The washed lipid
was named as the E. coli polar lipid extract and stored at -20 °C under N2 gas.
For liposome preparation, lipids were dissolved in chloroform at 20 mg/ml and mixed in
defined ratios (w/w). Chloroform was removed under reduced pressure on a rotary evaporator.
The remaining lipid film was rehydrated in reconstitution buffer (20 mM HEPES, 140 mM
NaCl, 5% (w/v) glycerol, pH 7.5) by bath sonification for 5 min at room temperature. To
prepare homogenous large unilamellar vesicles, liposomes (10 mg/ml) were frozen in liquid
N2 and thawed at room temperature for five times, followed by extruding 11 times through a
400-nm polycarbonate filter (Avestin) with an Avestin mini-extruder. The liposomes were
diluted to 2.5 mg/ml in reconstitution buffer and titrated with Triton X-100 until light
scattering at 540 nm reached maximum and started to decrease. The Triton X-100-destabilized
liposomes were mixed with the purified protein in a mass ratio of 40:1 (the volume ratio of
9:1), and incubated for 30 min at 4 °C under gentle agitation. For detergent removal, 40 mg/ml
(wet weight) polystyrene beads (Bio-Beads SM-2; Bio-Rad) washed with methanol and water
and equilibrated with reconstitution buffer were added successively four times (1 h, O/N, 2
times 2 h at 4 °C). A Bio-spin column (Bio-Rad) was used to remove Bio-Beads, and
proteoliposomes were pelleted by centrifugation (300,000×g, 45 min, 4 °C). Finally,
proteoliposomes (5 mg/ml lipids) were resuspended in reconstitution buffer.
3.5.10 Freeze fracture electron microscopy
Proteoliposome preparations were placed between two small copper disks and rapidly frozen
in liquid ethane. Replicas were prepared in a freeze fracture unit (BAF 400T; Balzers) and
shadowed with platinum/carbon at an angle of 45°. Replicas reinforced by pure carbon were
cleaned from organic material in chromosulfuric acid and analyzed by a Philips EM208S
electron microscope. The experiment was performed by Dr. Winfried Haase (MPI of
Biophysics, Frankfurt)
3.5.11 ATPase activity assay
For measuring ATP hydrolysis, 1.25 μg of the digitonin-purified or reconstituted TAPL were
incubated in 25 µl elution (supplemented with 0.1% digitonin) or reconstitution buffer
supplemented with 2 mM ATP, 5 mM MgCl2, and inhibitors for other types of ATPases (1 mM
ouabain, 5 mM NaN3 and 50 µM EGTA) for 1 h at 37 °C. The reaction was started by additing
MgCl2 and terminated with 175 µl of 20 mM sulfuric acid (H2SO4). The concentration ofMethods
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inorganic phosphate (Pi) was determined by a colorimetric method (Baykov et al., 1988). 15
min after the addition of 50 μl of freshly prepared malachite green solution (0.096% (w/v)
malachite green, 1.48% (w/v) ammonium molybdate, and 0.173% (w/v) Tween-20 in 2.9 M
H2SO4), the absorbance was measured at 620 nm in 96-well plates. All measurements were
performed under conditions giving a linear rate of product formation (Pi). Calibration of free
phosphate concentration was carried out with Na2HPO4 (5–80 μM) in 200 μl of 20 mM
H2SO4.
3.5.12 Peptide transport assay
The peptide transport was performed either with fluorescein-labeled (Neumann and Tampé,
1999) or
125I-labeled peptides. For peptide transport, proteoliposomes (1.25 µg TAPL, 50 µg
phospholipids) were preincubated with 5 mM MgCl2 and 1 μM
125I-labeled or 3 µM
fluorescein-labeled peptides in PBS on ice. The transport was initiated by adding 3 mM ATP.
After incubation for 10 min at 37 °C, the transport was stopped by the addition of 200 µl of
ice-cold stop buffer (10 mM EDTA/PBS). Subsequently, the samples were transferred to a
microfilter plate (MultiScreen plates, Durapore PVDF membrane, 0.65-µm pore size;
Millipore) preincubated with 0.3% polyethyleneimine. Filters were washed twice with 250 µl
of ice-cold stop buffer. The amount of radiolabeled peptide was quantified by a γ-counter
(Beckman Coulter). If the fluorescent peptides were used, the washed filters were incubated
with 250 µl of 1% SDS/PBS for 5 min at room temperature. Fluorescent peptides were
quantified  by  a  fluorescence  plate  reader  (λex/em=485/520 nm; Polarstar Galaxy, BMG
Labtech). Background transport activity was measured in the absence ofATP.
When crude membranes were used for transport assay, the membranes (25 μg total protein)
containing TAPL were incubated with 5 mM MgCl2and radiolabeled or fluorescence labeled
peptide in 50 μl PBS for 3 min at 37 °C, in the presence or absence of 3 mM ATP. The rest of
experimental steps were as described above.
3.5.13 Peptide transport assay (glycosylation assay)
To investigate peptide transport into the endoplasmic reticulum (ER), a glycosylation based
assay was used. Crude membranes (100 μg of total protein) were incubated with 5 mM MgCl2
and 3 μM of fluorescence labeled peptide (RRYQNSTC
fL, where f indicates
iodoacetamidofluorescein coupled via a cysteine residue) in 50 μl PBS for 3 min at 37 °C, in
the presence or absence of 3 mM ATP. The reaction was stopped by adding 1 ml of ice-coldMethods
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stop buffer. After centrifugation at 20,000×g for 8 min at 4 °C, the membrane pellets were
solubilized in 850 μl of lysis buffer (50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 5 mM KCl,
1 mM CaCl2, 1 mM MnCl2 and 1% NP-40) for 15 min at room temperature. The insoluble
material was removed by centrifugation, and the supernatant was incubated with 50 μl
Concanavalin A (ConA)-Sepharose (50% (w/v), Sigma-Aldrich; washed twice with 500 μl
lysis buffer) for 1 h at 4 °C. The ConA beads were pelleted by centrifugation at 1500×g for
2 min at 4 °C and washed twice with 500 μl of lysis buffer. Finally, the glycosylated peptides
were eluted with freshly prepared 200 mM methyl-α-D-mannopyranoside/lysis buffer and
quantified with a fluorescence plate reader (λex/em=485/520 nm).
3.5.14 Co-immunoprecipitation
Membranes prepared from Sf9 cells (5 mg of total protein) containing Haf-Myc/Haf-9-His10
were solubilized in 1 ml of IP solubilization buffer (20 mM Tris/HCl, pH 7.4, 150 mM NaCl,
5 mM MgCl2, 1% proteinase inhibitor mix HP (Serva), 1% digitonin) for 60 min on ice.
Insoluble proteins were removed by centrifugation at 100,000×g for 45 min at 4 °C. An aliquot
of the solubilizate (500 μl) was incubated for 2 h at 4 °C with Dynabeads
® M-280 sheep
anti-mouse IgG (Dynal Biotech), which were preloaded with a mouse anti-Myc monoclonal
antibody (Millipore). As a negative control, Dynabeads
® loaded with a monoclonal MHC class
I-specific antibody (HC10) were used. Afterwards, the beads were washed three times with
1 ml washing buffer (20 mM Tris/HCl, pH 7.4, 150 mM NaCl, 0.1% digitonin), and finally the
precipitated protein was eluted with 30 μl of 1×SDS sample buffer (62.5 mM Tris/HCl, pH 8.0,
2% SDS, 10% glycerol, 0.1% bromphenol blue) for 20 min at 65 °C. Fractions from the
co-immunoprecipitation procedure were analyzed by immunoblotting using anti-His and
anti-Myc antibodies, respectively.
To prepare the antibody-coupled magnetobeads, 150 μl of the beads slurry were first washed
two times with 1 ml IP buffer (20 mM Tris/HCl, pH 7.4, 0.5% BSA, 150 mM NaCl, 5 mM
MgCl2), and then incubated with 10 μg anti-Myc antibody (in 500 μl IP buffer) or 500 μl of
HC10 for 2 h at 4 °C. After washing three times with 1 ml IP buffer, the beads were ready to
use.Results
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4 Results
4.1 Functional expression of TAPL
For the functional characterization and structural studies, human TAPL wild-type with a
C-terminal His10-tag or a Strep-tag II was heterologously expressed by baculovirus infection
(with a MOI of 2). The Sf9 cells were harvested 48 h after infection and crude membranes
were prepared. By BCA assay, around 150 mg of crude membrane proteins could be prepared
from 1 L of cell culture. The protein expression was detected by immunoblotting using a
TAPL-specific antibody. As a negative control, membranes from insect cells infected with
baculovirus encoding for tapasin had no cross-reaction (Figure 4-1A). Tapasin is a co-factor of
the MHC class I peptide-loading complex and does not bind or transport peptides (Koch et al.,
2004). Membranes containing TAPLshowed an ATP-specific transport of fluorescence-labeled
peptide RRYC
fKSTEL (Figure 4-1B), indicating that the expressed TAPL was functional. As
expected, tapasin-containing membranes did not show peptide transport.
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Figure 4-1. Functional expression of TAPL. A, expression of TAPL. Membranes (7.5 μg of total protein) derived
from insect cells infected with baculovirus-TAPL-His10 or baculovirus-tapasin were analyzed by immunoblotting
with an epitope-purified anti-TAPL polyclonal antibody. B, TAPL-specific transport. Membranes (25 μg of total
protein) were incubated with 3 μM fluorescein-labeled RRYC
fKSTEL (where f represencts fluorescein coupled
to cysteine) and 5 mM MgCl2 in PBS for 3 min at 37 °C, in the presence or absence of 3 mM ATP. After
stopping the reaction and washing, membranes were solubilized by 1% SDS, and fluorescent peptides were
quantified with a fluorescence plate reader (λex/em=485/520 nm). The experiments were performed in triplicate.
Error bars, S.D.Results
55
4.2 Solubilization of TAPL
Since biological membranes are very complex, detailed functional analysis of membrane
proteins and intracellular transport processes are extremely difficult. Therefore, purification
and reconstitution of membrane proteins are required and form a challenging task. It is of
utmost importance to decipher the substrate specificity of the lysosomal transporter TAPL,
since it is connected to its physiological function. Due to the high background and side
reactions, it was impossible to resolve the substrate specificity in crude membranes. Therefore,
a solubilization and reconstitution procedure was developed for thisABC transporter.
Since solubilization by detergent is a critical step in membrane protein purification, we first
screened for the optimal detergent for TAPL by comparing the solubilization efficiency of the
mild nonionic detergents digitonin, DDM, DM, OG, and Triton X-100 as well as the
zwitterionic detergents Fos-14, CHAPS, and Zwittergent 3-12. TAPL was extracted from
crude membranes with a detergent concentration equivalent to a ρ value of 2. After 30-min
incubation on ice, insoluble material was removed by centrifugation. Solubilization
efficiencies of different detergents were analyzed by SDS-PAGE and immunoblotting using a
TAPL-specific antibody. The solubilization was normalized by the TAPL signal derived from
SDS-treated crude membranes (Figure 4-2). Fos-14 showed the highest solubilization
efficiency (112%), followed by Zwittergent 3-12 (65%), Triton X-100 (65%), digitonin (56%),
DDM (52%), CHAPS (40%), DM (34%), and finally OG (13%). Since detergent-solubilized
membrane proteins can denature and aggregate over time, I tested the stability of TAPL after
60 h of storage at 4 °C in the detergent containing buffers. After removing the aggregates by
centrifugation, soluble TAPL was analyzed by SDS-PAGE and immunoblotting (Figure 4-2).
TAPL stored for 60 h in digitonin, DDM, DM, Triton X-100, and Fos-14 did not precipitate,
since the immunoblotting signal stayed constant over time. However, in the presence of OG,
CHAPS, and Zwittergent 3-12, roughly 50% of the solubilized TAPL precipitated and could
not be detected in the soluble fraction over the same period.Results
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Figure 4-2. Solubilization and stability of TAPL. A, crude membranes (M) from insect cells (1.0 mg of total
protein) were solubilized in 200 µl of solubilization buffer supplemented with detergents (ρ=2) and proteinase
inhibitors. After solubilization for 30 min on ice, the supernatant (0h) was collected after centrifugation (1 h;
100,000×g), stored for 60 h at 4 °C, and centrifuged again, resulting in the second supernatant (60h). Equal
amounts of crude membranes solubilized in 1% SDS and both supernatants were analyzed by SDS-PAGE (10%)
and subsequent immunoblotting using a TAPL-specific antibody. B, immunoblotting signals were quantified by
chemiluminescence. The signals were normalized to the solubilization efficiency of crude membrane with 1%
SDS. Filled and open bars symbolize TAPL in the supernatant after 0 and 60 h of solubilization. TX-100, Triton
X-100; Fos-14, Foscholine-14; Zwitt 3-12, Zwittergent 3-12.
Previously, some detergents were reported to disrupt membrane protein complexes (Herget et
al., 2007); therefore, the existence of TAPL homologous complex in the presence of the
stability-preserving detergents was analyzed by co-expression of TAPL with a C-terminal
His10-tag (TAPL-His) and TAPL with a C-terminal Strep-tag II (TAPL-Strep) in Sf9 insect
cells. TAPL was then solubilized using different detergents and isolated via the His10-tag. Due
to the low affinity of His10-tag to Ni-NTA agarose beads (Qiagen), high amount of TAPL was
lost in the flow-through and washing steps. Importantly, TAPL-Strep could be co-precipitated
with TAPL-His in the presence of Triton X-100, DDM, DM and digitonin, whereas
Foscholine-14 appeared to disrupt the TAPL complex (Figure 4-3). For further studies,
digitonin and DDM were used to extract TAPL from Sf9 crude membranes, because it had
high solubilization efficiency, preserved the homologous complex, and in particular, restored
peptide transport activity after reconstitution (see below). Triton X-100 solubilized TAPL did
not show any activity, but was used to mediate the reconstitution procedure as described later.
Besides that, Triton X-100 had high absorbance at 280 nm, which is problematic for
purification with FPLC
TM system, therefore, no detailed trails was made for this detergent.Results
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Figure 4-3. Pull down assay via His10-tag. Membranes (1 mg of total protein) containing TAPL-His/TAPL-Strep
were solubilized with different detergents (ρ value of 2) and purified with Ni-NTA agarose (Qiagen) or Zn-IDA
(GE-healthcare) in the case of DDM. Fractions (1:100 aliquot) of the membrane (M), the solubilizate (S), the
flow-through and the eluate (E) were separated by SDS-PAGE (10%) and analyzed by immunoblotting against
the Strep-tag II using Strep-Tactin HRP. * represents cross reactivity.
4.3 Purification of TAPL
Multistep protein purifications suffer from the drop of protein recovery with each step and, in
addition, the protein can be inactivated by surface interactions. Therefore, I established a
gentle two-step method. First, impurities were removed by a cation exchange chromatography
without binding TAPL. Second, the flow-through from this step was loaded onto a
Zn
2+-iminodiacetate matrix, in which TAPL is specifically bound via its C-terminal His10-tag.
After stringent washing with up to 100 mM imidazole, TAPL was eluted with 250 mM
imidazole (Figure 4-4). By this procedure, a yield of about 500 µg/L cell culture of highly
purified TAPL was obtained.Results
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Figure 4-4. Purification of TAPL. A, Coomassie staining and immunoblotting. Crude membranes (M) from insect
cells (5 mg/ml) were solubilized in 1% digitonin. After centrifugation, the supernatant (S) was cleared from
contaminations by a cation exchange chromatography (SP Sepharose
TM Fast Flow), whereas TAPL was
recovered (80–90%) in the flow-through (FT1) as determined from immunoblotting signal quantification. In the
second step, FT1 was applied to a Zn
2+-iminodiacetate affinity chromatography. TAPL was not detected by
immunoblotting in the flow-through (FT2) but rather in the eluate (E) with a recovery of ~50% from the
solubilized TAPL. From fractions M, S, FT1 and FT2, 5 μl sample (aliquot of 1:6,000) was loaded for
SDS-PAGE separation and immunoblotting, whereas 10 μl sample (aliquot of 1:1,000) from the eluate was
loaded. For Coomassie staining, 3 μg purified TAPL was loaded. B, FPLC
TM chromatogram of affinity
purification via His10-tag. The 1 ml HiTrap
TM Chelating HP column was first washed by a linear imidazole
gradient (20–100 mM) of 20 column volumes, followed by another 20 column volumes of washing with constant
100 mM imidazole. Finally, TAPL was eluted by 10 column volumes of 250 mM imidazole. The flow rate for
loading was 0.5 ml/min, and 1 ml/min for washing and eluting. The imidazole gradient is depicted in red and the
chromatogram at 280 nm in blue.Results
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4.4 Oligomeric status
Some ABC transporters seem to form also higher oligomers. For example, the full transporter
CFTR was reported to form monomeric (Marshall et al., 1994; Chen et al., 2002; Haggie and
Verkman, 2008), dimeric (Eskandari et al., 1998; Li et al., 2004) or larger complexes
(Ramjeesingh et al., 2003) in the membranes even though its minimal functional unit is a
monomer (Ramjeesingh et al., 2001). Moreover, the multidrug resistance-associated
transporter ABCG2 which is considered to be a half transporter and forms a homodimer, can
be detected also in higher oligomeric states (McDevitt et al., 2006; Xu et al., 2007). To
investigate the oligomeric status of TAPL, two strategies were employed: gel filtration and
blue native PAGE. The gel filtration was performed in elution buffer supplemented with 0.1%
digitonin. On Superose
TM 6 PC gel filtration column, the slightly concentrated TAPL
(0.3 mg/ml) showed one peak which is almost monodisperse at 1.53 ml (Figure 4-5A). This
peak was correlated with TAPL as shown by immunodetection (Figure 4-5B). The peak at
1.75 ml could be small amounts of impurities and digitonin micelles which are supposed to
have slight light scattering at 260 nm as well as 280 nm. The soluble protein standards were
applied in the same conditions and used to compare the hydrodynamic radius with TAPL as
described in the method parts (3.5.7). The void volume (Vo) of the column was determined by
blue dextran (around 2,000 kDa) to be 0.85 ml, whereas the protein standard thyroglobulin
(669 kDa) was eluted at 1.28 ml, apoferritin (443 kDa) at 1.45 ml, β-amylase (200 kDa) at
1.56 ml and BSA (66 kDa) at 1.69 ml. Based on these soluble standard proteins (Figure 4-5A
inset), the size of TAPL was determined to be similar as the size of a soluble protein of
200 kDa, which was ~20% higher than the theoretical molecular weight of homodimeric TAPL
calculated from the amino acid sequence, i.e. 172 kDa. When TAPL was further concentrated
to 3 mg/ml, the main peak was still at 1.53 ml, but two additional small peaks at 0.89 (void
volume) and 1.15 ml (>1700 kDa) appeared (Figure 4-5C). On Coomassie stained SDS-PAGE
gel (Figure 4-5D), TAPL showed very high purity in every gel filtration fraction. Therefore,
these two additional peaks indicated the formation of aggregates or higher oligomers.Results
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Figure 4-5. Oligomeric state of TAPL analyzed by gel filtration chromatography. A, gel filtration chromatogram
of TAPL purified via IMAC. The eluate (15 μg, 0.3 mg/ml) from Zn-IDA column was applied on Superose
TM 6
PC 3.2/30 column, and eluted with elution buffer (20 mM HEPES, 140 mM NaCl, 250 mM imidazole, 15% (w/v)
glycerol, pH 7.5) supplemented with 0.1% digitonin. The flow rate was set to 50 μl/min. Fractions of 100 μl were
collected. The inset, protein standard curve was made as described in the methods part. The marker proteins
(20 μg for each protein) in use were thyroglobulin (669 kDa), apoferritin (443 kDa), β-amylase (200 kDa) and
BSA (66 kDa). The size of TAPL (indicated by the arrow) was estimated based on the linear regression of the
retention of the markers. Vo and Vt indicate the void volume and total column volume. B, immunodetection.
Aliquots (30 μl) from each fraction were analyzed by SDS-PAGE (10%) and immunoblotting using an
anti-TAPL antibody. C, gel filtration of concentrated TAPL. TAPL was concentrated to 3 mg/ml and 150 μg of
protein was applied to gel filtration as described above. D, Coomassie blue staining. An aliquot (25 μl) from each
fraction was subjected to SDS-PAGE (10%) followed by staining with Coomassie blue R-250.
The oligomeric status of TAPL was also studied by blue native PAGE (BN-PAGE), which can
be used for one-step isolation of protein complexes from biological membranes, total cells or
tissue homogenates, as well as for determining native protein masses, oligomeric states and
identifying physiological protein-protein interactions (Wittig et al., 2006). TAPL wild-type
purified in the presence of 0.1% digitonin was analyzed by BN-PAGE and stained with
Coomassie blue R-250. As a standard, bovine heart mitochondria (a kind gift from Prof. Dr.
Hermann Schägger and Dr. Ilka Wittig, Uni-Frankfurt) were solubilized with digitonin, and
loaded side by side with TAPL. Purified TAPL migrated roughly monodisperse with theResults
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similar migration rate as mitochondrial respiratory chain complex IV (200 kDa). The apparent
molecular weights were consistently determined to be 200 kDa in both gel filtration and
BN-PAGE. Together with the pull down data about TAPL forming complexes in the presence
of digitonin (Figure 4-3), the existence of monomeric TAPL can be ruled out. Therefore, it is
rational that digitonin-purified TAPL is a dimeric complex, although the micellar weight of
digitonin, the number of bound dyes and lipids are unknown. (Figure 4-6).
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Figure 4-6. Oligomerization of TAPL studied by BN-PAGE. Purified TAPL (7.5 μg) in the presence of 0.1%
digitonin was mixed with 5% Ponceau S solution and applied on BN-PAGE (4–13%). As markers, the respiratory
chain complexes of bovine heart mitochondria (100 μg, a kind gift from Prof. Dr. Hermann Schägger and Dr. Ilka
Wittig, Uni-Frankfurt) were used. The size and components of each complex were described in the original
protocol (Wittig et al., 2006).
4.5 Functional reconstitution of TAPL
Functional reconstitution of membrane proteins is a critical step depending on different
parameters. Therefore, I optimized TAPL reconstitution into liposomes composed of
Escherichia coli lipids for the highest transport activity with respect to the liposome
preparation, destabilization of liposomes, lipid-to-protein ratio, and detergent removal. The
substrate transport was determined with fluorescein-labeled peptide RRYC
fKSTEL (where f
represents fluorescein coupled to cysteine) in the presence or absence of 3 mM ATP at 37 °C
(Figure 4-7A). The highest transport activity was obtained using large unilamellar liposomes
(diameter≤400 nm), destabilized by Triton X-100 to the point slightly beyond the maximal
light scattering (Rsat) (Figure 4-7B), a lipid-to-protein ratio of 40:1 (w/w), and removal of
detergents by serial addition of polystyrene beads. The membrane insertion of TAPL was
confirmed by freeze-fracture transmission electron microscopy (performed by Dr. Winfried
Haase, MPI of Biophysics, Frankfurt), by which membrane incorporated particles are visible
only after reconstitution of TAPL(Figure 4-7C).Results
62
A
C
100 nm
0
100
200
300
400
500
p
e
p
t
i
d
e
t
r
a
n
s
p
o
r
t
(
p
m
o
l
m
i
n
-
1
m
g
-
1
)
ATP
ATP
+
-
B
0 2 4 6 8
0.0
0.1
0.2
0.3
0.4
0.5
Rsat
Rsol
Triton X-100 (mM)
O
D
5
4
0
A
C
100 nm
0
100
200
300
400
500
p
e
p
t
i
d
e
t
r
a
n
s
p
o
r
t
(
p
m
o
l
m
i
n
-
1
m
g
-
1
)
ATP
ATP
+
-
B
0 2 4 6 8
0.0
0.1
0.2
0.3
0.4
0.5
Rsat
Rsol
Triton X-100 (mM)
O
D
5
4
0
Figure 4-7. Functional reconstitution of TAPL. A, ATP-dependent peptide transport of reconstituted TAPL. 50 µl
of proteoliposomes (1.25 µg of TAPL in E. coli lipids) in PBS were incubated with 3 µM fluorescein-labeled
peptide RRYC
fKSTEL and 5 mM MgCl2 in the presence or absence of 3 mM ATP for 10 min at 37 °C. After
washing, the proteoliposomes were solubilized by 1% SDS, and the fluorescent peptides were quantified by a
fluorescence plate reader (λex/em=485/520 nm). The experiments were performed in triplicate. Error bars, S.D. B,
Titration of preformed liposomes with Triton X-100. Liposomes (10 mg/ml) composed of E. coli lipids were
extruded through a 400 nm polycarbonate filter, diluted to 2.5 mg/ml with reconstitution buffer and exposed to
increasing Triton X-100 concentrations at room temperature. The turbidity of liposomes was measured by
absorbance at 540 nm. Rsat and Rsol indicate detergent concentrations at which liposomes were saturated and
solubilized. The arrow indicates the Triton X-100 concentration which was used to destabilize liposomes. C,
reconstitution of TAPL. After reconstitution via polystyrene beads, proteoliposomes were analyzed by
freeze-fracture electron microscopy (Dr. Winfried Haase, MPI of Biophysics, Frankfurt). The particles indicate
the incorporation of protein into the membranes.Results
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After reconstitution into proteoliposomes, TAPL showed almost the same transport activity as
in crude membranes, since the Michaelis-Menten constants (Figure 4-8) for the
fluorescein-labeled nonapeptide RRYC
fKSTEL (KM(pep)=10.5 ± 2.3 µM) and ATP
(KM(ATP)=97.6 ± 27.5 µM) were in a good agreement with those determined from crude
membranes (KM(pep)=6.8 ± 2.8 µM, KM(ATP)=17.6 ± 2.4 µM) (Wolters et al., 2005). The
maximal transport activity (Vmax) was determined to be 286.2 ± 18.3 pmol min
-1 mg
-1.
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Figure 4-8. Michaelis-Menten kinetics of reconstituted TAPL. A, peptide dependent transport activity. The
reconstituted TAPL (1.25 μg protein in 50 μg lipids) was incubated in PBS for 10 min at 37 °C with 5 mM MgCl2
and increasing concentrations of fluorescein-labeled peptide RRYC
fKSTEL, in the presence or absence of 3 mM
ATP. By fitting the ATP-dependent transport with the Michaelis-Menten equation, a KM(pep) of 10.5 ± 2.3 µM was
determined. A linear peptide uptake within the first 10 min at 30 μM peptide concentration is illustrated in the
inset. B, ATP-dependent transport activity. Peptide transport was followed under saturating peptide concentration
(20 μM), and a KM(ATP) of 97.6 ± 27.5 µM was determined. The data were fitted by the Michaelis-Menten
equation. The experiments were performed in triplicate. Error bars, S.D.Results
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4.6 Lipid activation of TAPL
The lipid composition is a critical parameter for the activity of reconstituted membrane
proteins. Therefore, I screened different lipid compositions. Since TAPL is expressed in
mammalian cells, I first compared the transport activity of TAPL reconstituted in liposomes
derived from lipid extracts of bovine heart, brain, and liver with E. coli lipids. Surprisingly,
TAPL was only active in E. coli lipids and not in any of the bovine lipid extracts (Figure
4-9A).
Since the E. coli lipid composition differs drastically from the phospholipid repertoire in
mammalian cells, I checked whether phosphatidylcholine, the most abundant phospholipids in
eukaryotic cells, was suitable for the functional TAPL reconstitution (DiRusso and Nystrom,
1998; van Meer et al., 2008). By mixing E. coli lipids with increasing concentrations of
synthetic DOPC, a bell-shaped curve for transport activity was detected with a maximal 3-fold
increase at 30% of DOPC compared with pure E. coli lipids. At DOPC concentrations higher
than 50%, the transport activity of TAPL was strongly decreased, whereas proteoliposomes of
pure DOPC were inactive in peptide transport (Figure 4-9B).
For two-dimensional crystallization as well as functional studies on the single-molecule level,
it will be beneficial to work with a defined lipid mixture of pure phospholipids. Therefore, I
reconstituted TAPL in liposomes containing a mixture of DOPC and either egg PG, DOPA,
DOPS, or DOPE at a fixed ratio of 9:1 (w/w). Peptide transport was detected in liposomes
containing DOPS or DOPA with a preference for DOPS (Figure 4-9C). Proteoliposomes
containing DOPE or PG were inactive in peptide transport. Next, TAPL activity in
proteoliposomes composed of different ratios of DOPS and DOPC was analyzed to find the
optimal phospholipid mixture (Figure 4-9D). TAPL activity showed a bell-shaped dependence
on the DOPS concentration with maximal transport at a DOPS/DOPC ratio of 1:1. These
results demonstrate that TAPL activity is dependent not only on the charge but also on the
specific head group of phospholipids.Results
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Figure 4-9. Lipid activation of TAPL. A, TAPL reconstituted in lipid extracts. The transport activity of TAPL
reconstituted in liposomes prepared from bovine heart, brain, or liver lipids or E. coli lipids. B,
phosphatidylcholine-dependent transport. TAPL was reconstituted in liposomes of E. coli lipids containing
increasing concentrations of DOPC, and the transport activity was quantified. C, reconstitution of TAPL in
liposomes of defined lipid composition. The transport activity of TAPL reconstituted in liposomes composed of
DOPC and either DOPA, DOPE, DOPS, or egg PG in a fixed ratio of 9:1 (w/w) was determined. For comparison,
the activity of TAPL reconstituted in E. coli liposomes is given. D, phosphatidylserine-dependent transport.
TAPL was reconstituted in liposomes composed of DOPC and increasing concentrations of DOPS, and the
transport activity was quantified. For comparison, the activity of TAPL reconstituted in E. coli liposomes is given.
The peptide transport was analyzed with 3 μM fluorescein-labeled peptide RRYC
fKSTEL for 10 min at 37°C.
For ATP-dependent transport, the background signal obtained in the absence of ATP was subtracted from the
fluorescence signal of peptide transport in the presence of 3 mM ATP. The experiments were performed in
triplicate. Error bars, S.D.Results
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4.7 Key positions for substrate recognition
TAPLhas a broad peptide length specificity, ranging from 6-mer peptides up to at least 59-mer
peptides (Wolters et al., 2005). Peptides are recognized via their backbone, the free N- and
C-terminus, and side chain interactions. To investigate the peptide specificity on the
single-residue level, I first focused on deciphering the key positions of the transported peptides.
Thus, single cysteine-containing derivatives of the antigenic peptide RRYQKSTEL were
labeled with 5-iodoacetamidofluorescein, which due to its size is expected to interfere with
peptide transport. The position-dependent effects of this bulky fluorophore on ATP-dependent
peptide transport can be grouped in four classes (Figure 4-10A): (i) peptides labeled on the N-
or C-terminal residue are not transported; (ii) the fluorophore at positions 2 and 3 interferes
with peptide transport, in comparison with (iii) positions 4–7, and (iv) fluorescein at position 8
shows no reduction of the transport rate compared with radioactive labeled peptide and does
not interfere with peptide transport.
In order to further investigate residues critical for substrate recognition by TAPL, peptide
transport was analyzed using
125I-labeled, totally randomized nonameric peptide libraries (X9),
which uncouples the studies from a specific peptide sequence context. In this combinatorial
peptide library, all naturally occurring amino acids except cysteine are equally distributed at
each position, as demonstrated by pool sequencing and mass spectrometry (Stevanovic and
Jung, 1993; Metzger et al., 1994; Wiesmuller et al., 1996). First, peptide transport of peptide
libraries with one D-amino acid at a given position was examined (Figure 4-10B). These
peptides differ only in the conformation of the side chain of this one residue in comparison
with all of the L-peptide libraries, allowing us to detect the influence of a single position on
transport. Peptide translocation was strongly impaired for peptide libraries with a D-amino acid
at the N- or C-terminal position. However, randomized peptides with D-amino acids on all
other positions except the N- and C-terminus showed transport rates comparable with the all
L-peptide library (X9). Notably, peptides with all D-amino acids are not transported by TAPL
(Wolters et al., 2005). Taken together, the data show that the N- and C-terminal residues are
crucial for peptide recognition by TAPL, whereas the internal amino acids form only minor
contacts with TAPL. Moreover, a bulky side chain at position 2 or 3 interferes with peptide
transport most likely by steric hindrance.Results
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Figure 4-10. Key position for peptide transport. A, peptide transport of fluorescein-labeled peptides.
Proteoliposomes containing TAPL (1.25 µg) were incubated in the presence or absence of 3 mM ATP with 3 µM
derivatives of the nonapeptide RRYQKSTEL, in which each position was subsequently substituted with cysteine
and labeled by iodoacetamidofluorescein. After 10 min incubation at 37 °C, transport was stopped, and the
ATP-dependent peptide transport was quantified by fluorescence intensity. B, peptide transport of combinatorial
nonapeptide libraries. TAPL-dependent transport was determined in the presence of 1 µM radiolabeled,
randomized peptide libraries containing one D-amino acid at a given position for 10 min at 37 °C. The
ATP-dependent transport was quantified by γ-counting. The experiments were performed in triplicate, and the
error bars show the S.D.
4.8 Sequence specificity of TAPL
To determine the amino acid preferences of the N- and C-terminal residues, we determined the
transport rates of randomized peptide libraries with a defined amino acid at either the N or C
terminus of the peptide (Figure 4-11). Importantly, in this analysis, all observed transport rates
were in the linear range and could be normalized to the transport of the totally randomized
peptide library (X9). In general, TAPL showed similar preferences for each of the termini.
Positively charged, long hydrophobic residues and the aromatic side chains of Phe and Tyr at
both positions are favored, whereas negatively charged residues as well as Asn and Met are
disfavored. The differences in transport rates of favored and disfavored amino acid residues
cover 2 orders of magnitude, and the differences are more pronounced for the C-terminal than
the N-terminal position.Results
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Figure 4-11. Transport activity of N- and C-terminal randomized nonameric peptide sublibraries.
125I-Labeled,
randomized nonapeptide sublibraries (1 µM) with defined N-terminal (A) or C-terminal (B) residues were
incubated with proteoliposomes containing TAPL (1.25 µg) in the presence or absence of 3 mM ATP for 10 min
at 37 °C. The ATP-dependent transport rates (ksub) were normalized by the transport rate (kX9) obtained with the
totally randomized peptide library X9. The experiments were performed in triplicate, and the error bars show the
S.D.
Since TAPL shows a broad length specificity ranging from 6-mer to at least 59-mer peptides, I
tested whether this recognition pattern is length-independent. To do so, I determined peptide
transport of a subset of randomized 6-mer peptide libraries with defined amino acids on the N-
or C-terminal end resembling favored, disfavored, or intermediate amino acids (Figure 4-12).
Strikingly, the pattern of preference in transport rates normalized by X6 library was veryResults
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similar to the 9-mer libraries. Again, positively charged and aromatic residues at both ends are
preferred, whereas negatively charged residues and Asn are disfavored. Moreover, as reflected
by the higher variation, the C-terminal residue of the X6 library has a stronger impact on
transport than the N-terminal residue, also agreeing with the results from the X9 library.
However, the polar Ser residue at either end is disfavored in the X6 library while favored in the
X9 libraries. In conclusion, the N- and C-terminal residues of the peptide constitute the key
residues independent of the peptide size with a distinct preference for positively charged and
aromatic amino acids.
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Figure 4-12. Transport of randomized hexameric peptide sublibraries.
125I-Labeled, randomized hexameric
peptide sublibraries (1 µM) with defined N-terminal or C-terminal residues were incubated with proteoliposomes
containing TAPL (1.25 µg) in the presence or absence of 3 mM ATP for 10 min at 37 °C. The ATP-dependent
transport rates (ksub) were normalized by the transport rate (kX6) obtained with the totally randomized peptide
library X6. The experiments were performed in triplicate, and the error bars show the S.D.
To investigate the influence of a single amino acid on each residue of a nonameric peptide, I
screened the transport efficiency of nonameric peptide libraries containing Arg or Asp at a
defined position, since these residues showed the strongest influence on transport selectivity
when present at either end (Figure 4-13). All peptide libraries containing Arg showed a higher
transport rate than the total randomized peptide library X9 (Figure 4-13A). Libraries with Arg
at positions 1–8 were similarly efficient, whereas Arg at the C-terminal position doubled the
transport rate in comparison with all other positions. The transport pattern of libraries
containing Asp was very different from the Arg-containing libraries. Asp at positions 1–3 and
especially position 9 disfavored transport (Figure 4-13B). A negative charge at the remainingResults
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positions had only minor influence on peptide transport. The libraries containing Asp at
position 4 or 8 exceeded slightly the transport rate of the X9 library. The peptide transport of
libraries containing Asp is reminiscent of the transport with the fluorescein-labeled peptides.
In conclusion, TAPL prefers positively charged amino acids with the strongest effect on the
C-terminal position, whereas negative charges at the three N-terminal positions or the
C-terminal position are disfavored.
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Figure 4-13. Transport of nonameric sublibraries containing Arg or Asp at defined positions.
125I-Labeled,
randomized peptide sublibraries (1 µM) containing Arg (A) or Asp (B) at a defined position were incubated with
proteoliposomes containing TAPL (1.25 µg) in the presence or absence of 3 mM ATP for 10 min at 37 °C. The
ATP-dependent transport rates (ksub) were normalized by the transport rate (kX9) obtained with the totally
randomized peptide library X9. The experiments were performed in triplicate, and the error bars show the S.D.
4.9 ATPase activity
An important mechanistic issue of ABC transporters concerns the stoichiometry between ATP
hydrolysis and substrate translocation, and whether both processes are strickly coupled under
physiological conditions. To specify the activity of purified or reconstituted TAPL, ATP
hydrolysis was measured. The ATPase activity was assayed by the release of the inorganic
phosphate from ATP, which was in a linear range for at least 1 h at 37 °C (Figure 4-14B inset).
In the assay, saturating ATP (2 mM) and peptide RRYQKSTEL (30 µM) concentrations were
used. No ATP regeneration system was included in the ATP hydrolysis assay to remove the
inhibitory product ADP since maximal 10% of total ATP was hydrolyzed. TAPL showed a
basal ATPase activity in both digitonin-solubilized and reconstituted states (Figure 4-14A,B),Results
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but no peptide stimulation was detected. It seems that the peptide transport activity and ATP
hydrolysis are not coupled. Importantly, the ATPase activity could be inhibited by 500 μM
sodium orthovanadate (inhibitor for ABC transporters and P-type ATPases). Vanadate is a
valid inhibitor of TAPL peptide transport with an IC50 value of 11.5 ± 1.0 μM. (Wolters et al.,
2005). The initial ATP hydrolysis rate for digitonin-solubilized TAPL was determined to be
45 ± 6 nmol min
-1 mg
-1, which was around six times lower than TAPL in the proteoliposomes
(v=268 ± 29 nmol min
-1 mg
-1). In order to ensure that the basal ATPase activity was TAPL
specific and did not refer to a copurified ATPase, the Walker A/H-loop mutant
TAPL-K545A/H699A (KAHA) was generated. Mutations of these conserved motifs abolish
the ATP hydrolysis and reduce ATP binding in ABC transporters (Holland and Blight, 1999;
Matsuo et al., 1999; Zaitseva et al., 2005a). This mutant showed no peptide translocation
activity (Figure 4-14C) and no ATPase activity when purified and reconstituted. Hence, the
ATP hydrolysis for the purified and reconstituted TAPL wt was TAPL specific. However, ATP
hydrolysis is not coupled with peptide transport. Therefore, determining the stoichiometry
between these two reactions is not meaningful.
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Figure 4-14. ATPase activity of TAPL. A, ATP hydrolysis of purified TAPL. Purified TAPL (1.25 µg) was
incubated with 2 mM ATP and 5 mM MgCl2for 1 h at 37 °C in the presence of elution buffer supplemented with
0.1% digitonin and ATPase inhibitors (1 mM ouabain, 5 mM NaN3 and 0.05 mM EGTA). The ATP
autohydrolysis was subtracted as background. The working concentration for sodium orthovanadate and peptide
RRYQKSTEL were 0.5 mM and 30 µM, respectively. B, the ATP hydrolysis of 1.25 µg reconstituted
TAPL wild-type (wt) or TAPL-K545A/H699A (KAHA) mutant was measured for 1 h at 37 °C, in the presence of
reconstitution buffer (20 mM HEPES, 5% (w/v) glycerol, 140 mM NaCl, pH 7.5) supplemented with 2 mM ATP,
5 mM MgCl2, and inhibitors for other ATPases. The same amount of liposmes incubated with ATP was used as
background control. The concentration of inorganic phosphate (Pi) was determined by a colorimetric method. C,
the reconstituted TAPL wt or KAHA mutant (0.625 µg protein) were tested for ATP-specific peptide transport.
Proteoliposomes were inbubated with 3 µM of fluorescent-labeled peptide RRYC
fKSTEL and 5 mM MgCl2 in
PBS for 10 min at 37 °C, in the presence or absence of 3 mM ATP. The transport activity was normalized to
TAPL wt. The experiments were performed in triplicate, and the error bars show the S.D.Results
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4.10 Functional solubilization and purification of TAPLby dodecylmaltoside
For structural studies, the digitonin extract from Digitalis purpurea is not suitable due to its
heterogeneity, aggregation even at 4 °C and high price. From the solubilization screen studies,
dodecylmaltoside (DDM) turned out to be a suitable detergent for TAPL solubilization.
However, when 1% DDM was used to solubilize and purify TAPL from Sf9 cell membranes,
no transport activity was observed after reconstitution. Therefore, the solubilization by DDM
was optimized in order to purify functional TAPL. The high detergent concentration usually
causes delipidation of membrane proteins. In order to reduce detergent amounts but still keep
relatively high solubilization efficiency, various concentrations (up to ρ value of 2) of DDM 
were used to extract TAPL from crude membranes. The extracted TAPL was quantified by
immunoblotting signal and compared with the membranes solubilized by 1% SDS (Figure
4-15). The solubilization of TAPL by DDM was concentration dependent. The maximum
solubilization was reached at 0.5% DDM (ρ=1.4). Interestingly, the solubilization efficiency
decreased at higher DDM concentrations. To prevent delipidation, 0.3% DDM (ρ=0.8) was
used for further solubilization tests since relative high amount (~40%) of TAPL could already
be solubilized at this concentration.
The solubilization efficiency of membrane proteins is also influenced by factors such as pH
value, protein concentration, ionic strength, and the presence or absence of chemical
‘chaperons’ such as glycerol and sucrose (Hunte et al., 2002). To analyze the influence of the
ionic strength on TAPL solubilization, membranes containing TAPL were solubilized with
0.3% DDM in the presence of increasing concentrations of NaCl. As indicated by
immunoblotting using an anti-TAPL antibody, the amounts of solubilized TAPL were NaCl
concentration dependent. The solubilization efficiency increased strongly at NaCl
concentration of 150 mM. The solubilization reached maximum at 150 mM NaCl, but reduced
slightly at higher NaCl concentrations (Figure 4-16).Results
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Figure 4-15. Solubilization of TAPL by various concentrations of DDM. A, the extraction of TAPL from Sf9 cell
membranes with DDM. TAPL-containing membranes (5 mg/ml total protein) were solubilized in solubilization
buffer supplemented with 1 mM PMSF, 2.5 mM benzamidine and increasing concentrations of DDM (up to ρ=2)
for 30 min on ice. After removing the insoluble proteins by centrifugation (100,000×g; 30 min), 3 μl aliquots of
supernatant were analyzed by 10% SDS-PAGE and immunoblotting using an anti-TAPL antibody. The
membranes solubilized with 1×SDS sample buffer (containing 1% SDS) served as reference. B, quantification of
immunoblotting signals normalized to the SDS solubilizate.
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Figure 4-16. Ionic strength-dependent solubilization of TAPL. The TAPL-containing membranes (5 mg/ml total
protein) were solubilized in solubilization buffer supplemented with 1 mM PMSF, 2.5 mM benzamidine, 0.3%
DDM, and increasing concentrations of NaCl. Subsequently, the insoluble proteins were removed by
centrifugation (100,000×g; 30 min), and 3 μl aliquots of supernatant were analyzed by SDS-PAGE (10%) and
immunoblotting using an anti-TAPL antibody.
After obtaining the optimized solubilization conditions (0.3–0.5% DDM and 150 mM NaCl),
TAPL was solubilized in the presence of 0.3% DDM and purified in two steps similar to theResults
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purification with digitonin. The presence of TAPL in each purification fraction was analyzed
by immunodetection using the anti-TAPL antibody. Around 50–75% (differs from batch to
batch) of TAPL could be recovered from the solubilizate. However, the purity of the eluate
was not as high as digitonin-purified TAPL as indicated in the Coomassie staining (Figure
4-17).
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Figure 4-17. Purification of TAPL by DDM. Crude membranes (M) from insect cells (5 mg/ml total protein)
were solubilized in 0.3% DDM. After centrifugation, the supernatant (S) was cleared from contaminations by a
cation exchange chromatography (SP Sepharose
TM Fast Flow), whereas TAPL was left in the flow-through (FT1).
In the second step, FT1 was applied to a Zn
2+-iminodiacetate affinity chromatography. Only small fraction of
TAPL (~10%) was detected by immunoblotting against TAPL in the flow-through (FT2). The purity of the eluate
(E) was indicated by Coomassie staining.
To investigate the oligomeric status of DDM-purified TAPL, gel filtration and BN-PAGE were
carried out. Comparing with the monodisperse peak of the digitonin-purified TAPL, the
DDM-purified TAPL showed two peaks on the gel filtration chromatogram (Figure 4-18A).
The first peak was in the void volume (Vo) of Superose
TM 6 column and might contain lipids
or impurities such as DNAsince the signal at 260 nm was slightly higher than 280 nm. Asmall
amount of aggregated TAPL was also present in the peak as indicated by Coomassie stained
elution fractions (Figure 4-18B). The second peak eluted at 1.53 ml was very broad and
asymmetric, containing mainly TAPL and impurities co-eluted. Similar as the
digitonin-purified TAPL, there was a shoulder peak at 1.74 ml, which could be light scattering
of DDM micelles and contaminated proteins. From the elution profile of soluble proteinResults
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standards, DDM-purified TAPL was estimated to have the same hydrodynamic radius as a
soluble protein of 200 kDa, which is slightly bigger (~20%) than the theoretical molecular
weight (172 kDa) of dimeric TAPL. Since the amount of bound DDM is not clear, the
DDM-purified TAPL could still be a dimeric complex considering the complex formation in
the presence of DDM (Figure 4-3).
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Figure 4-18. Oligomeric state of DDM-purified TAPL analyzed by gel filtration chromatography. A, gel filtration
chromatogram. TAPL (35 μg) was applied on a Superose
TM 6 PC 3.2/30 column, and eluted with elution buffer
supplemented with 0.05% DDM. The flow rate was 50 μl/min. Fractions of 100 μl were collected. The protein
standards from Sigma were applied according to the manufacturer’s instruction. Vo and Vt indicate the void
volume and total volume of the column. B, Coomassie blue staining. 25 μl aliquots from each fraction were
subjected to SDS-PAGE (10%) followed by staining with Coomassie blue R-250.
On BN-PAGE, DDM-purified TAPL showed almost monodispersity and migrated similarly as
respiratory chain complex IV (200 kDa), which was the same as the digitonin-purified TAPLResults
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(Figure 4-19). Taken together, TAPL forms homodimeric complex when purified in the
presence of DDM.
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Figure 4-19. Oligomerization of DDM-purified TAPL studied by BN-PAGE. Purified TAPL (7.5 μg) in the
presence of 0.05% DDM was mixed with 5% (w/v) Ponceau S solution and applied on BN-PAGE (4–13%). As
markers, the respiratory chain complexes of bovine heart mitochondria (100 μg, a kind gift from Prof. Dr.
Hermann Schägger and Dr. Ilka Wittig) solubilized with DDM were used. The size and components for each
complex was described in the original protocol (Wittig et al., 2006).
To confirm the function of DDM-purified TAPL, the same reconstitution procedure for
digitonin-purified TAPL was applied for ease of comparison, and the transport activity of the
reconstituted TAPL was tested. DDM-purified TAPL showed almost identical transport
activity (551.1 ± 16.4 pmol min
-1 mg
-1) as digitonin-purified one (431.3 ± 15.2 pmol min
-1
mg
-1) (Figure 4-20 and Figure 4-7A). Collectively, DDM is a suitable detergent for functional
solubilization and purification of TAPL from Sf9 cell membranes. Comparing with digitonin,
DDM is cheaper and more stable in solution, therefore, will facilitate crystallization and many
biophysical applications.
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Figure 4-20. Functional reconstitution of DDM-purified TAPL. The ATP-dependent peptide transport of
reconstituted TAPL. 50 µl of proteoliposomes (0.625 µg of TAPL in DOPC/E. coli lipids (3/7, w/w)) in PBS
were incubated with 3 µM fluorescein-labeled peptide RRYC
fKSTEL and 5 mM MgCl2 in the presence or
absence of 3 mM ATP for 10 min at 37 °C. After washing on a filter plate, proteoliposomes were solubilized by
1% SDS, and the transported fluorescent peptides were quantified with a fluorescence plate reader
(λex/em=485/520 nm). The experiments were performed in triplicate. Error bars, S.D.Results
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4.11 Functional expression of TAPLcysteine-less mutant and single cysteine mutants
An important tool to investigate the structure, dynamics and transport mechanism of TAPL is
to construct a functional cysteine-less (cys-less, C-less) mutant. TAPL contains 8 cysteines
(C19, C54, C59, C90, C233, C264, C458, and C548) which are localized in the putative
transmembrane helices (C19, C54, C59, C90 and C233), intracellular loops or stretches of the
TMD (C264 and C458) and the NBD (C548) (Figure 4-21). If residues were conserved in
mouse, rat and human, cysteines were replaced by alanines. Instead of alanine, residue C548
was replaced by valine because valine is found in mouse, rat and human TAP1 as well as
TAP2 at this position. TAPL cys-less was expressed with the baculovirus expression system.
After membrane preparation, the presence of TAPL cys-less was detected by immunoblotting
using the TAPL-specific antibody (Figure 4-23A, left panel), and the signals were quantified
(Table 4-1). The TAPL cys-less mutant had 65% expression level of TAPL wt. The function of
expressed TAPL cys-less was confirmed by the peptide transport assay using
fluorescein-labeled nonapeptide RRYC
fKSTEL (Figure 4-23B). TAPL cys-less showed 3-fold
higher transport activity than the wild-type in crude membranes. The Michaelis-Menten
constants of reconstituted (in E. coli lipids/DOPC (7/3, w/w)) TAPL cys-less for ATP
(KM(ATP)=224.8 ± 24.9 µM) and the fluorescein-labeled peptide RRYC
fKSTEL (KM(pep)=5.2 ±
0.6 µM) were in good agreements with those determined for TAPL wt. The maximal transport
rate (Vmax=2.7 ± 0.1 nmol min
-1 mg
-1) was found to be 10-fold higher than TAPL wt in E. coli
lipids which might be due to the optimized lipid composition too.
With the fully functional TAPL cys-less in hand, single cysteine residues were introduced in
strategic positions (Figure 4-22). Based on the topology model of TAPL, the mutated residue
S105C is in the luminal loop of TMD0-TAPL; S170C is in the cytosolic connection loop
between TMD0- and TMD1-TAPL (core-TAPL); M222C is in the luminal loop 1 of
core-TAPL; A264C is in the cytosolic loop 1 of core-TAPL; Y409C is in the putative
transmembrane helix 9; V465C is in the cytosolic stretch following transmembrane helix 10,
which belongs to the putative peptide-binding region; and L701C is close to the conserved
H-loop motif within the NBD. These residues are in the α-helical structures to have less
mobility.
TAPL single cysteine mutants were also expressed in Sf9 insect cells. The amounts of TAPL
single cysteine mutants in crude membranes were detected and quantified by immunoblotting
(Figure 4-23A, right panel), and the expression levels were compared with TAPL wt (Table
4-1). The expression level ranges from 20% (L701C) to 160% (S170C).Results
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Figure 4-21. Positions of intrinsic cysteines in TAPL wt. To generate TAPL cys-less, 8 intrinsic cysteines were
replaced by LCR based mutagenesis into alanines (C19A, C54A, C59A, C90A, C233A, C264A and C458A) or
valine (C548V). The cysteines are depicted with filled circles in the topology model.Results
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Figure 4-22. Positions of single cysteines introduced in TAPL cys-less mutant. 7 single cysteine mutants (S105C,
S170C, M222C, A264C, Y409C, V465C and L701C) were produced by LCR. The cysteines are depicted with
filled circles in the topology model.
In the peptide transport assay, most of the single cysteine mutants had the similar transport
activity as the wild-type, except for the mutant L701C which showed impaired transport
(Figure 4-23B). This mutant is close to H699 in the H-loop, and perhaps changes the local
structure of the H-loop. Collectively, TAPL cys-less mutant is active in peptide transport. The
generation of active single cysteine mutants is a starting point for site-directed labeling.Results
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Figure 4-23. Expression analysis and peptide transport activity of TAPL mutants. A, expression level of TAPL wt
and its mutants. Crude membranes (50 μg of total protein) containing TAPL wt or its mutants were solubilized in
1×SDS sample buffer and analyzed by SDS-PAGE (10%) and immunoblotting by an anti-TAPL antibody. The
immunoblotting signals were quantified by Lumi-Imager
TM F1and normalized to TAPL wt. The expression levels
were listed in Table 4-1. B, peptide transport of TAPL and its mutants. The peptide transport was performed with
a filter assay. Membranes (25 μg of total protein) were incubated with 3 μM fluorescein-labeled peptide
RRYC
fKSTEL and 5 mM MgCl2 in PBS for 3 min at 37 °C, in the presence or absence of 3 mM ATP. The
ATP-specific transport for each mutant was normalized by TAPL expression level and the transport activity of
TAPL wt. The experiments were performed in triplicate. Error bars, S.D.
Table 4-1 Expression of TAPL wt and its mutants
Constructs Expression level (%)
TAPL wt 100
TAPL C-less 65
S105C 42
S170C 160
M222C 133
A264C 25
Y409C 36
V465C 27
L701C 20Results
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4.12 Characterization of TAPLorthologs from Caenorhabditis elegans
There are three TAPL orthologs (Haf-2, Haf-4 and Haf-9) in C. elegans, among which Haf-4
and Haf-9 have the closest sequence identity (~38%) with TAPL. Both proteins were identified
as half ABC transporters with a similar architecture of N-terminal 8 putative transmembrane
helices followed by the NBD domain (Sheps et al., 2004), and reported to be involved in
intestinal granules formation (Bauer, 2006; Kawai et al., 2009). To further understand the
physiological role and interactions of Haf-4 and Haf-9, both half transporters were expressed
in Sf9 insect cells and characterized in terms of peptide transport and interaction.
4.12.1 Expression of Haf-4 and Haf-9 in Sf9 insect cells
The genes of Haf-4 and Haf-9 were cloned by PCR into pFastBac1 vector. For interaction
studies and detection, Haf-4 had a C-terminal Myc-tag, and Haf-9 had a His10-tag on its
C-terminus. Both proteins were expressed with the baculovirus expression system under the
control of the polyhedrin promoter. The Sf9 cells were harvested 48 h after infection (with a
MOI of 2) and crude membranes were prepared. The protein expression was identified using
immunoblotting against the terminal tags (Figure 4-24A). The apparent molecular masses for
both Myc-tagged Haf-4 (85 kDa) and His10-tagged Haf-9 (82 kDa) were slightly smaller than
the theoretical molecular weight (Haf-4-Myc, 90 kDa; Haf-9-His10, 92 kDa) on 10%
SDS-PAGE. Beside that, Haf-9-His migrates a little faster than Haf-4-Myc. Actrually, similar
phenomena were observed for other membrane proteins, for example, TAPL migrates at
around 70 kDa, which is much smaller than its theoretical molecular weight (85 kDa). This
phenomenon is reasonable for membrane proteins since incomplete denaturation by SDS
might occur (Rath et al., 2009).
For co-expression, an equal amount of virus stock (MOI of 2 for each virus) was used for both
constructs. Interestingly, the co-expression of Haf-4 and Haf-9 caused significant increase of
expression for both proteins, suggesting that these two half transporters might stabilize and
interact with each other. When equal amounts of membranes from single expression and
co-expression were analyzed by immunoblotting against the C-terminal tags, Haf-4 expression
level was two-fold higher when co-expressed with Haf-9, whereas Haf-9 expressed five-fold
higher in the co-expression experiment (Figure 4-24B).
To compare the expression level of Haf-9 and TAPL, an anti-His antibody was used in the
immunoblotting since both proteins have His10-tags. From the quantitative immunoblotting,
TAPL and Haf-9 from Sf9 crude membranes had an immunoblotting signal ratio of 4:1Results
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(Figure 4-24C). The expression of Haf-4 and TAPL as well as Haf-4 and Haf-9 cannot be
compared directly due to different tags. Therefore, MRJ cells stably expressing Myc-tagged
TAPL KAHA mutant (generated by Irina Bangert) were used as a reference to compare the
relative expression of Myc-tagged Haf-4 and TAPL wt (Figure 4-24D). The same amounts of
Sf9 and MRJ cells were analyzed by immunoblotting. Haf-4 and TAPL KAHA had an
immunoblotting signal ratio of 1:1 analyzed by an anti-Myc antibody (Figure 4-24D, upper
panel). TAPL wt in Sf9 cells and TAPL KAHAin MRJ cells also had an immunobloting signal
ratio of 1:1 determined by the TAPL-specific antibody (Figure 4-24D, lower panel). By
comparing the relative expression of different tagged proteins, I concluded that Haf-4 and
TAPL had the same expression in Sf9 cells, and both proteins expessed 4-fold higher than
Haf-9.
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Figure 4-24. Expression analysis of Haf-4 and Haf-9. A, single expression of Haf-4 or Haf-9. Crude membranes
containing Haf-4-Myc or Haf-9-His were analyzed by SDS-PAGE (10%) and immunoblotting against different
tags. Membranes containing tapasin were used as a negative control. B, co-expression of Haf-4 and Haf-9.
Membranes containing Haf-4-Myc, Haf-9-His or Haf-4-Myc/Haf-9-His were analyzed by SDS-PAGE (10%) and
immunoblotting against Myc-tag or His-tag. Due to sensitivity reason, membranes containing 50 μg total
membrane protein was used for the anti-Myc blot, whereas 250 μg total protein was analyzed in the anti-His blot.
C, comparison of TAPL and Haf-9 expression. Membranes (50 μg of total protein) containing His10-tagged TAPL
and Haf-9 were analyzed by SDS-PAGE (10%) and immunoblotting against His-tag. D, comparison of TAPL
and Haf-4 expression. Sf9 cells and MRJ cells (7×10
5 cells) expressing Haf-4-Myc, TAPL wt and its KAHA
mutant were lysed in 1×SDS sample buffer and proteins were separated by SDS-PAGE (10%) followed by
immunoblotting against the indicated antibodies. The immunoblotting signal ratios were listed.
4.12.2 Haf-4 and Haf-9 are ATP-dependent peptide transporters
To understand the physiological functions of Haf-4 and Haf-9, it is essential to look for their
substrates. Since their human ortholog TAPL functions as a specific and ATP-dependentResults
83
peptide transporter, I investigated whether Haf-4 and Haf-9 could also transport peptide. The
crude membranes derived from insect cells infected with baculovirus coding for various
proteins were tested for transport by incubating with 3 mM ATP, 5 mM MgCl2 and 3 μM of
fluorescein-labeled peptide RRYC
fKSTEL for 3 min at 37 °C (Figure 4-25A). Haf-4, Haf-9
and co-expressed Haf-4/Haf-9 showed ATP-dependent transport as TAPL, however, the
transport (+ ATP) to background (- ATP) ratio was much smaller than for TAPL, indicating a
low transport activity for the given peptide. The membranes containing TAPL showed an
ATP-dependent transport rate of 145.2 ± 0.6 pmol min
-1 mg
-1 and a signal-to-background ratio
(SBR) of 19.6; Haf-4 membranes had a transport rate of 7.4 ± 1.0 pmol min
-1 mg
-1 and a SBR
of 3.6; Haf-9 membranes showed a transport rate of 4.1 ± 1.0 pmol min
-1 mg
-1 and a SBR of
1.7; membranes containing Haf-4 and Haf-9 had a transport rate of 7.5 ± 2.5 pmol min
-1 mg
-1
and a SBR of 2.5; membranes containing tapasin were not active in transport as expected.
Based on the expression level quantified by immunobloting (Figure 4-24C,D), Haf-4 and
Haf-9 have 20- and 9-fold lower transport activities than TAPL, respectively. Haf-4 is 2-fold
more active than Haf-9. Besides that, the co-expressed Haf-4 and Haf-9 show a decrease in
transport (4- and 5-fold lower than Haf-4 and Haf-9, respectively) when they exclusively form
heteromers (see below).
Since C. elegans is normally cultivated at 20–25 °C, I tested whether the transport activity of
Haf-4 and Haf-9 shows a temperature dependence distinct from TAPL (Wolters et al., 2005).
Therefore, the transport activities of TAPL, Haf-4 and Haf-9 at 37 °C and 25 °C were
compared (Figure 4-25B). Similar to TAPL which showed 60% reduced peptide transport at
25 °C compared to 37 °C, Haf-4 and Haf-9 also showed reduced transport (~25%) at 25 °C,
suggesting that physiological temperature of nematode is not optimal temperature for the
transport activity of Haf-4 and Haf-9 expressed in Sf9 insect cells.
In contrast to TAPL, of which transport is saturated after 3–4 min (Wolters et al., 2005), the
transport rates for Haf-4 and Haf-9 were still in the linear range within at least 10 and 20 min,
respectively (Figure 4-25C,D inset). Therefore, the following transport experiments were
performed for 10 min and 20 min for Haf-4 and Haf-9, respectively, to get a better
signal-to-background ratio.
The specificity of ATP-dependent transport was studied in detail using several nucleotides as
controls. The peptide transport of Haf-4 and Haf-9 was specifically driven by ATP hydrolysis
because the addition of ADP as well as non-hydrolyzable ATP analogues AMP-PNP and
ATPγS showed the similar background fluorescence as controls with apyrase or no nucleotideResults
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(Figure 4-25C,D). The peptide specificity of Haf-4 and Haf-9 dependent transport was
demonstrated by the competition of transport with a 200-fold excess of unlabeled competitor
peptide RRYQKSTEL (Figure 4-25E). In conclusion, Haf-4 and Haf-9 show ATP- and
peptide-specific transport.
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Figure 4-25. Peptide transports of Haf-4 and Haf-9. A, Haf-4 and Haf-9 specific transport. Membranes derived
from Sf9 cells (25 μg of total protein) containing TAPL, Haf-4, Haf-9, Haf-4/Haf-9 or tapasin were incubated
with 3 μM fluorescein-labeled peptide RRYC
fKSTEL and 5 mM MgCl2 in PBS for 3 min at 37 °C, in the
presence or absence of 3 mM ATP. B, temperature-dependent peptide transport. Two temperatures were tested
for peptide transport (37 °C and 25 °C). The transport was performed as described above, but the transport timeResults
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for TAPL, Haf-4 and Haf-9 were 3 min, 10 min and 20 min, respectively, to get better signal to background ratios
(also for the following experiments). C and D, ATP-dependent transport of Haf-4 (C) and Haf-9 (D). All kinds of
nucleotides or nucleotide analogues in the transport assay had a concentration of 3 mM, whereas the backround
transport activity was measured in the presence of apyrase (1 unit) or no nucleotide. E, peptide-dependent
transport. Transport was performed with 1 μM of fluorescein-labeled peptide RRYC
fKSTEL in the presence or
absence of 200 μM unlabeled competitor peptide RRYQKSTEL, and in the presence or absence of 3 mM ATP.
The experiments were performed in triplicate. Error bars, S.D. The insets indicate that the transport was
measured in the linear range.
The weak transport of Haf-4 and Haf-9 could be caused by the retention of both transporters in
the ER and the resulting peptide export from microsomes. However, glycosylation traps
peptides in the ER (Koopmann et al., 2000). In order to get a hint of Haf-4 and Haf-9
localization, a glycosylation transport assay was performed for Haf-4, Haf-9 or both proteins
co-expressed, and TAPL served as control. The peptide used in the glycosylation assay was
RRYQNSTC
fL (NST is a glycosylation sequence) which could be purified via the ConAbeads
after glycosylation in the ER lumen. Haf-4, Haf-9 or co-expressed proteins had weak transport
in this assay. In comparison with transport rates in the direct transport assay, Haf-4, Haf-9 and
co-expressed proteins showed 30-, 110- and 30-fold decreased transport, respectively, which is
similar to the lysosomal transporter TAPL (50-fold decreased transport in the glycosylation
assay). Since peptide glycosylation only happens in the ER compartment, the results indicate
that most of Haf-4, Haf-9 and co-expressed proteins are not localized in the ER of Sf9 cells
(Figure 4-26). The slight transport activities might come from transporters which are
synthesized in the ER but haven’t trafficked to the other subcellular compartments.
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Figure 4-26. ER-specific transport. Membranes (100 μg of total protein) containing Haf-4, Haf-9 or both proteins
co-expressed were incubated with 5 mM MgCl2 and 3 μM fluorescein-labeled peptide RRYQNSTC
fL for 3 min
at 37 °C, in the presence or absence of 3 mM ATP. The glycosylated peptides were pulled down by 50 μl ConA
beads as described in the Methods part. For a negative control, membranes containing TAPL were treated in the
same way. The data represent the average of triplicate measurements and the error bars show S.D.Results
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4.12.3 Interaction between Haf-4 and Haf-9
Since Haf-4 and Haf-9 were predicted half transporters and found in the same cells and the
same compartment, the question whether they form homo- and/or heterodimers was raised.
The single expressed Haf-4 and Haf-9 were active in peptide transport, which could be an
indication for the homodimerization of these two half transporters. The interaction between
Haf-4 and Haf-9 was investigated by co-immunoprecipitation. Sf9 cell membranes containing
co-expressed Haf-4-Myc/Haf-9-His were solubilized with 1% digitonin and applied to
anti-mouse IgG magnetobeads coupled with a mouse monoclonal anti-Myc antibody. The
specific interaction between Haf-4 and Haf-9 was clearly proved by co-immunoprecipitation
of His10-tagged Haf-9 with the anti-Myc antibody coupled magnetobeads. The precipitation
was antibody specific since an unrelated antibody (monoclonal antibody HC10 against MHC
class I molecule) could precipitate neither Haf-4 nor Haf-9 (Figure 4-27). From signal
quantification on both anti-Myc and anti-His immunoblots, the signal ratios between the input
(the solubilizate) and eluate were identical (10:1). In conclusion, Haf-4 and Haf-9 seem to
form heteromers (likely heterodimers) exclusively when co-expressed.
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Figure 4-27. Co-immunoprecipitation of co-expreesed Haf-4/Haf-9. Sf9 cell membranes (2.5 mg of total protein)
containing co-expressed Haf-4-Myc and Haf-9-His were solubilized with 1% digitonin and applied onto
manetobeads coupled with an anti-Myc antibody. The beads were washed and eluted as described in the Methods
part. Fractions from the solubilizate (input, aliquot of 1/50) and eluate were analyzed by SDS-PAGE (10%) and
immunoblotting using antibodies against different tags. The magnetobeads coupled with a monoclonal antibody
against MHC class I (HC10) were used as a negative control (NC).Discussions
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5 Discussions
Based on systematic screens of various detergents for the solubilization as well as the
optimization of the purification and reconstitution procedures, I succeeded in the functional
reconstitution of the human lysosomal transport complex TAPL, a milestone for the research
on eukaryotic ABC transporters. In contrast to the multidrug transporters as well as the
lipid/cholesterol transporters reconstituted so far, TAPL transports hydrophilic peptides, which
are easily quantified and are also good targets for systematic modifications.
The functional reconstitution enabled me to decipher the substrate specificity of TAPL with
the help of combinatorial peptide libraries. The key residues are restricted to the N- and
C-terminal positions, of which the positively charged, aromatic and large hydrophobic amino
acids are preferred and the negatively charged residues as well as Asn and Met are disfavored.
Moreover, peptides with a positive net charge are favored in contrast to the negatively charged
peptides.
For studying the structure, mechanism and dynamics of TAPL during peptide transport cycle,
using biophysical methods such as EPR or FRET, TAPL cys-less and single cysteine mutants
were generated and characterized. Most of them are fully functional in terms of peptide
transport, therefore, could be subjected to spin or fluorescence labeling for further projects.
To understand the physiological functions of TAPLorthologs Haf-4 and Haf-9 from C. elegans,
both proteins were expressed in insect cells and characterized as ATP-dependent peptide
transporters. Moreover, for the first time, it was shown that both half transporters form
heteromers.
5.1 Solubilization, purification and reconstitution
5.1.1 Solubilization
A prerequisite for the analysis of substrate specificity was the solubilization, purification, and
reconstitution of TAPL. From the solubilization screen, digitonin and DDM were the most
powerful detergents with respect to efficiency, stability, and function of TAPL. OG, CHAPS,
and Zwittergent 3-12 showed low solubilization efficiency paired with strong destabilization
of TAPL. Short alkyl chain detergents and also zwitterionic detergents are beneficial for the
reconstitution because of their high critical micelle concentration. However, they often suffer
from the low solubilization efficiency as well as low long term stability of membrane proteins
(Seddon et al., 2004). Fos-14 was acceptable as regards to solubilization and stability butDiscussions
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disrupted the homodimeric peptide transport complex. This also has been reported for other
membrane proteins (Herget et al., 2007). A similar solubilization pattern was derived from
TAPLexpressed in Schneider cells (Ohara et al., 2008).
Digitonin was used for most of the substrate specificity studies, however, DDM was also
found to preserve TAPL function after proper optimization of the detergent concentration and
ion strength in the solubilization trials. Solubilization by DDM was concentration dependent,
the solubilization efficiency reached maximum at 0.5% DDM and decreased upon increasing
DDM concentrations. The observation was different from digitonin, of which the
solubilization efficiency stayed constant after reaching maximum at 1% digitonin (data not
shown). Moreover, the effects of NaCl concentration on solubilization were significant.
Solubilization efficiency was maximal at 150 mM NaCl, but reduced at higher concentrations.
The same was true for LacS, of which the reduced solubilization efficiency at high salt
concentration was due to protein aggregation (Knol et al., 1996). Remarkably, the activity of
reconstituted TAPL was strongly dependent on the DDM concentration used for solubilization.
Using 0.3–0.5% DDM for the solubilization of membranes, reconstituted TAPL showed the
same activity as TAPL purified in the presence of digitonin. However, TAPL solubilized with
1% DDM was inactive after reconstitution. Lower DDM concentrations might prevent the
strong delipidation by mimicing the effect of digitonin, which is believed to be less
delipidating during the solubilization of membranes (Wittig et al., 2006).
5.1.2 Purification
To obtain high purity of the transport complex required for biochemical and biophysical
studies with few purification steps, TAPLcontaining a C-terminal Strep-tag II or His10-tag was
generated (Wolters et al., 2005) to facilitate purification in one step. However, the
Strep-tagged TAPL did not bind to the Strep-Tactin Superflow matrix (IBA) tightly and the
purity was very low. For the His-tag affinity chromatography, different column resins from
various companies were tested and compared. TAPLdid not show high affinity for the Ni-NTA
agarose from Qiagen, but bound tightly with the HIS-Select
® Nickel Affinity Gel (agarose
beads, Sigma) and Hitrap
TM Chelating HP column (IDA(iminodiacetic acid)-agarose beads,
GE healthcare) loaded with Zn
2+. Zn
2+ is preferred for IDA column over Ni
2+ because it
significantly increases the affinity of TAPL on IDA column (data not shown). This might be
explained by the accessibility of His10-tag in the presence of detergent micelle since two
vincinal histidines are enough to bind Zn
2+, whereas Ni
2+ binds specifically to His-tagDiscussions
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(manufacturer’s instruction of IDA columns from GE healthcare). For ease of handling with
the FPLC
TM system, the prepacked Hitrap
TM Chelating HP column was used for purification.
After many trials on the optimization of single-step purification via the His10-tag, especially,
varying the imidazole concentration in the binding step and stringent washing with a high
concentration of imidazole, it was still difficult to achieve high purity. Therefore, the
combination of IMAC followed by anion exchange or affinity chromatography with
ATP-agarose was tested. However, the purity was still not improved by either of these
strategies. Moreover, TAPL was eluted at high salt concentration (500 mM NaCl) on strong
anion exchanger Q Sepharose
TM matrix (GE healthcare), which obviously was not a suitable
condition for the protein activity. TAPL did not bind to ATP-agarose tightly and ~85% of the
protein was lost in the flow-through and washing steps (data not shown).
Since TAPLtightly binds to the strong anion exchanger, I established a gentle two-step method.
First, impurities were removed by cation exchange chromatography because TAPL does not
bind to the cation exchange matrix, hence, the denaturation of TAPL by surface contacts as
well as its loss was minimized. In the second step, TAPLwas isolated to more than 95% purity
via IMAC. The cation exchange step was essential to remove background ATPase activity for
the precise quantification of TAPL-specific ATP hydrolysis. The purifications with digitonin
and DDM were performed in the same procedure but ended up with different purities.
Digitonin gave higher purity than DDM, and this difference might reside in the solubilization
of more contaminant proteins by DDM.
5.1.3 Reconstitution
The functional reconstitution of membrane proteins is a critical step depending on different
parameters. Therefore, I optimized TAPL reconstitution into liposomes for the highest
transport activity with respect to the detergent used in destabilization of liposomes,
lipid-to-protein ratio (LPR), detergent removal and temperatures.
The reconstitution procedure started with preparing large unilamillar liposomes by extruding
lipid suspension through a 400-nm filter. The preformed liposomes were then destabilized by
increasing concentrations of detergents. The destabilization process could be followed by
determining the turbidity of the suspension (Figure 4-7B). The solubilization of liposomes can
be subdivided into three distinct phases. In the first phase, the light scattering increases due to
the enlargement of liposomes by the incorporation of detergents into the phospholipid bilayer
until a saturated detergent concentration (Rsat) is reached. In the second phase, the lamellarDiscussions
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structures are disrupted and the mixed micelles of lipids and detergents start to form, resulting
in a drastic decrease of turbidity by increasing detergent concentrations. In the third phase, the
liposomes are completely solubilized and, consequently, the solution becomes optical
transparent. The detergent concentration at which liposomes are completely solubilized is
called Rsol (Paternostre et al., 1988). Liposome destabilization was essential for efficient
reconstitution of TAPL since a drastic reduction in the transport activity was shown when the
preformed liposomes were not destabilized. However, no significant difference in TAPL
activity was observed for Triton X-100 concentrations between Rsat and Rsol, indicating that the
total solubilization of liposomes was not beneficial. Similar observations were also made for
other membrane proteins including F0F1-ATPase from chloroplasts (Richard et al., 1990), the
glutamate carrier from B. stearothermophilus (Gaillard et al., 1996), the lactose transport
protein from S. thermophilus (Knol et al., 1996), and the erythrocyte membrane anion
exchanger, band 3 (Boulter et al., 1996). It is likely that Triton X-100 mediated the
unidirectional incorporation of TAPL into liposomes as for other membrane proteins.
For liposome destabilization, the mild detergents are preferred to prevent membrane protein
denaturation (Geertsma et al., 2008). It was also true for TAPL, when the digitonin-purified
protein was mixed with the OG-destabilized liposomes, no transport activity was observed,
which may be due to a reduced protein stability in OG. The peptide transport activities of the
reconstituted TAPL were preserved when Triton X-100, DDM or DM were used to destabilize
liposomes at a concentration slightly above Rsat. However, Triton X-100 gives the highest
activity among these detergents followed by DDM and then DM (data not shown). The distinct
activity of reconstituted TAPL mediated by different detergents could be explained by many
critical parameters of detergents: the partition into lipid bilayer, molecular shape and flip-flop
rate in the bilayer (Knol, 1999). Triton X-100 has a high degree of lipophilicity which is
consistent with its rapid equilibration in lipid bilayer and high flip-flop rate between the outer
and inner leaflets of membrane (le Maire et al., 1987; Kragh-Hansen et al., 1998). Based on
cryo-EM observations (Knol et al., 1998; Lopez et al., 1998), it has been speculated that Triton
X-100 has a molecular shape allowing lipid bilayer to exist over a broad range of detergent
concentrations without disrupting liposomes (Knol et al., 1998). This stability of Triton X-100
saturated liposomes makes membrane protein incorporation efficiently and unidiretionally
over a broad detergent concentration range. In contrast, detergents with the shape of inverted
cones (DDM and OG, may be also DM) partition into lipid bilayer very slowly and cause the
liposomes to form sheets at Rsat followed by long thread-like micelles at higher detergentDiscussions
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concentrations (Knol et al., 1998; Lambert et al., 1998). If membrane proteins only randomly
incorporate into the membrane sheets that are formed relatively slowly upon removing
detergents, unstable proteins might loss their activity and/or form aggregates (Groth and
Walker, 1996; Knol et al., 1996).
Once the best detergent has been determined, other parameters such as the lipid-to-protein
ratio (LPR), temperature, and detergent removal must be optimized. The activity of many
membrane proteins depends strongly on the lipid-to-protein ratio (Richard et al., 1990; Pitard
et al., 1996; le Coutre et al., 1997; Spooner et al., 2000). To study the factor of lipid-to-protein
ratio, the initial concentration of protein is very important. The higher this initial concentration
is, the lower is the amount of detergent brought with the protein into the equilibrated
lipid-detergent mixtures (Rigaud and Levy, 2003; Poolman, 2005), assuming free detergent
micelles (generally <50 kDa) are removed when concentrating via a 100 kDa-cutoff filter.
Therefore, the protein volume used for reconstitution was always 10% of the total lipid-protein
mixture. Proteoliposomes prepared at LPR of 20 (w/w) showed peptide transport. However, no
peptide transport was observed at a LPR of 200 (data not shown). Interestingly, no significant
difference in protein incorporation efficiency was observed for the above two LPRs as
analyzed by freeze-fracture EM (see below). TAPL activity decreased drastically upon
concentrating, suggesting TAPL aggregation may occur in the concentrating process. The
detailed studies on LPR were difficult since low LPR (<20 (w/w)) needs further concentrating
of proteins, resulting in complete loss of TAPLactivity (data not shown).
For some relatively stable membrane proteins, the standard protocol for reconstitution is the
incubation of proteins with destabilized liposomes for 30–60 min at room temperature
followed by successive additions of Bio-Beads to remove detergents at room temperature
and/or 4 °C (Pitard et al., 1996; Borths et al., 2005; Geertsma et al., 2008; Zehnpfennig et al.,
2009). The protein incorporation is improved by mixing the liposomes and protein at 20 °C
rather than 4 °C, which is probably related to increased fluidity of the lipid bilayer and/or a
change in micellar size (Hjelmeland, 1980; Knol et al., 1998; Knol, 1999). Therefore, different
temperatures (30, 25 or 4 °C) were tested for incubation of protein with destabilized liposomes.
Working in the cold room (4 °C) all the time gives higher transport activities and an increased
reproducibility (data not shown), indicating TAPL inactivation may happen at higher
temperatures. On the other hand, the detergent adsorption rate by Bio-Beads doubles every
12 °C, although the total binding capacity is independent of temperature (Levy et al., 1990;
Rigaud et al., 1997; Rigaud et al., 1998). However, the fast detergent removal could also beDiscussions
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harmful for the protein, if the detergent removal is faster than membrane insertion of the
protein. Therefore, Bio-Beads were added four times with a concentration of 40 mg/ml and
incubated for 1 h, overnight, 2 h and another 2 h at 4 °C for slow and complete removal of
detergents as well as preventing TAPLdenaturation.
Once the purified membrane protein has been mixed with detergent-destabilized liposomes,
subsequent controlled, slow removal of detergent is needed for the formation of tightly sealed
proteoliposomes. The detergent removal can be performed using different techniques: (i)
dilution; (ii) dialysis, (iii) gel filtration, or (iv) adsorption via polystyrene beads (Rigaud et al.
1995, 2003). The first two methods are mostly limited to remove detergents with high CMC.
The gel filtration is a rapid technique that sometimes causes incomplete and/or
inhomogeneous protein incorporation as well as heterogeneous size distribution of
proteoliposomes (Rigaud et al., 1998; Rigaud and Levy, 2003). To remove the mild and low
CMC detergents, such as DDM or Triton X-100, using polystyrene beads is a more efficient
way with sufficient reproducibility. A similar observation was also made for removing Triton
X-100 with dialysis, gel filtration (Sephadex G-50) and Bio-Beads in TAPL reconstitution
trials. TAPL showed almost no transport after removal of detergents with dialysis and gel
filtration, comparing with Bio-Beads adsorption. Moreover, proteoliposomes prepared with
Bio-Beads are tightly sealed (N. Kreissig, R. Tampé, and R. Abele, unpublished data), and
could be snap-frozen in liquid N2 followed by storage at -80 °C for couples of weeks, which
all facilitate the characterization of reconstituted TAPL.
Given the mammalian origin of TAPL, it was surprising that TAPL was inactive when
reconstituted in lipid extracts from bovine heart, brain, or liver but showed the similar activity
as in crude membranes when reconstituted in the E. coli lipid extracts. Although the activities
of TAPL are similar in the total and polar E. coli lipids, I prefer the polar extract due to easier
extrusion during the liposome preparation and high reproducibility. Whether the lack of
transport activity in bovine lipid extracts is due to the lipid composition, impurities in the
extract, or incomplete sealing of the liposomes was not further investigated. The addition of
DOPC to the E. coli lipids substantially increased the transport activity of TAPL. Hence,
phosphatidylcholine, which is the bulk phospholipid in most mammalian membranes, but
absent in E. coli (DiRusso and Nystrom, 1998; van Meer et al., 2008), seems to have a
stimulating effect on TAPL activity. Furthermore, introducing negatively charged
phospholipids to pure DOPC increased TAPL activity. However, this is not only due to the
negative charge of the lipid head group, since phosphatidylserine and phosphatidic acid areDiscussions
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preferred, whereas no transport is detected with PG.
Cholesterol is only found in eukaryotes, particularly in the animal plasma membranes,
lysosomes, endosomes and Golgi apparatus. The concentration of cholesterol is especially
high in the animal plasma membranes (20–30%) (Voet and Voet, 2004). Cholesterol can also
be included into phospholipid mixtures to provide greater stability and better impermeability
of the reconstituted proteoliposomes to ions and small polar molecules (Rigaud and Levy,
2003). However, the reconstitution in lipid mixtures containing DOPC and E. coli lipids doped
with 5–30% cholesterol or a mixture of cholesterol (10%) and sphingomyelin (20%)
resembling lysosomal lipid environment did not recover TAPL activity. TAPL appeared to be
aggregated but not incorporated into liposomes in the presence of cholesterol and
sphingomyelin since the transporter was found at the bottom of a sucrose gradient (10–45%
sucrose) after centrifugation (data not shown).
To confirm TAPL incorporation into liposomes, freeze-fracture EM was performed. The size
of proteoliposomes was heterogenous and smaller (mean diameter of 100 nm) than expected.
No difference in protein incorporation was observed when using different LPRs (200 or 20,
w/w). In general, only low incorporation was detected with a lot of empty liposomes. One
explanation for this data could be the low incorporation efficiency of TAPL into liposomes,
which is independent of LPR. Nevertheless, the theoretical protein molecules per liposome
would be 1 or 10 (LPR of 200 or 20, w/w), assuming the molecular weight for TAPL and
phospholipids of 172 kDa and 700 Da, respectively, the averaged liposome diameter of 100
nm and the lipid headgroup area of 0.7 nm
2. Therefore, it may be difficult to detect in each
liposome a TAPL molecule at the given LPR with freeze-fracture EM considering the presence
of slight protein aggregation during reconstitution, protein loss in EM sample treatment, and
visualization of only less than 50% of the surface of each liposome. Remarkably, in the
dual-color fluorescence-burst analysis (DCFBA) (using a LPR of 40), almost each liposome
was filled with fluorescent peptides in an ATP- and TAPL-dependent manner, indicating most
of the liposomes contained active TAPL (data not shown). In DCFBA, the cross-correlation
signal of a liposome doped with fluorescently labeled lipid analogs and a fluorescence-labeled
peptide is recorded.
5.2 Oligomeric status
Using the size exclusion chromatography and blue native PAGE, TAPL purified in the
presence of digitonin or DDM had the size of a dimer, which was consistent with theDiscussions
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homodimer formation confirmed by the pull down assay (Wolters et al., 2005), dihydrofolate
reductase protein-fragment complementation assay in SKOV3 cells (Leveson-Gower et al.,
2004) and cross-linking assay (Ohara et al., 2008). The dimerization region seems to be within
the TMD of core-TAPLsince the core-TAPLalso migrates at the size corresponding to a dimer
on BN-PAGE (data not shown).
Determining the oligomeric status of integral membrane proteins is notorious difficult since
the amount of associated detergents and lipids are usually unknown (Slotboom et al., 2008).
The mass ratios of detergent-to-protein are in the range of 1–5, depending on the volume ratio
of the hydrophobic and hydrophilic domains of membrane proteins (Yernool et al., 2003; Wei
et al., 2004; Bamber et al., 2006; Kunji et al., 2008; Slotboom et al., 2008). Moreover, in gel
filtration, water-soluble proteins do not bind to detergents (Wittig and Schägger, 2008) and the
elution volumes are not affected by detergents (Kunji et al., 2008). Therefore, gel filtration
using soluble protein standards is a low-resolution method for determining the molecular
weight of membrane proteins like TAPL, unless bound detergents are investigated carefully by
observing the hydrodynamic radii in detergent series (Bamber et al., 2006). In gel filtration,
the digitonin-purified TAPL had a single monodisperse species with a hydrodynamic radius
corresponding to a soluble protein of 200 kDa. The result shows only a 20% deviation from
the theoretical molecular weight (172 kDa) of TAPL dimer without any information of bound
detergents and lipids. The DDM-purified TAPL was not as pure as digitonin-purified protein
and showed a broad peak roughly corresponding to the same hydrodynamic radius as
digitonin-purified TAPL. Digitonin and DDM were reported to account for 80% and 70% of
mass of the yeast mitochondrial ADP/ATP exchanger, respectively (Bamber et al., 2006).
Therefore, it seems that 20% weight contribution of the bound detergents to detergent-TAPL
complex was underestimated. Remarkably, α-hemolysin from Staphylococcus aureus binds
less DDM (0.3 g/g protein) (Yernool et al., 2003). Moreover, the possibility that TAPL exists
as monomer in the presence of digitonin and DDM can be ruled out by the pull down assay of
different tagged TAPL (Figure 4-3). Thus, TAPL forms a dimer in the presence of digitonin
and DDM.
Determination of the molecular mass and oligomeric status by blue native PAGE also have
more than 10% error due to various amount of lipids and/or Coomassie blue dyes bound to
membrane proteins, although most of the bound detergents are replaced by Coomassie blue
during electrophoresis (von Jagow et al., 1977; Schägger et al., 1990; Heuberger et al., 2002;
Wittig and Schägger, 2008). For example, the respiratory chain complex III (~500 kDa) stillDiscussions
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binds 80–100 lipid molecules (56–70 kDa) after isolated chromatographically (Schägger et al.,
1990), and various amounts of dyes bind to the respiratory chain complexes (0.4, 0.35, 0.5 and
0.59 g/g for complex I, III, IV and V, respectively) after BN-PAGE (Wittig and Schägger,
2008). Moreover, some membrane transporters were reported to bind even higher amount of
Coommassie dyes (0.8 g/g) (Heuberger et al., 2002). Therefore, it is not surprising that the
determined apparent molecular weight (200 kDa) of TAPL dimer has 20% deviation from the
theoretical value. In some of the BN-PAGE trials, TAPL solubilized by digitonin did not only
form dimers but also higher oligomers. However, the formation of higher oligomers could be
an artifact caused by protein overexpression, solubilization conditions or different properties
among distinct batches of detergents. Interestingly, the Strep-tagged TAPL solubilized with
digitonin often shows the presence of different oligomers with dimers as the dominant
population, which is really puzzling to explain. The BN-PAGE of solubilized endogenous
TAPL from mammalian cells might help to address the oligomeric status of this ABC
transporter under physiological conditions. Nevertheless, BN-PAGE for endogenous TAPL
needs to be optimized in terms of solubilization and detection.
5.3 Substrate specificity
Based on the data presented herein together with our earlier study (Wolters et al., 2005), the
substrate specificity of TAPL has been deciphered. TAPL recognizes peptides via the N- and
C-terminal residues and also the free N- and C-termini. The sequence in between can be
highly variable in length and composition, allowing the translocation of a broad spectrum of
peptides by one transporter (Figure 5-1). Clearly, the C-terminal position has the strongest
effect on peptide selectivity, since modification at this position has the strongest impact on
transport activity. Moreover, the variability at this position is also higher than at the N-terminal
position. Positions 2 and 3 of the peptide seem to have minor effects on peptide selectivity.
Those positions had no influence in the D-amino acid scan, whereas fluorescein or aspartate at
these positions only marginally disfavored peptide transport. Since fluorescein as well as the
side chain of Asp are negatively charged at physiological pH, electrostatic repulsion can cause
decreased transport rates. Further electrostatic interactions appear to be responsible for the
preferred transport of positively charged peptides. Two scenarios can be considered: (i) the
environment of the peptide-binding pocket or the translocation pathway is negatively charged
and therefore favors positively charged peptides, or (ii) the negatively charged membrane
increases the local concentration of positively charged peptides in the vicinity of theDiscussions
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transporter, which partially explains the dependence of peptide transport on the concentration
of phosphatidylserine in the proteoliposomes.
N
H
H
H
C
O-
O
TAPL contact site
promiscuity
in sequence and length
key residue
key residue
TAPL contact site
+
N
H
H
H
C
O-
O
TAPL contact site
promiscuity
in sequence and length
key residue
key residue
TAPL contact site
+
Figure 5-1. Peptide recognition by TAPL. The key residues contacting TAPL are depicted in blue circles, and the
uncritical ones which are promiscuous in sequence and length are shown in line-filled circles.
Besides this global effect, there are also minor differences between the single positions. TAPL
shows some preference for peptides with an Asp at position 4. Moreover, a peptide with a
negatively charged fluorescein at position 4 is favored in transport. Therefore, it is feasible that
the negative charge at this position is counterbalanced by positive charged residues in the
peptide-binding pocket. Derived from the fluorescein scan, the second last position in the
peptide seems to have a high degree of freedom. It could be conceivable that the side chain at
this position does not stay in contact with TAPLbut points into the liquid-filled environment.
The selectivity of TAPL and the related heterodimeric antigenic peptide transporter TAP,
which share 40% sequence identity (Zhang et al., 2000), show a strong overlap. Not only free
N- and C-termini but also the key positions and selectivity principles are almost identical.
Moreover, the C-terminal residue shows the highest impact on peptide selectivity (Heemels et
al., 1993; Momburg et al., 1994; Uebel et al., 1995; van Endert et al., 1995; Gromme et al.,
1997; Uebel et al., 1997). However, there are distinct differences. Positions 2 and 3 of the
peptide are also critical for recognition by TAP (Hinshelwood et al., 1995; van Endert et al.,
1995; Uebel et al., 1997), whereas these residues have only a minor impact on TAPL
selectivity. The importance of positions 2 and 3 for selectivity of TAP is slightly dependent on
the method used for analysis. By peptide binding and competition assays, positions 2 and 3
show the same impact on TAP binding as position 1 (van Endert et al., 1995; Uebel et al.,
1997). However, by transport assays in semipermeabilized cells, which rely on trapping
peptides in the endoplasmic reticulum by glycosylation, minor effects of positions 2 and 3 forDiscussions
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peptide selectivity were detected (Neefjes et al., 1995).
TAPLtransports peptides with a broad length specificity ranging from 6- to at least 59-mer but
low affinity (Wolters et al., 2005). In contrast, TAP translocates peptides between 8 and 16
amino acids in length with high affinity, whereas 6-mer peptides are no substrate (Neefjes et
al., 1993; Androlewicz and Cresswell, 1994; van Endert et al., 1994). If the peptide selectivity
of TAPL results from the binding step, as shown for TAP (Androlewicz and Cresswell, 1994;
Neumann and Tampé, 1999; Gorbulev et al., 2001), the differences must reside in the binding
pocket. Based on peptide photocross-linking studies and truncation studies, the
peptide-binding region of TAP1 and TAP2 is localized at the cytosolic loop between
transmembrane helix 4 and 5 of the core complex (peptide-binding region 1 (PBR1)) and a
stretch of 15 residues C-terminal of the last transmembrane helix connecting the TMD with
the NBD (PBR2) (Nijenhuis and Hammerling, 1996; Ritz et al., 2001). The substrate-binding
pocket in the TAP complex seems to be formed between TAP1 and TAP2 subunits, since
peptides neither bind to nor are transported by single subunits (Meyer et al., 1994; van Endert
et al., 1994), although homodimers can be formed (Antoniou et al., 2002; Oancea et al., 2009).
Moreover, the asymmetry of the binding pocket restricts the orientation of the peptide, since
TAP2 alleles in rats determine the selectivity for the C-terminal residue (Heemels et al., 1993;
Powis et al., 1996; Wang et al., 1996). In contrast, TAPL forms a homodimeric complex,
which has no sequence-based asymmetry (Leveson-Gower et al., 2004; Wolters et al., 2005).
Interestingly, the putative PBR1 of TAPLshows a much higher sequence identity to TAP1 than
TAP2, whereas PBR2 is more homologous to TAP2 than TAP1. Based on the fluorescence
cross-correlation spectroscopy experiments with TAP (M. Herget, R. Tampé, and R. Abele,
unpublished data) and on the sequence comparison of both peptide transporters, I assume that
TAP contains one peptide-binding site formed mainly by PBR1 of TAP1 and PBR2 of TAP2,
whereas the two corresponding regions (PBR2 in TAP1 and PBR1 in TAP2) are inactive as
regards binding. On the other hand, TAPLcan bind one peptide simultaneously to each subunit,
since two active peptide-binding pockets are present. The different modes of peptide binding
could also explain the broader length specificity of TAPLin comparison with TAP.
5.4 ATPhydrolysis
To study the transport mechanism of TAPL, ATP hydrolysis was measured in the detergent
solubilized and reconstituted states. Reconstituted TAPLshowed 6-fold higher ATPase activity
than the digitonin solubilized form, suggesting lipids are important for keeping the function ofDiscussions
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this ABC transporter. Similar observations were also made for other ABC transporters. For
example, the ATP hydrolysis of ABCB1 (P-gp) and ABCC3 (MRP3) drastically increases (2–5
fold, depending on lipid compositions) in the presence of lipids (Lerner-Marmarosh et al.,
1999; Chloupkova et al., 2007). Lipid compositions might affect the function of TAPL by
changing the conformation or inhibiting the structural flexibility with curvature stress and/or
lateral pressure as proposed for other membrane proteins (Gruner, 1985; Cantor, 1997;
Lundbaek et al., 1997; Bezrukov, 2000; Curnow et al., 2004).
Peptide transport and ATP hydrolysis seem to be uncoupled for TAPL since no peptide
stimulation was detected. In contrast, TAP shows peptide stimulated ATP hydrolysis which is
2.8-fold over basal ATPase activity. The ATPase activity shows hyperbolic dependency on
peptide concentration (with Vmax of ~2 μmol min
-1 mg
-1). In addition, the Michaelis-Menten
constant for ATP hydrolysis (KM(pep)) directly correlates with the affinity constant (KD) for the
peptide, indicating a strict correlation between peptide binding and stimulated ATP hydrolysis
(Gorbulev et al., 2001). The maximal transport rate (Vmax) of TAPL was roughly calculated to
be ~0.3 nmol min
-1 mg
-1 (~0.05 peptide/min), which was in the same range of P-gp
(~110 pmol min
-1 mg
-1) and MRP1 (ABCC1, ~125 pmol min
-1 mg
-1), but one order of
magnitude lower than MRP3 (~4.7 nmol min
-1 mg
-1) (Dong et al., 1996; Mao et al., 2000;
Zehnpfennig et al., 2009). Comparing with the transport activity, the basal ATPase activity for
either purified (~45 nmol min
-1 mg
-1; 7.8 ATPs/min) or reconstituted TAPL (~270 nmol min
-1
mg
-1; 46 ATPs/min) was much higher. One explanation for the uncoupled ATP hydrolysis
could be that a lot of purified and reconstituted TAPL was not active in transport but can still
hydrolyze ATP. Nevertheless, the transport activity of TAPL could also be underestimated due
to unknown amount of incorrectly inserted protein after purification and reconstitution.
Notably, the uncoupled ATPase activity was also reported for other ABC transporters like P-gp,
BtuCD and Pdr5 (Al-Shawi et al., 2003; Borths et al., 2005; Ernst et al., 2008). Moreover,
completely coupled ATP hydrolysis and substrate transport (assuming 2 ATPs are hydrolyzed
per substrate) was only observed for the OpuA system (Patzlaff et al., 2003; Poolman, 2005).
More generally, the ATPase and transport rates differ by 1–3 orders of magnitude (Davidson
and Nikaido, 1990; Chen et al., 2001; Patzlaff et al., 2003; Borths et al., 2005).
On the other hand, the uncoupled ATPase activity was believed to be evolutionarily conserved
since a constant turnover of ATP induced conformational changes that always keep the
cytosolic substrate binding sites accessible (Al-Shawi et al., 2003; Ernst et al., 2008). Instead
of wasting energy, the basal ATPase activity was believed to keep the transporter in theDiscussions
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transport-competent state for rapid detoxification from the cells (Ernst et al., 2008). This
seems to be true for TAPL, since this transporter might serve as a vaccum cleaner to remove a
large variety of cytosolic peptides constantly and efficiently.
5.5 TAPLcys-less and single cysteine mutants
For studying the structure, dynamics and transport mechanism of TAPL, a TAPL cys-less
mutant was generated. TAPL cys-less had 3-fold increased peptide transport activity over
TAPLwt but consistent peptide transport kinetic constants for peptide and ATP. The functional
cys-less mutant is a basis for introducing single cysteines into strategic positions and an
optimal negative control for site-specific labeling reaction. Based on primary structural
alignment with Sav1866, TAPL single cysteine mutants were introduced into putative rigid
helical regions of TAPL cys-less. All single cysteine mutants were expressed by the
baculovirus expression system and characterized for peptide transport activity. The mutants in
the highly variable TMD showed similar activity as TAPL wt, however, the mutant L701C in
the NBD had impaired peptide transport. The latter is close to the conserved H-loop motif and
might interfere with ATP hydrolysis. Those functional single cysteine mutants are good
starting points for cysteine-specific labeling. The distance changes between two labels will
provide much information about the molecular dynamics during transport cycle. Besides
pulsed EPR measurements, chemical cross-linking and FRET can also be used to study TAPL
structural dynamics.
The strategy of site-directed labeling on single cysteines has been successfully applied to
study transport mechanism of several ABC transporters in detergent micelles and liposomes
(Borbat et al., 2007; Grote et al., 2008; Goetz et al., 2009; Grote et al., 2009). For example, the
conformational changes during transport cycle of the Gram-negative bacteria lipid A exporter
MsbA were investigated by pulsed dipolar EPR and fluorescence homotransfer (Borbat et al.,
2007). The distance distributions between single cysteines labeled with spin- or
fluorescent-probes revealed large-scale movements of MsbAhomodimer uponATP hydrolysis.
5.6 Haf-4 and Haf-9
Due to the high sequence identity with the peptide transporter TAPL, the intestinal half size
transporters from C. elegans, Haf-4 and Haf-9 were first analyzed for their peptide transport
activity. Haf-4, Haf-9 and both proteins co-expressed showed significant ATP-dependent
peptide transport when expressed in Sf9 insect cells. Nevertheless, the transport activities areDiscussions
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quite low comparing to TAPL for a 9-mer peptide. The explanation for the low activity could
be the different substrate specificity as TAPL, missing of important cofactors for their function
or distinct temperature requirements. The transport activities of Haf-4 and Haf-9 showed the
similar temperature dependence as TAPL. The physiological temperature of C. elegans (25 °C)
is not optimal for transport. Similar as TAPL, both transporters do not seem to localize in the
ER since almost no glycosylated peptide was detected in the transport assay, which fits well
with their lysosomal localization in C. elegans (Kawai et al., 2009). The slight transport
observed in the glycosylation assay could come from transporters which still reside in the ER.
The peptide transport activity of Haf-4 may contribute to the formation of the large intestinal
granules, as indicated by data from an inactive Walker A mutant (K539M). This mutant is
supposed to be ATP hydrolysis deficient and cannot rescue the phenotype in haf-4 deletion
mutant (gk240). Moreover, TAPL could rescue Haf-4 function in gk240 (Bauer, 2006).
Whether this is true for Haf-9 or not, needs to be clarified too.
Also similar to their human ortholog TAPL, Haf-4 and Haf-9 appear to form homodimers as
indicated by the peptide transport activities. However, they also interact heterologously. The
situation is similar to the two subunits of the TAP transporter, an active heterodimeric complex
formed by TAP1 and TAP2 (Powis et al., 1991; Spies and DeMars, 1991), whereas there are
also reports about TAP1 and TAP2 forming homodimers (Antoniou et al., 2002; Oancea et al.,
2009). Nevertheless, TAP1 or TAP2 alone is not active in peptide binding and transport
(Meyer et al., 1994). Remarkably, co-expressed Haf-4 and Haf-9 seem only form heteromers.
The heteromers have significantly decreased peptide transport. Therefore, the questions about
whether both Haf-4 and Haf-9 colocalize in the same granule, and if yes, what is the function
of the heteromers need to be answered by further experiments. It is likely that heterologous
interaction is a negative regulation mechanism for Haf-4 and Haf-9 function.
Haf-4 and Haf-9 from C. elegans were reported to be expressed in intestinal granules from
larval to adult stage, and required for the formation of enlarged non-acidic granules. In
addition to granule defects, other phenotypes such as reduced brood size, slow growth and
prolonged fececation cycles were also observed in haf-4 and haf-9 deletion animals. These
phenotypes are all attributable to intestinal granule defects since nutrients are not expected to
be supplied adequately. Therefore, Haf-4 and Haf-9-positive granules were speculated to be
involved in the storage and transport of nutrients including peptides. Haf-4 and Haf-9 may be
required for the normal growth and spermatogenesis at the larval stage; in adult stage, their
expressions may lead to the proper oogenesis (Kawai et al., 2009). More interestingly, Haf-4Discussions
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was shown as a functional ortholog of TAPL which restores the granule phenotype in haf-4
deletion aminal (gk240) and increases the life span of the animal under starving conditions
(Bauer, 2006). Together with the ATP-dependent peptide transport activity of Haf-4 and Haf-9
characterized in current project, I speculate that both half transporters are involved in
autophagy which is strongly induced by starvation (Finn and Dice, 2005). Notably, this
physiological function of TAPLorthologs may reflect the ancestral role of TAPL.Abbreviations
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6 Abbreviations
ABC ATP-binding cassette
ADP Adenosine-5’-diphosphate
AEBSF 4-(2-aminoethyl)-benzosulfonylfluoride
AMP Adenosine-5’-monophosphate
AMPPNP 5’-Adenylyl-β,γ-imidodiphosphate
ANS 8-Anilinonaphthalene-1-sulfonic acid
APS Ammonium persulfate solution
ATP Adenosine-5’-triphosphate
ATPγS Adenosine-5’-(γ-thio) triphosphate
BSA Bovine serum albumine
CFTR Cystic fibrosis transmembrane conductance regulator
CHAPS 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
CHO-K1 Chinese hamster ovary cells
ConA Concanavalin A
CPM Counts per minute
CTP Cytidine-5’-triphosphate
DCFBA Dual-color-fluorescence-burst analysis
DDM n-Dodecyl-β-D-maltoside
DM n-Decyl-β-D-maltoside
DMF Dimethylformamide
DMSO Dimethyl sulfoxide
dNTP Deoxyribonucleotides
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine
DOPE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
DOPS 1,2-dioleoyl-sn-glycero-3-phospho-L-serine
DOPA 1,2-dioleoyl-sn-glycero-3-phosphate
DTT 1,4-Dithiothreithol
ECL Enhanced chemilumiscence
EDTA Ethylenediaminetetraacetic acid
EEA1 Early endosomal antigen 1
eGFP Enhanced green fluorescent proteinAbbreviations
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Egg PG Egg L-α-phosphatidylglycerol
EGTA Ethyleneglycoltetraacedic acid
ER Endoplasmic reticulum
EPR Electron paramagnetic resonance
Fos-14 Foscholine-14
FRET Fluorescence energy transfer
GFP Green fluorescent protein
GTP Guanosine-5’-triphospate
HEK-293 Human embryonic kidney 293 cells
HEPES N-2-Hydroxyethylpiperazine-N’-2-ethanesulfonic acid
5-IAF 5-Iodoacetamidofluorescein
ICLs Intracellular loops
IMAC Immobilized metal affinity chromatography
IPTG Isopropyl-β-D-thiogalactopyranoside
LAMP Lysosome-associated membrane protein
LAMP-2A Lysosome-associated membrane protein 2A
LMP-1 LAMP homologue in C. elegans
LPR Lipid-to-protein ratio
MALDI-TOF Matrix-assisted laser desorption/ionisation-time of flight
MHC Major histocompatibility complex
MOI Multiplicity of infection
MOPS 3-(N-Morpholino)propanesulfonic acid
NAD Nicotinamide adenine dinucleotide
NBD Nucleotide-binding domain
NHS N-hydroxyl succinimide
Ni-NTA Nickel-nitrilotriacetic acid
OG n-Octyl-β-D-glucopyranoside
PA Phosphatidic acid
PBR Peptide-binding region
PDB Protein data bank
PG Phosphatidylglycerol
P-gp P-glycoprotein
PBS Phosphate-buffered salineAbbreviations
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PEI Polyethylene imine
Pfu Pyrococcus furiosus
PI-mix Protease inhibitor mix
PVDF Polyvinylidene difluoride
R9LQK RRYQKSTEL(peptide)
SEC Size exclusion chromatography
SBR Signal-to-background ratio
SDS Sodium dodecyl sulfate
Sf Spodoptera frugiperda
TAE Tris-acetate-EDTA
TAP Transporter associated with antigen processing
TAPL TAP-like
TAPLC-less TAP-like cysteine less
TAPLwt TAP-like wild-type
TBS Tris-buffered saline
TEMED N,N,N’,N’-Tetramethylethylene diamine
TFA Trifluoroacetic acid
TMD Transmembrane domain
TRICINE N-(Tri(hydroxymethyl)methyl) glycine
TRIS Tris(hydroxymethyl)aminomethane
UTP Uridine-5’-triphosphate
Zn-IDA Zinc-iminodiacetic acidReferences
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